Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
43055554	cb-be	mmol/l (mmol/l)	18120	61183	0.00%
43055554	cb-be	— (—)	12979	35849	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other acute lower respiratory infections

2916

13171

2.24

321.84

6.0

3.8

2.01

1.58

mmol/l

8.32

2247

9493

Substance abuse

2963

13488

2.21

320.62

4.0

3.4

1.78

1.54

mmol/l

2.33

2236

9798

Hypertensive heart and/or renal disease

1489

3923

3.20

317.23

5.6

3.1

1.72

1.94

mmol/l

1.17

1112

2978

Diseases of the respiratory system

2905

6448

2.34

316.47

3.9

2.7

1.86

1.20

mmol/l

15.21

2179

4471

Asthma (diagnoses ohter than nonallergic)

4178

19296

1.93

308.08

3.9

2.03

1.56

mmol/l

13.32

3149

14016

Substance abuse, excluding more controls

2963

11012

2.49

307.65

4.0

3.3

1.78

1.55

mmol/l

2.22

2236

7994

Other pulmonary diagnosis

3922

7678

2.67

307.65

3.9

2.6

1.89

1.18

mmol/l

23.64

2932

5328

Other heart diseases, wide

4506

13232

2.21

307.65

4.9

3.4

1.87

1.39

mmol/l

13.87

3361

9652

Aplastic and other anaemias

2689

10651

2.59

307.65

6.2

3.6

1.45

1.85

mmol/l

5.14

1967

7899

COPD

3123

8845

3.23

307.65

5.2

3.3

2.65

1.53

mmol/l

41.79

2525

6365

Cerebrovascular diseases (FINNGEN)

1473

3321

3.37

307.65

4.7

2.5

1.57

1.56

mmol/l

0.05

1092

2518

Implicit bacterial Sepsis

3098

7868

4.12

307.65

7.2

2.9

2.04

1.75

mmol/l

2.88

2387

5708

Dialysis

542

832

9.69

307.65

16.6

4.6

0.22

1.85

mmol/l

16.66

389

627

Diabetes, varying definitions

5463

14664

2.34

307.65

3.9

3.4

1.61

1.69

mmol/l

0.71

3963

10864

Benzodiazepine use

4899

18008

2.02

307.65

3.8

3.4

1.79

1.63

mmol/l

2.05

3742

13073

Insulin, combination of fast acting with intermediate-acting or long-acting

3733

14773

2.50

307.65

4.8

3.6

1.58

1.70

mmol/l

0.92

2661

10919

COPD, hospital admission 2, with asthma infections

2234

6564

3.25

307.65

6.0

3.3

2.89

1.58

mmol/l

42.10

1841

4682

Diarrhoea and gastroenteritis of presumed infectious origin

3603

15962

2.15

307.65

6.1

3.4

1.39

1.64

mmol/l

3.55

2616

11623

Persons encountering health services in other circumstances, wide

6229

16955

1.98

307.65

4.1

3.7

1.73

1.59

mmol/l

1.86

4498

12466

Cardiovascular diseases

2790

6066

2.61

307.65

6.1

3.4

1.45

1.15

mmol/l

4.23

2074

4282

Non-invasive ventilation

1400

2333

6.29

307.65

10.4

3.4

3.10

1.48

mmol/l

33.88

1235

1693

Obesity related asthma

2174

7029

3.43

307.65

3.8

3.4

2.12

1.65

mmol/l

6.97

1717

5209

Cardiovascular diseases (excluding rheumatic etc)

3110

6717

2.80

307.65

5.8

3.3

1.47

1.21

mmol/l

3.64

2299

4803

All pneumoniae

6478

16238

2.96

307.65

5.6

3.2

2.11

1.35

mmol/l

42.20

5011

11578

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

6282

16298

2.91

307.65

5.6

3.2

2.14

1.38

mmol/l

40.32

4854

11656

Chronic lower respiratory diseases

6011

17437

1.94

307.65

4.4

3.6

2.05

1.39

mmol/l

32.36

4580

12475

Heart failure, strict

4012

9968

3.22

307.65

5.7

3.2

2.49

1.54

mmol/l

32.12

3108

7311

General symptoms and signs

5716

13211

2.26

307.65

4.2

3.1

1.59

mmol/l

0.05

4239

9562

Hypothyroidism (congenital or acquired)

1103

1404

4.73

307.65

4.0

2.8

1.20

1.21

mmol/l

0.03

793

988

Dialysis, with operation codes

1375

2576

6.93

307.65

12.9

3.6

0.12

1.85

mmol/l

43.72

960

1932

Intestinal infectious diseases

4642

19097

1.97

307.65

5.5

3.4

1.44

1.66

mmol/l

3.46

3383

13960

Viral Sepsis

1441

3745

4.43

307.65

8.4

3.2

1.94

1.69

mmol/l

1.39

1112

2690

Diabetes, insulin treatment (Kela reimbursement)

5460

15516

2.26

307.65

3.9

3.4

1.61

1.73

mmol/l

1.30

3919

11564

Hypothyroidism, levothyroxine purchases

1072

1371

4.71

307.65

3.8

2.8

1.25

1.21

mmol/l

0.12

769

970

Other heart diseases

2539

5536

3.22

307.65

5.6

3.2

1.90

1.33

mmol/l

11.02

1937

4047

Explicit Sepsis

3087

9199

3.59

307.65

6.8

3.2

1.67

1.64

mmol/l

0.12

2333

6656

Continuous positive airway pressure

2795

2581

12.72

307.65

4.7

4.6

1.30

1.32

mmol/l

0.13

2222

1881

Early onset COPD

1459

4840

3.37

307.65

5.4

3.2

2.70

1.49

mmol/l

24.77

1183

3497

Diseases of oesophagus, stomach and duodenum

5290

16597

2.02

307.65

4.0

3.5

1.54

1.69

mmol/l

2.01

3950

12117

Antihypertensive medication - note that there are other indications

2693

5873

2.61

307.65

5.5

3.0

1.32

1.40

mmol/l

0.53

1964

4189

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1310

4122

3.39

307.65

3.3

3.0

1.37

1.48

mmol/l

0.43

989

2934

Any gastric operation

4219

8294

2.67

307.65

4.9

2.6

1.46

1.71

mmol/l

3.54

3105

5751

Concussion

2264

7064

2.91

307.65

3.8

4.4

1.64

1.58

mmol/l

0.33

1668

4991

Oxycodone

2310

7303

3.37

307.65

5.1

3.3

2.22

1.77

mmol/l

5.45

1827

5341

COPD related to multimorbidity

2629

8137

3.02

307.65

5.5

3.3

2.72

1.59

mmol/l

36.21

2120

5848

Heart failure and bmi 25plus

2440

6622

2.82

307.65

6.0

2.9

2.47

1.39

mmol/l

26.57

1952

4920

Obesity

3812

12556

3.27

307.65

3.7

3.4

1.83

1.56

mmol/l

3.84

2882

9159

Care involving dialysis

1077

1581

9.96

307.65

13.3

3.5

-0.18

1.62

mmol/l

35.48

764

1161

L04AD Calcineurin inhibitors

921

2383

4.66

307.65

14.8

4.2

0.51

1.60

mmol/l

15.31

632

1773

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5823

11801

3.33

307.65

5.3

2.8

2.14

1.38

mmol/l

34.67

4510

8339

Hypertension, essential

4069

8564

2.87

307.65

3.9

2.7

1.58

1.74

mmol/l

1.68

2976

6409

COPD differential diagnosis

3841

7734

2.60

307.65

3.8

2.6

1.90

1.17

mmol/l

24.34

2864

5378

Obesity due to excess calories

3128

9000

3.86

307.65

3.6

3.4

1.70

1.57

mmol/l

0.96

2350

6566

Other anaemias

2400

10020

2.49

307.65

5.5

3.6

1.56

1.85

mmol/l

2.58

1752

7411

5823

11801

3.33

307.65

5.3

2.8

2.14

1.38

mmol/l

34.67

4510

8339

Other diseases of the respiratory system

1697

4805

4.13

307.65

8.5

3.8

3.63

1.55

mmol/l

71.02

1494

3438

Asthma, excluding more controls

3663

6767

3.03

307.65

3.9

2.5

1.94

1.10

mmol/l

30.20

2749

4704

Tramadol

4069

10985

2.51

307.65

4.1

3.0

1.70

1.66

mmol/l

0.24

3027

7973

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5366

15880

2.43

307.65

6.2

3.2

1.47

1.66

mmol/l

3.00

3922

11648

Other bacterial diseases

6332

15496

3.06

307.65

5.8

3.1

1.80

1.63

mmol/l

2.43

4825

11259

Malaise and fatigue

2746

8948

2.73

307.65

4.3

3.3

1.86

1.70

mmol/l

1.16

2078

6517

Depression medications

1260

1385

4.78

307.65

3.0

2.2

1.45

1.31

mmol/l

0.57

938

965

Pneumonia, organism unspecified

6149

15068

3.20

307.65

5.7

3.2

2.15

1.37

mmol/l

41.06

4779

10777

Extracorporeal dialysis

766

1276

8.69

307.65

12.9

3.8

-0.05

1.91

mmol/l

29.85

540

942

Asthma (only as main-diagnosis)

3337

7610

2.77

307.65

3.8

2.6

1.92

1.17

mmol/l

22.87

2518

5283

Type 2 diabetes, definitions combined

4609

12969

2.22

307.65

3.6

3.1

1.72

1.77

mmol/l

0.39

3354

9674

Type 2 diabetes

5125

13355

2.40

307.65

3.9

3.1

1.66

1.75

mmol/l

0.91

3744

9937

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5306

16799

1.87

307.65

4.5

3.7

1.71

1.59

mmol/l

1.35

3809

12370

Hypothyroidism and >3 levothyroxin purchases

1072

1371

4.71

307.65

3.8

2.8

1.25

1.21

mmol/l

0.12

769

970

Disorders of lipoprotein metabolism and other lipidaemias

4015

12376

2.14

307.65

4.0

3.1

1.50

1.80

mmol/l

5.02

2857

9311

Other and unspecified anaemias

2383

9960

2.50

307.65

5.5

3.7

1.56

1.85

mmol/l

2.72

1741

7367

Hypertensive diseases (excluding secondary)

2820

4948

3.53

307.65

5.4

2.7

1.45

1.41

mmol/l

0.22

2065

3643

Fitting and adjustment of other devices

2170

7600

2.90

307.65

3.9

3.2

1.73

1.87

mmol/l

0.87

1634

5594

Other special examinations and investigations of persons without complaint or reported diagnosis

3329

7323

2.40

307.65

4.1

3.0

1.51

1.94

mmol/l

7.38

2389

5297

Medical observation and evaluation for suspected diseases and conditions

4218

7320

3.14

307.65

4.1

3.0

1.30

1.94

mmol/l

17.94

3116

5296

COPD (mode)

2425

4089

5.40

307.65

5.4

2.6

2.75

1.27

mmol/l

49.47

1981

2852

General examination and investigation of persons without complaint and reported diagnosis

3632

7302

2.79

307.65

4.8

3.0

1.46

1.94

mmol/l

10.68

2663

5284

Persons encountering health services in other circumstances

2234

8159

2.95

307.65

3.9

3.7

1.78

1.58

mmol/l

1.64

1692

5976

Preparatory care for dialysis

551

840

9.82

307.65

14.8

3.4

-1.06

1.94

mmol/l

50.45

431

624

COPD/asthma related infections

5383

11808

2.39

307.65

4.4

2.8

1.98

1.38

mmol/l

21.98

4092

8343

COPD, hospital admissions 1, only main diagnosis

2371

7438

3.01

307.65

5.7

3.3

2.88

1.60

mmol/l

41.98

1950

5344

Mental and behavioural disorders due to psychoactive substance use

3040

13700

2.20

307.65

4.1

3.4

1.78

1.55

mmol/l

2.28

2291

9957

Abnormal findings on diagnostic imaging of lung

2789

11374

2.58

307.65

5.1

3.4

2.03

1.75

mmol/l

3.53

2269

8321

Metabolic disorders

5334

14357

2.44

307.65

4.9

3.2

1.63

1.70

mmol/l

0.60

3880

10648

Hypertension

4054

9207

2.62

307.65

4.9

3.0

1.56

1.68

mmol/l

1.08

2968

6862

First line medication for Crohn's disease

6331

14640

2.48

307.65

5.2

3.0

1.65

1.53

mmol/l

1.47

4746

10462

ILD differential diagnosis

3840

7733

2.60

307.65

3.8

2.6

1.90

1.17

mmol/l

24.23

2863

5377

Asthma (only as main-diagnosis), excluding more controls

3246

6767

3.00

307.65

3.8

2.5

1.89

1.10

mmol/l

25.34

2446

4704

Parasetamol

3817

8447

2.40

307.65

3.6

3.0

1.54

1.50

mmol/l

0.23

2750

6078

Pure hypercholesterolaemia

3538

11658

2.14

307.65

4.3

3.2

1.44

1.83

mmol/l

7.10

2566

8772

Bacterial Sepsis

3434

8859

3.90

307.65

7.0

2.9

2.03

1.70

mmol/l

3.88

2641

6436

Nausea and vomiting

1671

5998

2.99

307.65

7.5

4.2

1.57

1.72

mmol/l

0.86

1266

4383

5468

15584

1.92

307.65

4.4

3.2

1.84

1.59

mmol/l

4.86

4159

11220

Dyspnoea

5604

16190

2.85

307.65

4.5

3.5

1.99

1.59

mmol/l

10.87

4282

11734

Oral corticosteroids

6137

15649

2.51

307.65

4.4

3.0

1.91

1.56

mmol/l

9.36

4709

11244

Anaemias

1548

1657

6.84

307.65

7.1

4.0

1.14

1.08

mmol/l

0.23

1142

1172

Oedema, not elsewhere classified

1793

6094

3.19

307.65

4.8

3.3

2.13

1.77

mmol/l

3.10

1379

4463

ILD medications: immunosuppressive drugs

3003

12664

2.39

307.65

7.4

3.0

1.42

1.59

mmol/l

1.69

2222

9157

Abnormalities of breathing

5699

12010

3.01

307.65

4.2

3.6

1.81

1.45

mmol/l

8.61

4247

8583

Cardiac arrhythmias

2681

7164

2.58

307.65

4.2

3.0

1.81

1.54

mmol/l

3.10

2003

5286

Episodal and paroxysmal disorders

6729

12661

2.89

307.65

3.4

4.5

1.46

1.68

mmol/l

4.56

4999

9081

Heart failure, not strict

5539

11187

3.81

307.65

6.1

2.8

2.05

1.52

mmol/l

15.19

4258

8210

Fever of other and unknown origin

3338

10957

3.04

307.65

5.6

3.3

1.70

1.62

mmol/l

0.57

2489

7927

COPD, hospital admissions 3, with asthma pneumonia sepsis

1855

5490

3.21

307.65

6.3

3.3

3.00

1.59

mmol/l

39.55

1528

3890

Insulin, fast-acting or short human

2332

9180

2.76

307.65

5.1

3.7

1.60

1.61

mmol/l

0.03

1663

6709

Early onset COPD, excluding more controls

1459

3125

5.31

307.65

5.4

2.6

2.70

1.21

mmol/l

33.75

1183

2184

Diabetes medication

5386

15327

2.24

307.65

3.8

3.4

1.61

1.70

mmol/l

0.78

3897

11366

Insulin, intermediate and long-acting

3436

13732

2.66

307.65

4.7

3.5

1.56

1.70

mmol/l

1.10

2459

10182

Mood disorders, excluding more controls

4316

13721

1.98

307.65

3.5

3.3

1.62

1.63

mmol/l

0.10

3257

10004

Chronic kidney disease

3367

6530

6.55

307.65

8.2

3.2

0.58

2.10

mmol/l

65.46

2242

4883

Other antidepressants

4964

13664

1.96

307.65

3.4

3.5

1.69

1.62

mmol/l

0.60

3723

9830

Pain in throat and chest

3913

11205

2.22

307.65

3.4

3.2

1.63

1.51

mmol/l

1.03

2879

8047

Neurological diseases

4738

9035

2.77

307.65

3.8

4.5

1.44

1.58

mmol/l

1.39

3478

6367

Septicaemia

3013

9048

3.59

307.65

6.9

3.4

1.69

1.70

mmol/l

0.07

2285

6566

Symptoms and signs involving the urinary system

4105

15104

2.22

307.65

4.4

3.6

1.61

1.77

mmol/l

1.67

3055

11169

Codeine

4505

11585

2.22

307.65

3.5

3.0

1.69

1.60

mmol/l

0.71

3319

8342

Sleep apnoea

7533

12161

4.74

307.65

3.1

3.8

1.57

1.80

mmol/l

4.99

5795

8848

All-cause Heart Failure

3941

9838

3.20

307.65

5.7

3.2

2.50

1.55

mmol/l

32.13

3053

7212

Implicit viral Sepsis

1441

3741

4.44

307.65

8.4

3.2

1.94

1.68

mmol/l

1.41

1112

2688

Atrial fibrillation and flutter

1554

3049

3.54

307.65

4.4

2.3

2.08

1.59

mmol/l

4.83

1180

2337

COPD/asthma/ILD related infections

5383

11808

2.39

307.65

4.4

2.8

1.98

1.38

mmol/l

21.98

4092

8343

Later onset COPD, excluding more controls

1429

2705

4.70

307.65

5.1

2.7

2.70

1.36

mmol/l

25.38

1154

1839

Other chronic obstructive pulmonary disease

3026

8604

3.25

307.65

5.3

3.3

2.69

1.52

mmol/l

43.87

2454

6194

Heart failure,strict

3727

7935

3.80

307.65

5.8

2.8

2.44

1.53

mmol/l

27.17

2890

5808

Unspecified kidney failure

848

1847

5.59

307.65

7.7

2.9

0.82

2.15

mmol/l

12.30

589

1343

Asthma, hospital admission 2, infections

3154

14345

2.29

307.65

4.9

4.0

2.14

1.58

mmol/l

14.37

2416

10446

Symptoms and signs involving the circulatory and respiratory systems

5026

12050

2.17

307.65

3.9

3.6

1.58

1.45

mmol/l

1.40

3689

8614

Type 2 diabetes, wide definition

4692

11809

2.78

307.65

4.3

3.2

1.73

1.82

mmol/l

0.70

3421

8895

Neurological diseases, wide definition

1738

2157

4.28

307.65

4.6

5.2

1.29

1.37

mmol/l

0.29

1270

1498

Endocrine, nutritional and metabolic diseases

4170

8643

2.56

307.65

4.6

3.5

1.46

1.50

mmol/l

0.26

2986

6311

Other chronic obstructive pulmonary disease, including avohilmo

3433

10944

2.86

307.65

5.0

3.3

2.60

1.57

mmol/l

39.81

2751

7968

Codeine or tramadol medication

5334

16091

1.90

307.65

3.5

3.3

1.71

1.65

mmol/l

0.46

3961

11747

Other diseases of pleura

3256

9976

3.23

307.65

6.6

3.5

2.97

1.48

mmol/l

76.57

2711

7171

Other septicaemia

2728

8172

3.69

307.65

7.1

3.4

1.67

1.73

mmol/l

0.29

2069

5924

Renal tubulo-interstitial diseases

6443

14820

3.68

307.65

6.2

3.0

1.23

1.85

mmol/l

22.98

4543

11026

Asthma, unspecified (mode)

3066

6852

3.82

307.65

4.0

2.6

2.10

1.21

mmol/l

28.23

2365

4763

Excluding asthma or asthma-COPD overlap

3892

7678

2.65

307.65

3.8

2.6

1.89

1.18

mmol/l

23.23

2904

5328

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5227

14160

2.38

307.65

3.9

3.4

1.60

1.71

mmol/l

1.06

3766

10543

Asthma (mode)

3482

7733

2.58

307.65

3.6

2.6

1.85

1.17

mmol/l

20.10

2588

5377

Secondary hypertension

924

1074

11.20

307.65

10.6

3.3

0.08

1.52

mmol/l

19.73

671

788

COPD-related respiratory insufficiency

1147

2472

5.83

307.65

8.3

3.4

3.35

1.56

mmol/l

34.63

1000

1750

Erysipelas

2786

11054

2.44

307.65

5.1

2.9

2.10

1.74

mmol/l

4.41

2141

8082

Covid-19 confirmed case

1893

6269

3.36

307.65

6.0

3.7

2.19

1.61

mmol/l

10.14

1443

4550

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5788

17473

2.53

307.65

5.3

3.5

1.64

mmol/l

0.02

4289

12815

Biguanides

4518

14237

2.04

307.65

3.4

3.3

1.71

1.77

mmol/l

0.44

3271

10620

Any reimbursement code in KELA

2583

4819

2.79

307.65

4.9

2.4

1.41

1.24

mmol/l

1.49

1895

3358

Codes for special purposes

2314

9953

2.47

307.65

6.0

3.6

2.11

1.51

mmol/l

13.42

1765

7142

Insulin medication

3729

12421

2.77

307.65

4.8

3.6

1.57

1.73

mmol/l

1.32

2658

9247

Heart failure and antihypertensive medication

1948

2476

5.94

307.65

6.1

2.8

2.43

1.82

mmol/l

6.87

1517

1919

Insulin, fast-acting

2323

8719

2.91

307.65

5.1

3.7

1.61

1.63

mmol/l

0.09

1657

6386

Atrial fibrillation and flutter with reimbursement

1375

2496

3.80

307.65

4.4

2.4

2.24

1.59

mmol/l

6.77

1040

1920

Nephropathy related operations

1288

2772

5.97

307.65

13.3

4.0

0.28

1.72

mmol/l

29.59

892

2038

Complications of surgical and medical care, not elsewhere classified

4671

17845

1.95

307.65

4.7

3.3

1.74

1.67

mmol/l

0.59

3483

13079

Obesity and other hyperalimentation

3828

12615

3.27

307.65

3.7

3.4

1.84

1.57

mmol/l

3.89

2895

9201

Respiratory insufficiency

944

1157

10.89

307.65

10.0

3.4

4.35

1.12

mmol/l

73.13

866

792

GASTRO-related operations

4219

8294

2.67

307.65

4.9

2.6

1.46

1.71

mmol/l

3.54

3105

5751

Substance use, excluding alcohol

1187

3414

3.84

307.65

4.1

3.1

1.94

1.53

mmol/l

2.91

931

2519

Sleep disorders (combined)

7778

12930

4.39

307.65

3.2

3.9

1.57

1.75

mmol/l

3.51

5959

9326

Diseases of arteries, arterioles and capillaries (FINNGEN)

1287

2469

3.94

307.65

5.3

2.6

1.65

1.57

mmol/l

0.27

946

1902

Inflammatory bowel disease treatment related agents

6270

16433

2.27

307.65

5.0

3.1

1.78

1.53

mmol/l

5.31

4764

11761

Nutritional anaemias

2647

11444

2.40

307.65

5.3

3.6

1.74

1.78

mmol/l

0.21

1965

8400

ILD medications: prednisolone, methylprednisolone, prednisone

6573

14813

2.66

307.65

5.3

2.9

1.69

1.57

mmol/l

1.53

4952

10627

Diabetes mellitus

5493

14664

2.35

307.65

3.9

3.4

1.61

1.68

mmol/l

0.70

3988

10862

Other disorders of fluid, electrolyte and acid-base balance

2189

6079

3.93

307.65

5.9

3.3

2.01

1.92

mmol/l

0.43

1676

4537

ILD medications

6592

15236

2.51

307.65

5.3

3.0

1.65

1.55

mmol/l

1.17

4930

10905

Asthma, unspecified (mode), excluding more controls

2990

6074

4.18

307.65

4.0

2.5

2.09

1.14

mmol/l

31.87

2298

4225

Bronchitis

5207

18051

1.97

307.65

4.6

3.2

1.83

1.61

mmol/l

4.14

3962

13042

Pneumonias (Asthma/COPD co-morbidities)

6459

16182

2.97

307.65

5.6

3.2

2.12

1.36

mmol/l

41.77

5003

11541

Glucagon-like peptide-1 (GLP-1) analogues

3134

10787

2.57

307.65

4.5

3.5

1.49

1.88

mmol/l

5.37

2251

8168

Intracranial trauma

2694

7234

2.92

307.65

4.0

4.3

1.65

1.56

mmol/l

0.53

1991

5117

Infections, IBD-co-morbidities

1075

1143

7.62

307.65

6.5

3.8

1.43

1.75

mmol/l

1.25

810

819

Type 2 diabetes, definitions combined, including avohilmo

4588

12911

2.20

307.65

3.5

3.1

1.72

1.76

mmol/l

0.25

3356

9611

Other (not insulin) diabetes medications

4711

13768

2.16

307.65

3.6

3.2

1.67

1.78

mmol/l

0.91

3422

10275

Renal failure

4548

9249

5.49

307.65

7.5

3.1

0.76

2.07

mmol/l

58.90

3107

6976

Non-ischemic cardiomyopathy

1951

5278

3.38

307.65

5.7

3.3

2.77

1.59

mmol/l

24.32

1548

3896

Transplanted organ and tissue status

1057

1994

6.92

307.65

14.4

3.6

0.60

1.58

mmol/l

13.00

760

1492

Iron deficiency anaemia

2318

9573

2.58

307.65

5.5

3.6

1.74

1.79

mmol/l

0.21

1739

7015

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3605

14555

2.46

307.65

5.0

3.5

2.00

1.71

mmol/l

4.46

2870

10665

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

783

849

7.75

307.65

5.9

3.8

2.18

1.97

mmol/l

0.57

621

612

Gastro-oesophageal reflux disease

3430

14688

2.18

307.65

3.9

3.6

1.42

1.76

mmol/l

6.38

2599

10809

Provisional assignment of new diseases of uncertain etiology

2310

9939

2.47

307.65

6.1

3.6

2.10

1.51

mmol/l

13.26

1762

7132

All influenza

1476

5078

3.17

307.65

6.5

3.2

1.96

1.33

mmol/l

8.73

1143

3626

Opioids

4612

11796

2.13

307.65

3.5

3.0

1.58

1.60

mmol/l

0.07

3393

8471

Implicit Sepsis

5244

13006

3.45

307.65

6.1

3.0

1.97

1.63

mmol/l

6.39

3989

9486

Acute tubulo-interstitial nephritis

3386

11934

2.69

307.65

5.7

3.0

1.61

1.91

mmol/l

3.89

2487

8852

Glomerular disorders in diseases classified elsewhere

1175

2364

6.32

307.65

8.6

3.4

0.47

1.80

mmol/l

21.65

832

1726

Sleep apnoea, including avohilmo

7564

12325

4.45

307.65

3.1

3.8

1.58

1.79

mmol/l

4.58

5797

8939

Other respiratory disorders and diseases

1697

4805

4.13

307.65

8.5

3.8

3.63

1.55

mmol/l

71.02

1494

3438

Asthma-related infections

3154

14345

2.29

307.65

4.9

4.0

2.14

1.58

mmol/l

14.37

2416

10446

Polyarthropathies

3441

10907

2.20

307.65

4.6

3.5

1.70

1.67

mmol/l

0.18

2487

7969

Glomerular diseases

1622

4113

4.73

307.65

9.1

3.8

0.64

1.73

mmol/l

22.43

1154

3025

Influenza and pneumonia

6690

15974

2.95

307.65

5.5

3.1

2.08

1.34

mmol/l

40.22

5154

11363

COPD, hospital admissions

3063

9497

3.02

307.65

5.3

3.3

2.71

1.57

mmol/l

44.20

2485

6873

Asthma

3803

7610

2.81

307.65

3.9

2.6

1.96

1.17

mmol/l

27.69

2853

5283

Type 2 diabetes, strict (exclude DM1)

4619

13064

2.21

307.65

3.5

3.1

1.73

1.77

mmol/l

0.27

3362

9744

Kidney transplant status

644

1189

7.63

307.65

16.3

4.9

0.16

1.62

mmol/l

16.63

415

879

Other nutritional deficiencies

3971

13119

3.21

307.65

3.8

3.4

1.80

1.56

mmol/l

3.19

2994

9559

Hypertensive diseases

4059

9225

2.62

307.65

5.0

3.0

1.57

1.68

mmol/l

1.03

2973

6877

Condition for Implicit Sepsis (Organ dysfunction codes)

5560

14036

3.12

307.65

5.9

2.9

1.92

1.60

mmol/l

5.91

4209

10206

Certain infectious and parasitic diseases

5000

11950

2.18

307.65

4.7

2.9

1.69

1.59

mmol/l

1.05

3728

8578

Acute renal failure

1863

4149

5.45

307.65

7.7

2.9

0.89

2.05

mmol/l

17.96

1325

3079

Bacterial infection, other or unspecified

3863

10502

3.71

307.65

6.0

3.1

1.77

1.74

mmol/l

0.21

2979

7640

COPD, early/later onset

3061

9548

2.99

307.65

5.3

3.3

2.69

1.57

mmol/l

42.41

2482

6914

Persons encountering health services for specific procedures and health care

5814

16976

2.23

307.65

5.6

3.2

1.68

1.58

mmol/l

1.03

4260

12371

Dental caries

1602

5945

2.91

303.53

8.0

3.5

1.44

1.60

mmol/l

0.92

1198

4280

Poisoning by drugs, medicaments and biological substances

1289

4293

3.25

301.76

3.6

3.3

1.29

1.56

mmol/l

1.51

971

3119

Asthma-related pneumonia

2056

8692

2.54

301.70

5.9

3.9

2.42

1.71

mmol/l

14.33

1618

6345

Asthma-related pneumonia or sepsis

2060

8716

2.54

301.70

5.9

3.9

2.42

1.71

mmol/l

14.27

1621

6364

Asthma, hospital admissions 3, pneumonia

2060

8716

2.54

301.70

5.9

3.9

2.42

1.71

mmol/l

14.27

1621

6364

Other and unspecified iron deficiency

1819

7335

2.68

296.84

5.5

3.6

1.82

1.76

mmol/l

0.25

1369

5354

Anxiety disorders, excluding more controls

3607

12274

2.02

292.57

3.7

3.3

1.65

1.63

mmol/l

0.12

2685

8949

Psychiatric diseases

5144

14534

1.83

291.96

4.3

3.7

1.69

1.59

mmol/l

1.03

3835

10597

Any mental disorder

5275

15024

1.82

291.56

4.3

3.6

1.73

1.60

mmol/l

1.51

3945

10961

Acute bronchitis

2273

9966

2.38

290.80

6.0

3.7

2.14

1.64

mmol/l

8.21

1772

7219

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1779

4248

2.77

290.80

4.2

2.3

1.56

1.47

mmol/l

0.42

1334

3140

Viral pneumonia

849

2242

4.30

290.32

6.7

3.7

2.35

1.27

mmol/l

13.65

686

1600

Type 1 diabetes, wide definition, subgroup 1

1254

4214

3.24

289.58

5.1

3.9

1.33

1.58

mmol/l

1.33

898

3080

Bleeding

4066

16025

1.93

289.43

5.2

3.6

1.74

1.71

mmol/l

0.15

2993

11921

Gout

1663

5916

2.80

286.58

5.6

3.5

1.53

1.80

mmol/l

1.63

1173

4367

Complications of medical and surgical care

3420

16946

2.00

285.98

5.0

3.4

1.64

1.75

mmol/l

0.93

2564

12493

2288

10265

2.34

284.67

5.1

4.2

2.02

1.52

mmol/l

8.89

1752

7473

Presence of cardiac and vascular implants and grafts

2418

8319

2.35

283.38

4.5

3.3

1.54

1.88

mmol/l

3.69

1761

6221

Type 1 diabetes

1460

5397

2.91

282.00

5.3

3.9

1.29

1.55

mmol/l

1.62

1055

3927

Hypo-osmolality and hyponatraemia

1061

3296

3.59

281.53

5.5

3.3

2.08

2.07

mmol/l

0.02

813

2469

Poisoning by medicine

1158

3792

3.31

279.23

3.5

3.3

1.29

1.58

mmol/l

1.60

864

2753

Other diseases of intestines

4924

16385

1.80

276.21

4.2

3.7

1.47

1.60

mmol/l

1.44

3630

11881

Diabetic nephropathy, excluding more controls

1145

3118

3.58

276.14

7.3

3.1

0.92

1.51

mmol/l

4.40

784

2287

Dentinal caries

1404

5147

2.96

275.33

6.9

3.3

1.47

1.64

mmol/l

0.85

1044

3720

Other disorders of urethra and urinary system

3235

12379

2.04

274.82

4.8

3.3

1.74

mmol/l

0.01

2443

8947

Presence of other functional implants

2803

9629

2.17

273.08

4.3

3.3

1.89

1.92

mmol/l

0.13

2064

7244

Other dialysis

427

700

9.57

272.79

16.9

4.9

-0.01

1.65

mmol/l

13.58

317

531

Other soft tissue disorders, not elsewhere classified

4304

14763

1.86

271.43

3.7

3.8

1.64

1.62

mmol/l

0.09

3175

10695

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1594

2814

2.94

271.42

3.8

2.9

1.54

1.43

mmol/l

0.48

1177

1994

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

929

2735

3.72

267.26

3.4

3.1

1.13

1.52

mmol/l

2.20

698

2005

Diseases of pulp and periapical tissues

1829

7758

2.51

265.37

4.4

3.2

1.41

1.72

mmol/l

2.79

1350

5713

Other CVD (FINNGEN)

643

1080

5.22

264.84

4.0

2.4

1.72

1.66

mmol/l

0.13

475

832

Headache

2734

11214

2.11

263.33

3.7

3.1

1.50

1.60

mmol/l

0.69

1975

8097

Cough

1977

8307

2.41

263.06

4.7

4.0

1.57

1.53

mmol/l

0.24

1507

6015

Hernia of abdominal wall, postoperative

915

2695

3.69

262.02

5.3

2.6

1.54

2.02

mmol/l

3.11

682

1909

Type 1 diabetes, wide definition

1285

4626

3.00

261.48

5.2

4.0

1.32

1.57

mmol/l

1.37

921

3351

Depression

4163

16075

1.84

259.45

3.4

1.55

1.66

mmol/l

1.25

3099

11704

Fall on same level

5310

17648

1.73

257.55

4.1

3.7

1.67

1.55

mmol/l

1.39

3946

12785

Mood disorders

4530

17100

1.80

257.45

3.5

3.4

1.61

1.69

mmol/l

0.70

3396

12449

Pulmonary heart disease, diseases of pulmonary circulation

1736

7322

2.56

257.31

5.1

3.4

2.27

1.82

mmol/l

4.90

1358

5389

Mood [affective] disorders

4514

17057

1.80

256.95

3.5

3.4

1.61

1.69

mmol/l

0.78

3386

12418

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1280

4666

2.98

255.77

3.7

3.3

1.49

1.70

mmol/l

1.21

954

3523

Persons encountering health services for examination and investigation

2985

7323

2.11

255.63

4.0

3.0

1.40

1.94

mmol/l

10.50

2181

5297

Acute upper respiratory infections of multiple and unspecified sites

3391

13510

1.95

255.07

4.6

3.3

1.65

1.61

mmol/l

0.31

2522

9776

Other disorders of skin and subcutaneous tissue, not elsewhere classified

947

2935

3.64

254.91

5.8

3.4

1.28

1.86

mmol/l

4.03

752

2149

Asthma/COPD (KELA code 203)

4299

17274

1.81

254.83

4.5

3.6

2.13

1.40

mmol/l

30.37

3299

12353

Mental and behavioural disorders due to tobacco

628

1477

5.02

253.66

4.9

3.4

1.70

1.71

mmol/l

0.01

509

1097

Extreme obesity with alveolar hypoventilation

411

677

8.06

253.17

6.8

3.4

4.37

1.63

mmol/l

22.37

356

518

Smoking dependency

628

1488

4.98

251.28

4.9

3.4

1.70

1.73

mmol/l

0.05

509

1108

Obesity, other/unspecified

1480

5835

2.69

249.90

4.0

3.2

1.98

1.61

mmol/l

3.04

1126

4231

Disorders resulting from impaired renal tubular function

426

752

8.09

249.04

13.8

4.3

-0.23

1.60

mmol/l

14.20

284

563

Hypokalaemia

745

2014

4.20

246.58

5.9

3.5

2.75

2.05

mmol/l

3.35

600

1514

Depression or dysthymia

3234

9371

2.00

245.83

3.4

1.57

1.58

mmol/l

0.06

2413

6833

Autoimmune diseases excluding thyroid diseases

4799

15631

1.76

244.10

4.4

3.6

1.58

1.60

mmol/l

0.17

3528

11307

Disorders of lens

3175

10479

2.00

243.37

5.0

3.2

1.71

1.75

mmol/l

0.20

2331

7855

Syncope and collapse

2106

8615

2.28

242.72

3.7

3.2

1.61

1.70

mmol/l

0.49

1572

6291

Autoimmune diseases

5155

15783

1.72

237.74

4.3

3.6

1.51

1.59

mmol/l

0.81

3778

11411

Other functional intestinal disorders

2296

10606

2.17

237.46

4.7

4.1

1.82

1.73

mmol/l

0.47

1737

7771

Suicide or other Intentional self-harm

1227

4535

2.90

237.04

3.5

3.2

1.40

1.56

mmol/l

0.72

934

3313

L04AA Selective immunosuppressants

1217

4507

2.95

236.83

10.3

3.6

1.01

1.72

mmol/l

8.19

879

3339

Anxiety (asthma-related co-morbidities)

2417

9275

2.13

235.31

3.4

3.3

1.50

1.54

mmol/l

0.22

1792

6685

Autoimmune diseases excluding thyroid diseases, strict definition

4656

15256

1.75

235.27

4.4

3.6

1.55

1.59

mmol/l

0.26

3418

11030

Complications of procedures, not elsewhere classified

3539

17065

1.86

235.03

4.4

3.3

1.73

1.69

mmol/l

0.19

2633

12526

Symptoms and signs involving the digestive system and abdomen

4785

14115

1.75

234.72

4.6

3.7

1.49

1.64

mmol/l

1.65

3501

10295

Genitourinary diseases

2957

7479

2.05

234.56

5.6

3.5

1.26

1.67

mmol/l

6.84

2129

5483

Valvular heart disease excluding rheumatic fever

2226

7714

2.22

231.10

5.1

3.5

2.11

1.49

mmol/l

10.22

1656

5730

Examination and observation for other reasons

2455

7197

2.15

230.40

4.6

3.0

1.45

1.94

mmol/l

7.76

1785

5217

Abnormalities of heart beat

1553

6437

2.52

230.19

3.4

3.3

1.54

1.65

mmol/l

0.53

1148

4638

Gout, FINNGEN

1663

7259

2.49

229.62

5.6

3.4

1.53

1.77

mmol/l

1.48

1173

5324

Hyperlipidaemia, other/unspecified

1925

8389

2.31

228.53

4.4

3.2

1.60

1.90

mmol/l

2.67

1370

6320

Disorders of other endocrine glands

2175

10348

2.18

228.33

6.5

4.0

1.60

1.66

mmol/l

0.35

1629

7583

Convulsions, not elsewhere classified

1246

4665

2.82

228.26

5.4

3.5

1.48

1.45

mmol/l

0.10

903

3327

Recurrent or chronic depression

1658

5005

2.49

227.97

3.1

1.36

1.54

mmol/l

1.33

1212

3627

Neurotic, stress-related and somatoform disorders

3747

15084

1.82

227.53

3.7

3.3

1.62

1.65

mmol/l

0.18

2779

11013

Haemorrhage from respiratory passages

1676

6747

2.44

227.17

4.5

3.5

2.00

1.63

mmol/l

3.20

1258

4866

Other reaction to severe stress, and adjustment disorders

1539

6450

2.50

226.89

4.3

3.1

1.40

1.56

mmol/l

0.93

1118

4666

Non-rheumatic valve diseases

2177

7527

2.22

226.53

4.8

3.3

2.09

1.51

mmol/l

8.96

1611

5599

Symptoms and signs involving cognition, perception, emotional state and behaviour

4289

17721

1.75

226.27

3.6

1.65

1.68

mmol/l

0.20

3196

12971

Conduction disorders

1509

5166

2.60

225.45

4.7

3.3

1.93

1.50

mmol/l

3.64

1139

3803

Used for control exclusion in common control thyroid runs

4889

14873

1.71

224.21

4.4

3.7

1.45

1.57

mmol/l

1.33

3573

10738

Anxiety disorders

3782

15286

1.81

224.09

3.7

3.3

1.63

1.65

mmol/l

0.11

2804

11158

Personality disorders, excluding more controls

1058

3704

3.01

223.94

3.2

2.9

1.82

1.46

mmol/l

2.09

774

2639

ILD, hospital admission 2, with pulmonary infections

624

1597

4.49

223.81

6.9

3.2

2.45

1.36

mmol/l

9.43

513

1118

Other and unspecified disorders of skin and subcutaneous tissue

526

1196

5.29

223.07

5.7

3.4

0.85

1.86

mmol/l

6.56

433

876

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1310

5150

2.69

222.49

3.3

3.1

1.37

1.50

mmol/l

0.57

989

3689

Other diseases of urinary system

4633

15570

1.73

222.13

4.5

3.5

1.59

1.65

mmol/l

0.40

3436

11269

STROKE

2504

8709

2.08

220.64

4.2

3.0

1.69

1.77

mmol/l

0.51

1855

6575

Hypertensive Heart Disease

1210

3699

2.88

219.38

5.2

3.1

1.94

1.96

mmol/l

0.05

910

2806

Infections of the skin and subcutaneous tissue

2695

14176

1.98

219.28

5.2

3.9

1.63

1.52

mmol/l

0.73

2019

10319

Pain in limb

3490

14227

1.84

216.69

3.9

3.8

1.76

1.64

mmol/l

1.12

2598

10332

DVT of lower extremities and pulmonary embolism

2066

9987

2.19

216.54

4.5

3.4

2.05

1.82

mmol/l

1.83

1573

7373

Disorders of gallbladder, biliary tract and pancreas

4323

16602

1.73

215.60

4.0

3.4

1.64

1.74

mmol/l

0.89

3170

12263

Later onset COPD

1629

5576

2.49

215.43

5.2

3.3

2.70

1.66

mmol/l

19.60

1320

3951

Venous thromboembolism

2549

12939

2.01

213.93

4.4

3.4

2.02

1.80

mmol/l

2.11

1945

9560

Low back pain

3165

13432

1.88

213.85

3.3

3.4

1.81

1.63

mmol/l

1.94

2318

9799

Vocal cord dysfunction

614

1440

4.24

213.83

4.5

3.0

1.68

1.53

mmol/l

0.42

481

1068

Chronic laryngitis and laryngotracheitis

853

2755

3.44

213.46

3.5

1.32

1.87

mmol/l

4.28

663

2029

Chronic periapical parodontitis

1134

4268

2.88

213.22

5.1

3.2

1.27

1.78

mmol/l

4.11

839

3138

Hyperkalaemia

444

916

5.90

211.83

6.8

3.3

1.24

2.14

mmol/l

2.94

308

672

Pulmonary embolism

1519

6586

2.48

211.28

4.6

3.3

2.20

1.83

mmol/l

3.15

1171

4852

Heart failure and coronary heart disease

1873

6486

2.32

210.18

5.4

3.6

2.23

1.89

mmol/l

2.55

1397

4769

Other anxiety disorders

1804

7347

2.27

208.98

3.3

3.1

1.51

1.53

mmol/l

0.10

1333

5282

Abdominal and pelvic pain

4641

14078

1.70

208.01

4.2

3.6

1.50

1.64

mmol/l

1.69

3378

10260

All anxiety disorders

2445

10082

2.02

207.58

3.4

3.2

1.50

1.59

mmol/l

0.59

1811

7308

Pulmonary heart disease

1519

6648

2.45

206.78

4.6

3.4

2.20

1.85

mmol/l

2.86

1171

4910

Gout, idiopatic and unspecified

1410

6008

2.57

206.78

5.7

3.5

1.47

1.73

mmol/l

1.40

996

4376

Epilepsy

1457

6216

2.47

206.28

4.9

5.0

1.60

1.68

mmol/l

0.36

1082

4454

Follow-up examination after treatment for conditions other than malignant neoplasms

1800

5283

2.31

206.25

3.7

2.9

1.46

2.05

mmol/l

8.80

1373

3859

Diseases of arteries, arterioles and capillaries

3119

13030

1.87

201.57

4.8

3.5

1.59

1.83

mmol/l

2.59

2280

9725

Diabetic nephropathy

1156

4555

2.88

200.39

7.2

3.4

0.92

1.68

mmol/l

7.38

792

3313

Selective serotonin reuptake inhibitors

4401

13966

1.70

199.97

3.2

3.5

1.67

1.61

mmol/l

0.46

3294

10053

Senile cataract

2845

9499

1.94

199.60

4.6

3.2

1.76

1.78

mmol/l

0.12

2097

7121

Gastrointestinal diseases

2621

6713

2.01

199.41

4.9

3.1

1.41

1.60

mmol/l

1.66

1917

4783

Gout, unspecified

1192

4803

2.74

198.02

5.9

3.4

1.36

1.72

mmol/l

2.11

843

3491

Injuries to the head

4817

19657

1.64

197.56

4.0

3.9

1.64

1.62

mmol/l

0.10

3513

14378

Gout, strict definition

1084

4192

2.88

196.69

6.1

3.5

1.38

1.76

mmol/l

2.04

768

3049

Other disorders of skin and subcutaneous tissue

3042

15761

1.84

196.11

4.8

3.4

1.72

1.77

mmol/l

0.27

2293

11646

Familial hypercholesterolemia

939

3374

3.07

194.73

4.2

3.3

1.59

1.93

mmol/l

1.79

709

2516

Constipation

3984

17220

1.71

194.34

4.3

4.0

1.87

1.65

mmol/l

3.02

3029

12632

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2678

14669

1.89

192.10

5.0

3.4

1.65

1.78

mmol/l

0.96

2001

10804

Other retinal disorders

2917

13128

1.86

190.55

4.7

3.5

1.57

1.85

mmol/l

3.25

2116

9770

Factors influencing health status and contact with health services

1439

2937

2.55

188.16

4.0

2.6

1.60

1.84

mmol/l

1.39

1081

2126

2771

13829

1.87

186.87

4.1

3.4

1.67

1.56

mmol/l

0.60

2048

10086

Asthma, hospital admissions , main diagnosis only

3604

19359

1.72

186.08

4.1

3.8

1.94

1.58

mmol/l

7.42

2706

14092

Dorsalgia

4256

14065

1.68

185.84

3.3

3.4

1.67

1.62

mmol/l

0.38

3112

10229

2664

13521

1.88

185.39

4.1

3.4

1.68

1.56

mmol/l

0.72

1965

9853

Use of hypnotics and sedatives

4598

16644

1.64

184.73

3.8

3.5

1.68

1.63

mmol/l

0.34

3395

12211

Retention of urine

1754

7147

2.20

182.02

4.5

3.6

1.88

1.74

mmol/l

0.71

1309

5206

Anaemia in chronic diseases classified elsewhere

291

483

8.70

181.14

12.4

4.4

-0.19

1.91

mmol/l

11.90

210

355

Undetermined asthma, excluding more controls

572

1574

3.91

180.65

4.6

2.6

1.64

1.15

mmol/l

2.46

432

1096

Unspecified urinary incontinence

562

1556

4.12

180.33

3.7

3.8

1.62

2.13

mmol/l

2.46

453

1166

Nerve, nerve root and plexus disorders

4440

17494

1.64

180.02

3.8

3.3

1.75

1.69

mmol/l

0.47

3302

12839

Disorders of choroid and retina

3547

15448

1.73

179.74

4.5

3.5

1.54

1.82

mmol/l

3.82

2586

11512

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1474

6745

2.32

179.27

4.4

3.6

1.73

1.65

mmol/l

0.34

1040

4949

Osteopathies and chondropathies

2415

12440

1.92

179.03

4.9

3.4

1.84

1.76

mmol/l

0.44

1824

9203

Alcohol use disorder, Swedish definition

2528

12928

1.89

178.34

4.1

3.4

1.69

1.57

mmol/l

0.72

1874

9426

ILD, hospital admissions 3, with pneumonia sepsis

544

1490

4.21

178.06

6.8

3.3

2.53

1.54

mmol/l

7.14

452

1046

Hard cardiovascular diseases

3403

12876

1.76

177.47

4.4

3.4

1.77

1.78

mmol/l

0.09

2523

9687

Asthma, including avohilmo

5120

19288

1.58

177.14

3.9

1.98

1.51

mmol/l

15.31

3833

13993

Hypertensive Renal Disease

317

569

6.89

176.64

7.8

2.7

0.71

2.00

mmol/l

6.41

233

417

Problems related to lifestyle

569

1596

3.92

176.56

3.7

3.2

1.49

1.59

mmol/l

0.20

407

1181

Falls/tendency to fall

4826

15352

1.61

175.98

4.0

3.9

1.59

1.54

mmol/l

0.35

3548

11117

Other bacterial intestinal infections

979

3779

2.81

175.54

5.9

3.4

1.66

1.84

mmol/l

0.74

742

2782

Finngen Rheumatological endpoints

4050

14168

1.67

175.03

3.8

3.3

1.55

1.60

mmol/l

0.36

2968

10324

Mental and behavioural disorders due to alcohol

2319

12202

1.93

174.98

4.0

3.4

1.75

1.52

mmol/l

1.76

1718

8855

Volume depletion

607

1814

3.79

173.42

6.7

3.6

1.51

1.95

mmol/l

1.37

436

1296

Pleural effusion

893

3326

2.96

173.28

5.3

3.1

2.72

1.52

mmol/l

14.85

727

2352

Hypothyroidism, drug reimbursement

489

819

4.46

170.45

3.9

2.7

1.51

1.37

mmol/l

0.38

362

598

Glomerulonephritis

678

2209

3.48

169.17

10.0

4.5

0.95

1.65

mmol/l

5.08

474

1628

Lung cancer and mesothelioma

852

2605

2.99

168.96

4.2

2.7

2.73

1.28

mmol/l

19.56

707

1782

Other disorders of teeth and supporting structures

1074

4405

2.61

168.74

5.2

3.2

1.66

1.86

mmol/l

0.86

809

3244

Polycystic ovarian syndrome, consortium definition

2449

7948

1.91

168.67

3.4

3.0

1.83

1.79

mmol/l

0.21

1815

5825

Sub-endpoint used in defining T1D endpoints

1546

7254

2.22

168.50

5.2

3.9

1.31

1.62

mmol/l

2.24

1123

5227

Other medical care

1828

9064

2.07

167.36

4.8

3.2

2.37

1.79

mmol/l

6.35

1403

6665

Diseases of liver

1599

7767

2.18

167.11

4.5

3.5

1.36

1.76

mmol/l

3.28

1163

5779

Disorders of thyroid, IBD co-morbidities

570

1127

3.83

165.06

3.6

3.3

1.77

1.70

mmol/l

0.14

422

791

Paroxysmal tachycardia

914

2893

2.81

164.32

4.5

2.9

1.79

1.45

mmol/l

1.68

664

2189

Other respiratory diseases principally affecting the interstitium

1013

4128

2.69

163.84

5.9

3.7

2.21

1.78

mmol/l

3.10

810

3009

Diseases of the myoneural junction and muscle

738

2569

3.21

163.24

5.1

4.0

1.64

1.83

mmol/l

0.61

584

1888

Bacterial intestinal infections, IBD co-morbidities

980

3927

2.70

162.86

6.0

3.6

1.59

1.81

mmol/l

0.99

743

2880

Other arrhythmias

2420

10217

1.87

162.72

3.5

3.0

1.71

1.49

mmol/l

2.17

1773

7506

Unspecified haematuria

2001

9020

2.00

162.05

4.5

3.6

1.35

1.77

mmol/l

4.69

1465

6618

Presence of other devices

1125

4805

2.50

161.34

4.1

3.4

1.58

2.03

mmol/l

3.67

849

3570

Migraine

1518

6111

2.18

160.57

3.2

3.9

1.20

1.70

mmol/l

6.38

1078

4383

Other disorders of kidney and ureter

767

2758

3.10

159.95

10.2

3.8

0.60

1.80

mmol/l

11.77

522

2025

Undetermined asthma

572

1714

3.58

158.81

4.6

2.7

1.64

1.24

mmol/l

1.73

432

1202

Type of accident

1336

6193

2.29

157.41

4.5

3.6

1.72

1.67

mmol/l

0.17

934

4556

Acute upper respiratory infections

4375

17686

1.59

156.88

4.2

3.4

1.69

1.67

mmol/l

0.13

3259

12891

Exposure to unspecified factor

4082

20335

1.60

155.97

4.1

3.8

1.68

1.61

mmol/l

0.56

3027

14837

Other symptoms and signs involving the digestive system and abdomen

811

3012

2.89

155.84

5.1

3.6

1.59

1.91

mmol/l

1.49

620

2260

Benign neoplasm of colon, rectum, anus and anal canal

2295

9010

1.89

155.45

4.3

3.2

1.52

1.84

mmol/l

3.28

1712

6636

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2033

10961

1.93

155.37

4.1

3.4

1.80

1.53

mmol/l

2.09

1509

7981

Deposits [accretions] on teeth

618

1953

3.61

154.74

16.2

4.9

1.12

1.50

mmol/l

1.89

470

1417

Cholelithiasis, broad definition with cholecystitis

3557

15136

1.66

153.17

3.6

3.4

1.67

1.78

mmol/l

0.93

2614

11201

Pain, not elsewhere classified

1124

4890

2.41

152.89

4.4

3.3

1.85

1.66

mmol/l

0.84

824

3564

Non-selective monoamine reuptake inhibitors

1633

7971

2.07

152.35

3.8

3.4

2.02

1.80

mmol/l

1.51

1270

5809

Disorders of mineral metabolism

497

1418

3.97

152.34

6.0

3.6

1.99

1.82

mmol/l

0.40

373

1059

Alcohol use disorder, ICD-based

1882

10011

1.97

150.64

4.1

3.4

1.73

1.53

mmol/l

1.21

1401

7283

Other external causes of accidental injury

3608

11105

1.67

150.43

3.9

1.58

1.61

mmol/l

0.15

2642

8046

Peripheral artery disease

2127

9395

1.91

150.02

5.2

3.4

1.67

1.86

mmol/l

1.29

1521

6960

Diseases of the skin and subcutaneous tissue

4444

14430

1.58

149.38

4.1

3.5

1.54

1.66

mmol/l

1.25

3278

10437

Cerebrovascular diseases

3212

14096

1.69

148.62

4.3

3.6

1.68

1.82

mmol/l

1.22

2360

10564

ILD, hospital admissions

861

3418

2.78

147.82

5.9

3.8

2.24

1.82

mmol/l

2.68

691

2496

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2424

13983

1.80

147.77

4.8

3.4

1.67

1.78

mmol/l

0.68

1795

10338

Other interstitial pulmonary diseases

867

3453

2.77

147.72

5.9

3.8

2.26

1.81

mmol/l

2.96

697

2524

Spondylopathies

3321

12351

1.68

147.48

3.7

3.4

1.89

1.71

mmol/l

1.77

2455

9106

Disorders of calcium metabolism

409

1048

4.51

147.09

6.1

3.5

1.94

1.85

mmol/l

0.17

311

789

Lower back pain or/and sciatica

4130

18616

1.58

146.40

3.3

3.4

1.86

1.63

mmol/l

3.57

3043

13636

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

997

4099

2.57

146.31

9.9

5.3

1.37

1.33

mmol/l

0.15

735

2979

Interstitial lung disease endpoints

867

3470

2.76

146.24

5.9

3.8

2.26

1.81

mmol/l

2.98

697

2536

Interstitial lung disease

867

3470

2.76

146.24

5.9

3.8

2.26

1.81

mmol/l

2.98

697

2536

Other dorsopathies, not elsewhere classified

4174

14188

1.59

144.91

3.3

3.4

1.55

1.61

mmol/l

0.53

3046

10309

Diseases of the ear and mastoid process

4863

16407

1.53

143.30

3.7

3.6

1.47

1.69

mmol/l

3.57

3535

11965

Other cataract

1876

7739

1.96

142.69

5.1

3.2

1.85

1.79

mmol/l

0.30

1397

5788

Diagnoses used for exclusion with ILD

1253

5918

2.25

141.40

4.8

3.5

2.34

1.74

mmol/l

6.38

978

4327

Accidents

3563

11105

1.65

141.34

3.9

1.59

1.61

mmol/l

0.11

2591

8046

Coronary atherosclerosis

2906

11290

1.72

140.44

4.3

3.3

1.76

1.78

mmol/l

0.06

2116

8525

Ischemic heart diseases

3249

12593

1.67

140.05

4.3

3.3

1.90

1.77

mmol/l

1.08

2411

9468

Enterocolitis due to Clostridium difficile

631

2203

3.18

138.41

6.9

3.5

1.65

1.92

mmol/l

0.83

478

1590

Ischaemic heart disease, wide definition

3208

12439

1.67

137.75

4.3

3.3

1.87

1.78

mmol/l

0.72

2388

9359

Schizophrenia or delusion, excluding more controls

1146

5201

2.28

137.35

3.5

3.1

2.42

1.61

mmol/l

9.20

883

3774

ILD medications: azathioprine

721

2697

2.87

136.57

11.4

3.3

1.05

1.61

mmol/l

4.10

556

1949

External causes of morbidity and mortality

2830

8380

1.73

136.39

4.2

3.9

1.70

1.61

mmol/l

0.58

2061

6048

Other headache syndromes

1331

6462

2.13

136.15

3.1

3.7

1.50

1.90

mmol/l

4.15

981

4691

Explicit bacterial Sepsis

566

1871

3.33

135.85

5.9

3.1

1.77

1.64

mmol/l

0.31

431

1330

Diseases of the digestive system

2118

12051

1.83

135.48

6.0

3.8

1.53

1.71

mmol/l

1.24

1541

8861

Cystitis

3456

13345

1.62

135.32

4.2

3.5

1.66

1.69

mmol/l

0.17

2572

9622

Cholelithiasis

3360

14895

1.63

134.98

3.5

3.4

1.67

1.79

mmol/l

1.03

2467

11029

Disorders of adult personality and behaviour

1107

5040

2.30

134.86

3.2

3.1

1.72

1.47

mmol/l

1.31

814

3622

AV-block

853

3139

2.64

134.79

5.0

3.2

1.92

1.55

mmol/l

1.78

644

2291

Personality disorders

1058

4754

2.33

133.19

3.2

3.0

1.82

1.47

mmol/l

2.00

774

3430

Diverticular disease of intestine

2891

11713

1.69

133.13

3.8

3.3

1.64

1.84

mmol/l

2.07

2149

8669

Soft tissue disorders

4389

15130

1.54

133.02

3.6

3.9

1.50

1.62

mmol/l

1.20

3181

10941

Fungal Sepsis

284

596

5.78

132.99

9.0

3.2

2.10

1.74

mmol/l

0.68

227

434

Benign neoplasm: Colon

2005

8542

1.87

132.96

4.3

3.3

1.47

1.86

mmol/l

4.49

1499

6311

All influenza (not pneumonia)

733

2811

2.79

132.23

7.0

3.1

1.62

1.36

mmol/l

1.16

569

2007

Dizziness and giddiness

3037

15389

1.65

132.09

3.5

1.62

1.74

mmol/l

1.02

2291

11308

Exposure to other specified factors

2974

17431

1.65

131.48

4.0

3.7

1.37

1.62

mmol/l

3.43

2206

12682

Viral pneumonia (unknown virus, not influenza)

421

1189

4.02

131.24

6.1

4.1

2.16

1.60

mmol/l

2.65

351

879

Streptococcal septicaemia

501

1580

3.55

131.15

6.2

3.3

1.77

1.66

mmol/l

0.23

385

1114

Cellulitis

1044

4740

2.35

130.14

5.4

3.8

1.68

1.64

mmol/l

0.11

774

3466

Other abnormal uterine and vaginal bleeding

936

2787

2.52

129.98

3.6

3.2

2.01

2.06

mmol/l

0.14

723

2093

Myalgia

945

4098

2.43

129.87

3.4

1.59

1.75

mmol/l

0.77

715

3010

Hypothyroidism, strict autoimmune

2901

11803

1.67

128.89

3.8

3.2

1.63

1.68

mmol/l

0.25

2177

8590

Implicit fungal Sepsis

262

537

5.94

126.22

9.2

2.9

2.17

1.77

mmol/l

0.77

213

389

Other and unspecified myopathies

524

1742

3.39

126.20

4.9

3.8

1.73

1.86

mmol/l

0.30

408

1270

Autoimmune diseases related-to ILD

3349

19053

1.58

126.19

4.3

3.3

1.73

1.63

mmol/l

0.74

2516

13891

Myocardial infarction, without ST-elevation

1886

9782

1.87

126.04

4.7

3.5

1.81

1.82

mmol/l

0.03

1409

7187

Osteoporosis

1138

5149

2.24

125.90

5.4

3.5

2.22

2.11

mmol/l

0.39

882

3862

Bipolar affective disorders

746

2958

2.65

124.47

3.4

3.1

1.35

1.57

mmol/l

0.77

568

2123

Myocardial infarction

2252

9462

1.78

124.40

4.7

3.4

1.80

1.76

mmol/l

0.18

1671

7130

Dysphagia

1089

5117

2.25

124.00

5.2

3.4

2.33

1.80

mmol/l

4.19

850

3803

Intracranial injury

2453

14368

1.70

123.71

4.0

3.9

1.65

1.62

mmol/l

0.14

1795

10495

Cutaneous abscess, furuncle and carbuncle

1109

5252

2.22

123.46

5.3

3.6

1.44

1.61

mmol/l

0.70

830

3825

Hydronephrosis

566

1973

3.13

123.40

6.1

2.9

0.73

2.04

mmol/l

8.49

380

1461

Pain (limb, back, neck, head abdominally)

3265

10306

1.62

123.35

4.3

4.1

1.54

1.63

mmol/l

0.68

2398

7517

Azathioprine

721

2843

2.71

123.00

11.4

3.6

1.05

1.58

mmol/l

3.75

556

2066

Other specific joint derangements/joint disorders

2809

11643

1.66

122.09

3.6

3.5

1.43

1.59

mmol/l

1.50

2054

8443

Statin medication

2659

9001

1.70

121.97

4.2

3.0

1.48

1.83

mmol/l

4.91

1931

6728

Atherosclerosis, excluding cerebral and coronary sclerosis

1946

8846

1.84

121.87

5.2

3.4

1.59

1.88

mmol/l

2.18

1402

6536

ILD, hospital admissions 1, main diag only

751

3072

2.69

121.23

5.9

3.8

2.31

1.84

mmol/l

2.87

595

2237

Polyneuropathies and other disorders of the peripheral nervous system

1083

5152

2.25

121.02

5.5

3.7

1.48

1.76

mmol/l

1.58

855

3763

Other sleep disorders

503

1656

3.28

120.46

4.1

4.2

1.79

1.85

mmol/l

0.13

361

1196

Pain in joint

2308

9005

1.74

120.16

3.6

1.39

1.66

mmol/l

3.33

1698

6609

Lung diseases due to external agents

769

3195

2.62

119.00

5.7

3.6

2.60

1.75

mmol/l

7.12

609

2279

Moderate visual impairment, binocular

270

602

5.57

118.69

6.2

4.4

0.85

1.95

mmol/l

3.73

214

434

Other diseases of the digestive system

1513

8146

1.95

117.74

6.1

3.8

1.53

1.81

mmol/l

1.81

1113

5966

Alcohol abuse, main dg, excluding more controls

671

2607

2.74

117.70

4.0

3.3

1.49

1.55

mmol/l

0.13

504

1898

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

695

2768

2.75

117.47

4.9

3.6

0.56

1.83

mmol/l

12.32

532

1967

Primary_lymphoid and hematopoietic malignant neoplasms

1128

5500

2.18

117.29

5.3

4.0

1.77

1.80

mmol/l

0.09

899

4033

Other and unspecified polyneuropathies, also in other diseases

964

4443

2.34

117.03

5.7

3.6

1.37

1.78

mmol/l

2.60

764

3258

Sensorineural hearing loss

3143

14189

1.60

116.47

3.7

1.66

1.83

mmol/l

1.77

2316

10588

Specific personality disorders

900

4012

2.35

115.59

3.1

3.0

1.82

1.48

mmol/l

1.76

667

2896

Any operation in hilmo

179

11.57

114.35

3.4

1.5

1.26

0.79

mmol/l

0.36

122

Other problems related to primary support group, including family circumstances

690

2703

2.71

114.15

15.7

4.6

0.99

1.15

mmol/l

0.67

553

1934

Familial hypercholesterolemia, with ischemic heart disease

571

2104

3.03

114.11

4.5

3.6

1.52

1.86

mmol/l

1.27

427

1537

Stroke, including SAH

2689

12480

1.65

114.11

4.2

3.6

1.73

1.83

mmol/l

0.61

1982

9328

Ulcer of lower limb, not elsewhere classified

731

3028

2.63

114.07

6.1

3.6

1.85

mmol/l

0.00

554

2221

Paralytic ileus and intestinal obstruction

1137

5609

2.13

113.63

4.8

3.5

1.85

1.91

mmol/l

0.17

858

4125

Stroke, excluding SAH

2580

11923

1.66

113.51

4.2

3.6

1.75

1.84

mmol/l

0.58

1912

8896

Iron deficiency anaemia secondary to blood loss (chronic)

781

3328

2.52

113.43

6.0

3.5

1.45

1.91

mmol/l

2.23

584

2437

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

1731

8579

1.85

112.44

3.7

3.5

2.13

1.84

mmol/l

1.97

1312

6329

Conductive and sensorineural hearing loss

3262

14800

1.57

112.32

3.8

3.7

1.64

1.81

mmol/l

1.67

2418

11024

Chronic nephritic syndrome

305

775

4.69

112.30

7.4

3.3

0.58

1.82

mmol/l

6.24

197

578

Disorders of parathyroid gland

937

4268

2.30

112.06

6.1

3.4

1.59

2.06

mmol/l

2.85

697

3203

Chronic periodontitis

735

3073

2.57

111.51

5.7

3.3

1.40

1.87

mmol/l

2.55

584

2266

Systemic connective tissue disorders

1438

7773

1.93

109.65

4.7

3.4

1.72

1.90

mmol/l

0.97

1093

5772

Open wound of head

2245

13547

1.69

109.32

4.4

4.0

1.65

1.63

mmol/l

0.10

1674

9922

Emotionally unstable personality disorder

496

1707

3.09

109.17

3.0

2.8

1.60

1.32

mmol/l

0.83

368

1231

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

3791

16735

1.51

109.01

4.1

3.4

1.84

1.68

mmol/l

1.73

2857

12292

Insulin, fast-acting (human)

639

2515

2.70

108.93

5.5

3.0

1.29

1.63

mmol/l

1.43

454

1827

Elevated blood glucose level

487

1689

3.21

108.54

5.3

4.1

1.61

1.76

mmol/l

0.34

363

1235

Acute sinusitis

1873

10163

1.77

108.53

3.9

3.0

1.48

1.62

mmol/l

0.89

1376

7384

Fentanyl

521

1862

3.03

108.29

5.1

3.4

2.41

1.97

mmol/l

1.54

410

1324

Other/unspecified dorsalgia

1476

8023

1.90

107.84

3.8

3.3

1.87

1.75

mmol/l

0.59

1121

5877

Gonarthrosis [arthrosis of knee](FG)

2992

11344

1.59

107.13

3.4

3.2

1.74

1.76

mmol/l

0.12

2248

8436

Diabetic retinopathy, excluding more controls

1358

3970

2.06

107.06

5.5

3.1

1.31

1.54

mmol/l

1.10

986

2924

Visual impairment including blindness (binocular or monocular)

436

1443

3.42

106.09

6.2

4.6

1.12

1.90

mmol/l

3.29

329

1063

Dorsopathies

4140

14522

1.48

105.23

3.6

3.5

1.56

1.60

mmol/l

0.30

3021

10546

Major coronary heart disease event excluding revascularizations

2747

12156

1.61

104.95

4.5

3.4

1.77

1.80

mmol/l

0.15

2027

9152

Spinal stenosis

2130

10114

1.71

104.62

3.9

3.6

1.89

1.80

mmol/l

0.47

1623

7544

Mycoses

1122

5684

2.08

104.41

5.6

3.5

1.84

1.75

mmol/l

0.36

864

4164

Leisure time condition

824

3728

2.35

103.74

4.4

3.8

1.65

1.68

mmol/l

0.06

565

2723

Viral hepatitis, IBD co-morbidity

175

285

6.50

103.58

3.3

2.9

1.85

1.52

mmol/l

0.45

134

201

Injuries to the thorax

1861

11034

1.75

103.24

4.0

3.5

1.93

1.66

mmol/l

2.20

1389

8076

ILD-related respiratory insufficiency

268

666

5.02

103.20

9.4

4.3

2.71

1.90

mmol/l

2.72

229

491

Other CVD

934

4471

2.23

102.64

4.2

3.7

1.90

mmol/l

0.02

697

3260

Other intervertebral disc disorders

3181

12855

1.55

102.48

3.4

3.3

1.64

1.67

mmol/l

0.16

2353

9424

Diseases of the eye and adnexa

3305

10923

1.55

101.86

4.6

3.6

1.41

1.50

mmol/l

0.74

2404

7927

Follow-up care involving plastic surgery

243

554

5.05

101.64

4.4

2.8

1.28

1.74

mmol/l

1.03

193

409

Other disorders of ear

3703

16921

1.49

101.13

3.8

1.64

1.72

mmol/l

0.72

2737

12521

Injuries to the ankle and foot

2570

15031

1.60

100.71

3.7

3.6

1.33

1.56

mmol/l

2.58

1841

10941

Certain disorders involving the immune mechanism

882

4153

2.26

100.60

5.9

3.9

1.50

1.70

mmol/l

0.87

674

3068

Sulfonylureas

1623

7390

1.83

100.29

4.7

3.6

1.54

1.92

mmol/l

2.80

1143

5527

GI-bleeding

1464

8198

1.87

100.22

6.2

3.8

1.57

1.82

mmol/l

1.45

1070

6002

Bacterial pneumoniae

1554

7792

1.83

98.96

5.5

3.0

2.50

1.43

mmol/l

20.91

1173

5575

Hypotension

810

3731

2.33

98.41

3.9

3.7

1.81

1.94

mmol/l

0.38

601

2703

Cystic kidney disease

268

690

4.73

97.76

12.8

4.3

0.24

1.77

mmol/l

9.84

168

506

Primary_lymphoid and hematopoietic malignant neoplasms

1128

5881

2.03

97.46

5.3

4.1

1.77

1.75

mmol/l

0.07

899

4331

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2018

12120

1.68

97.23

3.6

1.45

1.72

mmol/l

2.88

1546

8888

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

730

3245

2.43

97.08

5.2

3.6

1.17

1.75

mmol/l

2.50

530

2395

Pneumonitis due to solids and liquids

475

1727

3.05

97.07

5.7

3.7

2.55

1.80

mmol/l

3.45

377

1238

Benign neoplasm of colon, rectum, anus and anal canal

2475

14378

1.60

97.00

4.2

3.5

1.50

1.88

mmol/l

5.20

1852

10734

Generalized anxiety disorder

557

2169

2.70

96.43

3.0

3.1

1.20

1.45

mmol/l

0.91

421

1545

Migraine without aura

591

2360

2.60

96.38

3.5

4.2

0.96

1.42

mmol/l

2.53

399

1650

Gastroduodenal ulcer

1164

6121

1.99

96.31

4.8

3.5

1.73

1.91

mmol/l

0.74

869

4438

Shoulder lesions

3005

12170

1.55

96.30

3.3

3.4

1.67

1.76

mmol/l

0.67

2198

8943

Menorrhagia

1214

3426

2.02

96.10

3.4

3.1

1.80

1.91

mmol/l

0.42

916

2524

Symptoms and signs involving the skin and subcutaneous tissue

2633

17161

1.57

95.99

4.2

3.7

1.51

1.70

mmol/l

1.99

2008

12579

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1112

5703

2.01

95.62

11.3

3.8

1.34

1.27

mmol/l

0.31

858

3992

Ischaemic Stroke, excluding all haemorrhages

2375

11442

1.62

94.80

4.2

3.6

1.76

1.85

mmol/l

0.56

1760

8530

Candidiasis

601

2469

2.61

94.47

6.0

3.7

1.86

1.75

mmol/l

0.27

464

1812

Behavioural syndromes associated with physiological disturbances and physical factors

1211

6487

1.94

94.26

4.4

3.7

1.65

1.44

mmol/l

1.36

886

4615

Other pleural conditions

542

2136

2.77

94.10

6.1

3.2

2.72

1.52

mmol/l

9.75

444

1495

Hyperparathyroidism

806

3718

2.27

93.67

6.2

3.3

1.40

2.10

mmol/l

4.67

587

2787

Hypothyroidism, other/unspecified

3404

15374

1.49

93.65

3.7

3.5

1.69

1.66

mmol/l

0.20

2553

11212

Hernia of abdominal wall

1848

11232

1.70

93.51

4.6

3.6

1.68

1.69

mmol/l

0.03

1375

8268

Viral and other specified intestinal infections

891

4204

2.16

93.25

9.1

3.6

1.19

1.42

mmol/l

1.09

617

2968

Congenital malformations, deformations and chromosomal abnormalities

2156

12986

1.63

93.17

5.8

3.5

1.44

1.50

mmol/l

0.30

1557

9404

Unspecified mental disorder

1496

8589

1.80

92.42

3.4

3.2

2.20

1.57

mmol/l

7.71

1131

6263

Other systemic involvement of connective tissue (FG)

992

4979

2.06

92.19

3.9

3.2

1.90

1.88

mmol/l

0.06

731

3697

Hypothyreosis and Thyroxine purchase for inclusion criteria

3491

15896

1.48

91.99

3.7

3.5

1.70

1.67

mmol/l

0.17

2615

11599

Major coronary heart disease event

2880

12800

1.54

91.70

4.4

3.5

1.78

1.81

mmol/l

0.15

2101

9639

Gonarthrosis

2550

9404

1.59

91.68

3.3

1.71

1.77

mmol/l

0.32

1906

6957

Other joint disorders

3409

12364

1.50

91.67

3.5

3.6

1.43

1.59

mmol/l

1.69

2466

8946

Diseases of the musculoskeletal system and connective tissue

2279

7092

1.65

91.66

4.3

4.4

1.40

1.49

mmol/l

0.59

1674

5063

Irritable bowel syndrome

995

5039

2.05

91.61

3.3

3.2

1.45

1.82

mmol/l

2.56

712

3721

Symptoms and signs concerning food and fluid intake

516

2004

2.78

91.38

7.5

3.8

1.90

1.63

mmol/l

0.88

389

1441

Panic disorder

535

2100

2.67

91.12

3.4

3.1

1.60

1.44

mmol/l

0.41

382

1510

Arthrosis

2766

9949

1.56

90.92

3.2

3.3

1.66

1.74

mmol/l

0.49

2035

7333

Motor neuron disease

135

199

8.23

90.74

4.9

3.8

3.51

1.69

mmol/l

4.81

125

148

Other or unspecified ileus, impaction or obstruction

821

3908

2.22

90.68

4.9

3.5

2.05

1.97

mmol/l

0.19

620

2862

Kela-code for severe mental illness

1377

7771

1.83

90.52

3.4

3.2

2.25

1.58

mmol/l

7.77

1055

5675

Arthropathies in other diseases classified elsewhere

238

587

4.69

90.35

6.8

3.4

1.64

1.80

mmol/l

0.24

181

444

Chronic gastritis

1157

6220

1.94

90.05

3.9

3.4

1.57

1.98

mmol/l

3.02

892

4576

Other diseases of blood and blood-forming organs, wide

968

4915

2.08

90.03

5.8

3.9

2.15

1.75

mmol/l

2.58

713

3661

Diseases of external ear

1406

8037

1.82

89.49

4.5

3.8

1.35

1.68

mmol/l

2.81

1042

5892

Malignant neoplasm, wide definition for exclusion

3364

13640

1.49

89.49

4.0

3.6

1.76

1.64

mmol/l

1.14

2584

9950

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

3363

13639

1.49

89.34

4.0

3.6

1.76

1.64

mmol/l

1.12

2583

9949

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

3366

13657

1.49

89.26

4.0

3.6

1.76

1.64

mmol/l

1.10

2585

9962

Other symptoms and signs involving the circulatory and respiratory systems

334

1035

3.54

89.26

5.2

4.0

1.57

1.48

mmol/l

0.13

255

751

Motor neuron disease (with DMD)

150

253

7.26

89.01

5.0

4.2

3.21

1.74

mmol/l

4.01

137

186

Parodontitis or operation codes

3383

17283

1.47

88.60

3.9

3.3

1.57

1.77

mmol/l

2.39

2513

12794

Sequelae of cerebrovascular disease

1530

7852

1.78

88.32

4.2

3.5

1.61

1.90

mmol/l

2.15

1136

5802

Congenital malformations of the urinary system

401

1415

3.23

87.85

12.2

5.5

0.54

1.36

mmol/l

5.11

258

1053

Coxarthrosis [arthrosis of hip](FG)

2131

9718

1.63

87.59

3.4

3.3

1.87

1.82

mmol/l

0.20

1573

7254

Acute suppurative otitis media

1007

4837

2.02

87.57

6.0

4.1

0.92

1.30

mmol/l

3.22

717

3409

Other viral diseases

1201

6572

1.90

87.18

8.3

4.2

1.44

1.41

mmol/l

0.09

891

4701

Parodontitis

3372

17288

1.47

87.05

3.8

3.3

1.57

1.77

mmol/l

2.33

2506

12799

Chronic periodontitis, including avohilmo

3358

17282

1.47

86.72

3.8

3.3

1.57

1.77

mmol/l

2.41

2495

12797

Coxarthrosis

1992

8386

1.66

86.29

3.5

3.4

1.83

1.82

mmol/l

0.05

1466

6243

Hernia

3608

17215

1.45

86.22

4.4

3.5

1.62

1.73

mmol/l

0.94

2705

12637

Injuries to the abdomen, lower back, lumbar spine and pelvis

1552

9135

1.75

86.16

4.3

3.5

2.04

1.74

mmol/l

2.36

1143

6680

Intestinal stricture

1296

7323

1.85

86.10

5.5

3.7

1.76

1.81

mmol/l

0.14

960

5449

Excessive, frequent and irregular menstruation

1298

3913

1.89

86.03

3.7

3.1

1.66

1.77

mmol/l

0.48

953

2818

Malignant neoplasm

3397

13961

1.47

85.96

4.0

3.7

1.75

1.66

mmol/l

0.68

2604

10217

Disorders of the thyroid gland

3622

16654

1.45

85.83

3.7

3.5

1.68

1.65

mmol/l

0.17

2692

12128

Injury, poisoning and certain other consequences of external causes

2216

6955

1.63

85.77

4.4

4.1

1.64

1.60

mmol/l

0.20

1617

5071

Other diseases of anus and rectum

1192

6570

1.89

85.12

4.4

3.5

1.72

1.86

mmol/l

0.59

892

4817

Acute peritonitis

379

1314

3.23

84.90

11.1

3.8

1.35

1.86

mmol/l

1.34

271

967

Hypothyroidism, strict autoimmune, 3 medication purchases required

3105

14554

1.48

84.00

3.7

3.4

1.71

1.69

mmol/l

0.08

2339

10604

Other pulmonary heart/vessel disease

296

896

3.79

83.86

8.2

4.5

2.63

1.91

mmol/l

2.24

250

659

Internal derangement of knee

1415

8206

1.77

83.69

3.4

3.3

1.60

1.68

mmol/l

0.38

1061

6033

Arthropathies

3543

12572

1.46

83.53

3.6

3.7

1.42

1.58

mmol/l

1.69

2546

9095

Injuries to the knee and lower leg

4568

19148

1.39

83.41

3.9

3.6

1.67

1.64

mmol/l

0.23

3413

13929

Second line medication for Crohn's disease

2123

13695

1.59

83.11

6.3

3.5

1.56

1.68

mmol/l

0.88

1599

10093

Chronic tubulo-interstitial nephritis

222

550

4.55

83.00

7.7

2.3

0.28

2.00

mmol/l

7.54

151

413

Secondary right heart disease

268

766

4.04

82.96

7.8

4.3

2.64

1.90

mmol/l

2.00

225

563

Enlarged lymph nodes

632

2801

2.37

82.87

4.5

3.5

2.11

1.63

mmol/l

2.64

474

2047

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

810

3579

2.15

82.87

7.3

5.4

1.04

1.01

mmol/l

0.11

531

2496

Pacemaker

1462

8411

1.77

82.47

4.5

3.7

1.92

1.88

mmol/l

0.14

1073

6193

Other disorders of glucose regulation and pancreatic internal secretion

456

1763

2.83

82.31

8.0

4.5

1.57

1.63

mmol/l

0.10

338

1291

KRA_PSY_EATING, excluding more controls

296

884

3.52

81.91

4.9

3.3

1.45

1.12

mmol/l

0.92

204

584

Alcohol dependence

1134

6243

1.89

81.86

4.2

3.4

1.96

1.55

mmol/l

2.68

850

4537

Diseases of oral cavity, salivary glands and jaws

3790

13808

1.43

81.32

5.2

3.6

1.52

1.72

mmol/l

2.40

2795

10127

Use of pramipexole

916

4732

2.04

81.05

4.2

3.5

1.86

1.92

mmol/l

0.18

725

3538

Abnormal results of function studies

424

1591

2.90

80.94

5.3

3.9

1.73

1.62

mmol/l

0.23

318

1155

Chronic ulcer of skin, not elsewhere classified

373

1314

3.15

80.88

6.1

3.4

1.99

1.93

mmol/l

0.08

282

963

Dermatitis

2266

14919

1.56

80.78

4.7

3.6

1.50

1.71

mmol/l

1.87

1716

10950

Emphysema

376

1329

3.11

80.71

5.0

3.3

2.22

1.55

mmol/l

2.46

294

932

L04AX Other immunosuppressants

2069

13383

1.59

80.07

6.4

3.5

1.59

1.69

mmol/l

0.61

1564

9851

Other diseases of liver

736

3528

2.20

79.99

4.5

3.5

1.42

1.79

mmol/l

1.53

532

2612

Bacterial pneumonia, not elsewhere classified

1420

7374

1.76

79.92

5.3

3.0

2.52

1.44

mmol/l

19.49

1071

5276

Other gastritis (incl. Duodenitis)

929

4841

2.01

79.61

4.1

3.5

1.73

1.90

mmol/l

0.68

680

3543

Unspecified fall

1980

12631

1.60

79.03

4.3

4.0

1.71

1.65

mmol/l

0.25

1482

9227

Nephrotic syndrome

272

823

4.01

79.00

15.0

6.1

1.03

1.46

mmol/l

1.21

189

604

Other diseases of hard tissues of teeth

2426

12029

1.54

78.66

6.3

3.4

1.33

1.67

mmol/l

4.97

1775

8830

Acute alcohol intoxication, ICD10

830

4182

2.08

78.54

3.9

3.4

1.44

1.58

mmol/l

0.40

618

3060

Alcohol abuse, main dg

671

3126

2.27

78.47

4.0

3.5

1.49

1.57

mmol/l

0.17

504

2294

Diseases of peritoneum

500

2064

2.62

78.44

9.1

3.6

1.47

1.90

mmol/l

1.47

363

1515

Fracture of rib(s), sternum and thoracic spine

1223

6981

1.83

78.43

4.2

3.5

1.95

1.73

mmol/l

1.16

934

5141

Dermatitis and eczema

4186

20099

1.39

78.41

4.2

3.7

1.47

1.67

mmol/l

2.68

3115

14650

Parodontitis and operation codes

3140

17117

1.46

78.29

3.8

3.4

1.58

1.76

mmol/l

1.92

2337

12685

Myocardial infarction, strict

1945

9030

1.62

77.83

4.5

3.4

1.73

1.75

mmol/l

0.08

1424

6786

Migraine with aura

637

2889

2.27

77.74

3.1

3.7

1.05

1.65

mmol/l

4.13

450

2045

Noninfective enteritis and colitis

1824

11536

1.63

77.67

5.0

4.0

1.50

1.60

mmol/l

0.50

1342

8460

Benign neoplasms

2810

10799

1.50

77.55

4.0

3.4

1.37

1.49

mmol/l

0.97

2029

7654

Injuries to the shoulder and upper arm

3180

18817

1.45

77.38

3.5

3.6

1.78

1.69

mmol/l

0.65

2359

13836

Exclusions for E4_PCOS_BROAD

803

4030

2.11

77.37

6.0

4.8

1.82

1.56

mmol/l

1.36

618

2965

Suppurative and unspecified otitis media

1312

6735

1.78

77.20

5.1

3.9

1.14

1.43

mmol/l

2.36

942

4764

Diabetic retinopathy, strict definition

972

4587

2.01

77.09

6.1

3.5

1.29

1.70

mmol/l

2.33

696

3300

Disorder of lipoprotein metabolism, unspecified

608

2752

2.36

76.79

4.7

3.3

1.30

1.95

mmol/l

3.02

447

2050

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

340

1165

3.18

76.78

4.1

3.8

1.46

1.45

mmol/l

0.02

244

844

Failure and rejection of transplanted organs and tissues

138

254

7.32

76.72

17.0

4.8

1.34

1.62

mmol/l

0.37

113

185

Somatoform disorder

614

2777

2.32

76.69

3.4

3.2

2.01

1.76

mmol/l

1.05

462

2020

Injuries to the hip and thigh

1859

10833

1.62

76.57

4.2

3.6

1.96

1.79

mmol/l

1.00

1393

7970

Irregular menses

1318

6177

1.77

76.41

3.1

2.9

1.52

1.61

mmol/l

0.42

951

4489

Inflammatory diseases of female pelvic organs

1798

8469

1.63

76.40

3.3

3.1

1.66

1.84

mmol/l

1.19

1332

6248

Neoplasms

2934

10782

1.48

76.38

4.3

3.8

1.48

1.43

mmol/l

0.35

2165

7611

Schizophrenia, schizotypal and delusional disorders

1155

6514

1.83

76.23

3.5

3.1

2.43

1.54

mmol/l

11.15

888

4769

Cardiomyopathy

724

3512

2.17

76.04

5.3

3.2

1.97

1.51

mmol/l

2.18

521

2579

Dental pulpitis 4

4246

16159

1.39

75.84

3.3

3.7

1.58

1.67

mmol/l

0.89

3086

11841

Other blood glucose lowering drugs, excl. Insulins

727

3547

2.17

75.62

3.9

3.5

1.70

1.94

mmol/l

0.85

532

2664

Dental pulpitis 1

4245

16168

1.39

75.55

3.4

3.7

1.58

1.67

mmol/l

0.82

3083

11849

Benign neoplasm: Colon

2053

13185

1.57

75.19

4.3

3.5

1.44

1.90

mmol/l

6.17

1537

9845

Schizophrenia or delusion

1146

6479

1.83

75.02

3.5

3.1

2.42

1.54

mmol/l

11.02

883

4739

Dental operations

2723

9479

1.51

74.66

4.3

3.8

1.62

1.80

mmol/l

1.59

2018

6939

Diseases of pulp and periapical tissues, including avohilmo

4235

16156

1.38

74.56

3.3

3.7

1.58

1.67

mmol/l

0.76

3077

11840

Dental caries 3 and operation codes

3655

13440

1.42

74.54

4.0

3.9

1.55

1.73

mmol/l

2.14

2709

9850

Emotional disorders starting during childhood or adolecense, excluding more controls

264

774

3.66

74.19

4.5

4.8

1.08

1.14

mmol/l

0.12

161

540

Visual disturbances and blindness

1941

12607

1.58

74.12

4.5

3.7

1.45

1.77

mmol/l

3.32

1420

9299

Gastric ulcer

776

3909

2.09

73.71

4.9

3.6

1.88

1.91

mmol/l

0.08

582

2831

Dental caries 1 and operation codes

3524

12902

1.43

73.67

4.2

3.8

1.56

1.75

mmol/l

2.27

2609

9460

Transport accidents

1577

8598

1.66

73.66

3.6

3.4

1.57

1.59

mmol/l

0.10

1176

6176

Amputation

514

2219

2.51

73.32

6.1

3.5

1.45

1.81

mmol/l

1.03

372

1592

Charcot foot

139

265

6.49

73.01

8.4

2.9

1.52

1.86

mmol/l

0.42

101

191

Carpal tunnel syndrome

2132

12740

1.55

72.95

3.5

3.3

1.76

1.77

mmol/l

0.05

1600

9434

Cardiomyopathies, Primary/intrinsic

547

2427

2.40

72.34

5.1

3.2

1.99

1.45

mmol/l

2.29

390

1768

Other neurological diseases

2778

15580

1.47

72.09

4.2

3.6

1.79

1.76

mmol/l

0.13

2028

11592

Idiopathic pulmonary fibrosis

418

1665

2.78

71.79

6.7

3.5

2.44

1.89

mmol/l

2.28

343

1189

Pain associated with micturition

513

2224

2.46

71.71

3.9

4.1

1.77

1.82

mmol/l

0.10

376

1617

Speech disturbances, not elsewhere classified

443

1808

2.67

71.65

4.4

3.5

2.26

1.93

mmol/l

1.10

351

1309

Superficial injury of lower leg

928

5000

1.93

71.48

4.0

3.5

1.77

1.73

mmol/l

0.13

688

3627

Fibrosis and cirrhosis of liver

380

1448

2.89

70.99

5.1

3.6

0.76

1.86

mmol/l

4.12

265

1068

Any event in cancer register

3363

14289

1.42

70.68

3.8

3.5

1.68

1.66

mmol/l

0.14

2557

10414

Benign neoplasms

3779

15383

1.39

70.54

3.9

3.5

1.47

1.62

mmol/l

1.53

2750

11118

Hyperkinetic disorders, excluding more controls

388

1439

2.76

70.05

5.5

4.2

1.00

1.08

mmol/l

0.19

257

977

Acidosis

161

363

5.48

69.97

7.5

3.7

0.46

1.67

mmol/l

1.98

120

281

Polyuria

915

4959

1.93

69.88

3.9

3.5

1.76

mmol/l

0.01

701

3594

Adrenocortical insufficiency

225

643

4.02

69.65

5.8

4.0

2.15

1.78

mmol/l

0.78

175

488

Speech and linguistic disorders, excluding more controls

417

1569

2.68

68.98

9.7

5.9

1.04

1.17

mmol/l

0.38

291

1111

Chronic periodontitis, complicated

454

1907

2.58

68.88

6.0

3.4

1.31

1.79

mmol/l

1.73

358

1414

Rheumatism, unspecified

521

2303

2.38

68.87

3.4

1.92

1.96

mmol/l

0.07

399

1776

Convalescence

264

832

3.48

68.87

3.3

3.0

1.14

1.85

mmol/l

2.79

210

624

Other disorders involving the immune mechanism, not elsewhere classified

224

650

4.05

68.41

7.4

5.0

0.46

1.66

mmol/l

4.64

164

477

Drug-induced cataract

182

460

4.79

68.10

12.1

3.7

0.95

1.95

mmol/l

2.83

145

349

Persistent mood disorders

715

3589

2.07

67.92

3.9

3.3

1.86

1.80

mmol/l

0.16

555

2617

Acute pancreatitis

821

4337

1.99

67.90

4.2

3.5

1.55

1.71

mmol/l

0.45

596

3200

Donors of organs and tissues

108

172

7.72

67.88

5.9

2.7

1.39

1.74

mmol/l

0.46

118

Acute alcohol intoxication

1035

5867

1.83

67.78

4.4

3.5

1.64

1.55

mmol/l

0.28

780

4246

IgA nephropathy (IgA glomerulonephritis)

177

438

4.83

67.78

7.6

3.4

0.32

1.60

mmol/l

3.80

126

326

Orthopaedic devices associated with adverse incidents

152

339

5.77

67.72

4.0

3.6

1.79

2.06

mmol/l

0.37

121

259

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

293

986

3.18

67.67

2.9

3.1

1.88

1.35

mmol/l

1.50

216

712

Dental caries 3

3368

12383

1.42

67.32

4.0

1.60

1.74

mmol/l

1.29

2488

9084

Other/unspecified cytomegaloviral diseases

157

359

5.45

67.26

11.3

5.5

0.80

1.49

mmol/l

1.41

118

273

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

215

617

4.12

66.94

7.5

5.0

0.46

1.60

mmol/l

4.08

158

450

Other noninfective gastroenteritis and colitis

1036

5897

1.83

66.94

6.1

4.5

1.36

1.63

mmol/l

1.44

769

4334

Artrosis, including avohilmo

3171

12425

1.43

66.89

3.1

3.5

1.65

1.67

mmol/l

0.14

2310

9131

Cardiomyopathy (excluding other)

552

2540

2.30

66.83

5.1

3.2

1.96

1.45

mmol/l

2.07

394

1842

Gonarthrosis,primary

3371

15397

1.40

66.53

3.3

3.5

1.73

1.79

mmol/l

0.42

2547

11437

Traumatic subdural haemorrhage

484

2068

2.42

66.42

4.1

3.7

1.89

1.93

mmol/l

0.07

355

1466

Other degenerative diseases of the nervous system

838

3330

1.96

66.19

3.2

3.6

1.91

1.87

mmol/l

0.11

627

2359

Other and unspecified effects of external causes

1010

5719

1.83

66.09

4.4

4.1

1.77

1.50

mmol/l

1.48

730

4161

Diabetic retinopathy

1663

6700

1.65

66.08

5.3

3.6

1.41

1.73

mmol/l

2.26

1198

4860

Other symptoms and signs involving cognitive functions and awareness

1698

10291

1.59

65.92

3.8

3.6

1.84

1.85

mmol/l

0.02

1251

7601

Hypoglycaemia, other or unspecified

366

1420

2.82

65.85

7.9

4.8

1.63

1.61

mmol/l

0.03

274

1051

Impingement syndrome of shoulder

952

5311

1.86

65.76

3.1

3.4

1.45

1.72

mmol/l

1.72

728

3972

Disorders of psychological development

608

2702

2.22

65.62

9.5

6.4

1.04

1.14

mmol/l

0.36

423

1921

Cytomegalovirus infection, IBD co-morbidity

173

434

4.84

65.47

11.0

5.4

0.89

1.64

mmol/l

1.70

131

335

Functional dyspepsia

919

5077

1.87

65.19

3.5

3.3

1.63

1.88

mmol/l

1.24

669

3730

Rheumatoid arthritis

1170

6271

1.75

65.12

3.9

3.3

2.09

1.83

mmol/l

1.67

869

4639

Other and unspecified dermatitis

1832

12083

1.55

64.99

4.8

3.6

1.42

1.74

mmol/l

3.26

1387

8865

Idiopathic gout

460

2001

2.51

64.95

5.2

3.5

1.97

1.79

mmol/l

0.36

322

1457

Mental and behavioural disorders due to opioids

181

462

4.31

64.60

3.7

2.8

2.48

1.27

mmol/l

3.52

141

329

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

402

1647

2.66

64.60

5.4

3.6

1.59

1.91

mmol/l

0.80

302

1191

Viral infections characterized by skin and mucous membrane lesions

1585

10144

1.61

64.53

5.8

3.9

1.37

1.62

mmol/l

1.88

1177

7424

Malignant neoplasm of bladder

410

1704

2.64

64.24

5.3

3.7

0.23

1.85

mmol/l

12.03

314

1207

Polyarthrosis

743

3695

2.01

64.04

4.0

3.4

2.40

2.06

mmol/l

1.61

566

2826

Symptoms and signs involving the nervous and musculoskeletal systems

2173

14893

1.49

63.80

3.8

4.0

1.99

1.64

mmol/l

4.13

1574

10979

Decubitus ulcer and pressure area

314

1148

3.03

63.76

6.1

3.5

2.19

1.90

mmol/l

0.52

240

841

Fibromyalgia

309

1105

2.96

63.63

2.6

3.1

1.76

1.72

mmol/l

0.07

232

818

Cytomegaloviral disease

174

447

4.68

63.61

10.9

5.0

0.90

1.66

mmol/l

1.79

132

336

Ventral hernia

947

5340

1.85

63.40

4.6

3.5

1.77

1.85

mmol/l

0.27

712

3938

Cirrhosis of liver, NAS

288

1013

3.21

63.36

4.9

3.6

0.71

1.91

mmol/l

3.50

193

755

Peripheral artery operations in Hilmo

596

2890

2.19

63.29

5.6

3.4

1.39

1.87

mmol/l

1.79

423

2079

Peripheral arterial reconstruction

767

4072

1.99

63.16

5.0

3.6

1.59

1.85

mmol/l

0.93

553

2947

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

910

5089

1.87

62.95

3.3

3.5

2.13

1.80

mmol/l

1.38

671

3744

Injuries to the wrist and hand

3617

19491

1.37

62.62

3.3

3.7

1.50

1.65

mmol/l

1.60

2606

14298

Other systemic involvement of connective tissue

1011

5822

1.80

62.62

4.0

3.4

1.87

1.91

mmol/l

0.10

746

4308

Cholecystitis

606

2966

2.16

62.57

4.2

3.6

1.74

1.83

mmol/l

0.19

438

2185

Phobic anxiety disorders

453

1962

2.41

62.37

4.4

3.2

1.20

1.37

mmol/l

0.42

338

1407

Osteomyelitis

348

1362

2.82

61.88

6.5

4.0

1.38

1.73

mmol/l

0.84

255

1001

Dental caries 1

3181

11758

1.41

61.67

4.2

4.0

1.59

1.77

mmol/l

1.77

2348

8641

Dental caries, including avohilmo

3176

11749

1.41

61.35

4.2

4.0

1.59

1.77

mmol/l

1.74

2345

8636

Focal epilepsy

909

5120

1.86

61.27

4.7

4.4

1.56

1.62

mmol/l

0.19

673

3742

Mental and behavioural disorders due to sedatives or hypnotics

300

1087

2.97

60.98

4.3

3.3

2.42

1.58

mmol/l

3.03

235

814

Diseases of middle ear and mastoid

2005

11110

1.51

60.79

4.4

3.6

1.26

1.52

mmol/l

2.79

1443

8018

Combinations of oral blood glucose lowering drugs

1064

6280

1.76

60.59

3.3

3.5

1.60

1.75

mmol/l

0.60

746

4719

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

193

541

3.93

60.47

7.3

2.7

1.41

1.33

mmol/l

0.10

142

407

Nonsuppurative otitis media

885

4250

1.86

60.16

6.1

4.3

1.17

1.41

mmol/l

1.26

633

2987

Haemorrhoids and perianal venous thrombosis

1087

6466

1.74

59.58

3.7

3.3

1.63

1.94

mmol/l

2.07

817

4764

Deforming dorsopathies

1006

5873

1.77

59.10

4.6

3.5

1.83

1.79

mmol/l

0.16

771

4334

Phlebitis and thrombophlebitis (not including DVT)

839

4661

1.87

58.91

3.8

3.3

1.92

1.78

mmol/l

0.51

630

3454

Hyperplasia of prostate

1581

5779

1.61

58.75

3.8

3.6

1.57

1.58

mmol/l

0.01

1138

4198

Other viral diseases, not elsewhere classified

803

4403

1.90

58.66

9.4

4.7

1.52

1.40

mmol/l

0.41

593

3204

Other disorders of adrenal gland

263

919

3.21

58.38

6.2

4.9

2.15

1.52

mmol/l

2.07

205

689

Urticaria and erythema

1292

8071

1.65

58.36

5.0

4.0

1.53

1.60

mmol/l

0.36

985

5903

Other arthritis (FG)

1095

6564

1.72

58.28

4.2

3.4

1.82

1.71

mmol/l

0.45

819

4836

Cervical disc disorders

1319

8291

1.64

58.10

3.6

3.5

1.64

1.77

mmol/l

0.65

981

6154

Allergic asthma (mode), excluding more controls

641

3194

2.02

57.90

3.1

2.6

1.44

1.07

mmol/l

1.79

454

2225

Dental pulpitis 2

2883

10621

1.42

57.69

4.3

4.0

1.56

1.78

mmol/l

2.19

2122

7810

Osteoporosis with pathological fracture (FG)

293

1084

2.93

57.55

5.2

3.2

2.54

2.31

mmol/l

0.39

229

834

Bacterial pneumonia (organism specified)

1713

10395

1.54

57.43

5.6

3.5

2.43

1.62

mmol/l

14.28

1292

7553

Alcoholic liver disease

463

2124

2.34

57.20

4.8

3.5

1.28

1.71

mmol/l

1.12

343

1553

Unknown and unspecified causes of morbidity

303

1139

2.83

57.05

3.9

3.2

1.71

1.67

mmol/l

0.06

206

827

Acute pancreatitis (for exclusion)

821

4592

1.87

56.79

4.2

3.5

1.55

1.78

mmol/l

0.75

596

3363

Open wound of lower leg

587

2944

2.10

56.56

5.0

3.6

1.89

1.78

mmol/l

0.27

442

2132

Vitreous haemorrhage

446

2022

2.36

56.52

6.3

3.5

1.19

1.87

mmol/l

3.66

322

1478

Other diseases of upper respiratory tract

4351

17449

1.32

56.22

3.9

4.0

1.49

1.72

mmol/l

4.04

3251

12731

Other and unspecified tonsillitis

1093

5566

1.71

55.91

4.4

3.2

1.25

1.28

mmol/l

0.12

771

3940

Coagulation defects, purpura and other haemorrhagic conditions

766

4222

1.90

55.53

5.8

4.1

1.77

1.67

mmol/l

0.28

566

3099

Childhood asthma (age<16), excluding more controls

414

1406

2.41

55.42

6.1

3.3

0.77

0.86

mmol/l

0.21

284

932

Assault

470

2180

2.25

55.25

3.5

3.1

1.34

1.41

mmol/l

0.14

341

1602

Other disorders of lacrimal gland

1176

7290

1.66

55.06

4.1

3.4

1.64

1.89

mmol/l

1.53

868

5461

Special screening examination for other diseases and disorders

327

1296

2.65

55.05

4.3

2.9

1.44

2.00

mmol/l

2.21

213

939

Other and unspecified nonorganic psychotic disorders

640

3323

1.99

55.04

3.2

3.1

1.98

1.44

mmol/l

3.02

481

2438

Fracture of lumbar spine and pelvis

836

4740

1.84

54.83

4.6

3.4

2.11

1.89

mmol/l

0.90

628

3509

Cholecystectomy

2464

15650

1.42

54.76

3.3

3.4

1.67

1.81

mmol/l

1.05

1805

11572

Other condition

540

2662

2.13

54.55

4.6

3.6

1.88

1.69

mmol/l

0.54

388

1960

Open wound of forearm

394

1717

2.44

54.53

4.2

3.5

1.13

1.65

mmol/l

1.83

287

1258

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

557

2785

2.12

54.49

4.6

3.5

2.38

1.84

mmol/l

3.21

464

2021

Ascites

319

1267

2.71

54.38

5.9

3.4

1.10

1.88

mmol/l

1.92

214

948

Other specified/unspecified arthritis

946

5558

1.76

54.34

4.3

3.4

1.75

1.73

mmol/l

0.05

712

4107

Childhood asthma (age<16)

415

1426

2.38

54.18

6.1

3.4

0.77

0.88

mmol/l

0.29

285

948

Other female pelvic inflammatory diseases

525

2559

2.14

54.17

3.4

3.1

1.66

1.94

mmol/l

1.02

398

1943

Amputation of toe

354

1489

2.59

53.98

5.7

3.6

1.30

1.86

mmol/l

1.55

247

1084

Complications of internal orthopaedic prosthetic devices, implants and grafts

866

4994

1.81

53.87

4.0

3.4

2.17

1.98

mmol/l

0.75

653

3706

Noninfectious colitis NAS

561

2822

2.09

53.72

5.5

4.3

1.42

1.77

mmol/l

1.31

421

2087

Angina pectoris

2214

10517

1.45

53.66

3.7

3.4

1.91

1.79

mmol/l

0.74

1611

7945

Other diseases of pericardium

222

739

3.31

53.21

6.4

4.1

2.02

1.37

mmol/l

1.52

170

539

Focal epilepsy, strict definition

828

4734

1.83

53.19

4.7

4.5

1.61

1.64

mmol/l

0.09

618

3467

Fracture of foot, except ankle

833

4754

1.81

53.15

3.7

3.5

1.47

1.65

mmol/l

0.67

613

3463

Impacted cerumen

474

2267

2.25

52.96

4.7

4.1

1.12

1.84

mmol/l

3.58

335

1637

Bronchiectasis

348

1459

2.57

52.91

6.3

3.4

2.25

1.69

mmol/l

1.95

285

1043

Dental pulpitis 2, only avohilmo

2920

10934

1.39

52.87

4.3

4.0

1.58

1.76

mmol/l

1.76

2144

8034

Exclusions for E4_PCOS_CONSORTIUM

2344

10420

1.43

52.82

3.9

3.7

1.92

1.66

mmol/l

2.65

1759

7603

Tubulo-interstitial nephritis, not specified as acute or chronic

288

1103

2.79

52.46

5.2

2.6

1.96

2.14

mmol/l

0.30

211

806

Fracture of femur

1045

5804

1.70

52.41

4.7

3.6

2.24

1.95

mmol/l

1.41

793

4247

Nonorganic sleeping disorders, excluding more controls

568

2879

2.04

52.35

4.3

3.6

1.61

1.54

mmol/l

0.20

419

2049

1161

6426

1.66

52.33

3.9

3.6

1.96

2.06

mmol/l

0.39

830

4781

Other symptoms and signs involving the nervous and musculoskeletal systems

1498

9925

1.55

52.24

3.6

3.9

1.97

1.61

mmol/l

3.57

1076

7315

Otitis externa

821

4706

1.81

51.94

4.5

3.8

1.38

1.64

mmol/l

1.31

622

3440

Pain and other conditions associated with female genital organs and menstrual cycle

560

2705

2.04

51.84

3.5

2.9

1.24

1.62

mmol/l

1.68

382

1922

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

370

1605

2.46

51.81

5.9

4.0

1.92

1.77

mmol/l

0.27

280

1185

Benign neoplasm: Colon, unspecified

899

5269

1.77

51.74

4.4

3.4

1.58

1.90

mmol/l

1.65

648

3875

Urticaria

1040

6357

1.68

51.44

5.1

4.2

1.45

1.57

mmol/l

0.59

798

4634

therapeutic use

179

539

3.81

51.36

4.4

3.6

1.68

1.99

mmol/l

0.54

139

415

Acute pharyngitis

554

2788

2.05

51.35

6.9

3.7

1.16

1.30

mmol/l

0.45

397

2026

Pleural plaque

472

2281

2.22

51.33

4.6

3.3

2.08

1.45

mmol/l

3.02

378

1600

Agranulocytosis

472

2276

2.20

51.11

6.9

4.1

2.09

1.77

mmol/l

1.05

355

1701

Congenital malformations of the circulatory system

701

3750

1.91

51.02

9.2

5.9

1.80

1.24

mmol/l

5.14

553

2721

Zoster [herpes zoster]

693

3808

1.90

50.87

4.7

3.6

1.41

1.93

mmol/l

2.74

510

2823

Dental caries 3, only avohilmo

3347

12874

1.35

50.66

3.6

4.2

1.57

1.74

mmol/l

1.70

2469

9445

Multiple myeloma, excluding all cancers (controls excluding all cancers)

246

896

3.05

50.54

5.4

3.4

0.88

2.02

mmol/l

4.15

179

638

DVT of lower extremities

732

4095

1.86

50.49

4.2

3.4

1.66

1.79

mmol/l

0.41

548

3035

Dentofacial anomalies [including malocclusion]

923

5428

1.73

50.48

9.0

3.3

1.55

1.61

mmol/l

0.25

686

3962

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

587

3070

2.01

50.35

4.2

3.5

2.27

1.77

mmol/l

2.39

457

2211

Multiple myeloma and malignant plasma cell neoplasms

244

887

3.06

50.32

5.4

3.4

0.87

2.01

mmol/l

4.12

177

632

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1169

7366

1.62

50.31

3.5

3.6

1.07

1.50

mmol/l

4.12

838

5315

Meniscus derangement

1964

9348

1.47

50.28

3.3

1.71

1.77

mmol/l

0.35

1439

6926

Acquired absence of limb

157

7.31

50.25

6.7

3.2

1.16

1.56

mmol/l

0.32

121

Non-follicular lymphoma, hilmo, excluding all cancers

413

1906

2.32

50.23

4.6

3.6

2.34

1.82

mmol/l

2.23

343

1372

Allergic asthma (mode)

641

3355

1.92

50.15

3.1

2.7

1.44

1.15

mmol/l

1.20

454

2351

157

443

4.13

49.98

7.0

3.5

2.83

1.73

mmol/l

2.64

127

324

Other diseases of intestine

490

2411

2.14

49.98

5.4

3.6

1.94

2.01

mmol/l

0.14

371

1774

Striking against or struck by other objects

1197

7628

1.61

49.84

3.9

4.0

1.37

1.51

mmol/l

0.70

877

5533

Open wound of wrist and hand

1512

10028

1.53

49.83

3.2

3.5

1.43

1.52

mmol/l

0.45

1100

7272

Primary gonarthrosis, bilateral

1861

11341

1.47

49.74

3.3

3.6

1.73

1.83

mmol/l

0.51

1416

8480

Other disorders of veins

1282

8298

1.58

49.60

3.8

3.2

2.03

1.84

mmol/l

1.01

998

6196

Coxibs

1125

3654

1.68

49.57

2.9

4.0

1.67

1.70

mmol/l

0.08

834

2616

Cardiac arrest

245

750

2.98

49.51

7.1

2.8

1.95

1.59

mmol/l

0.60

181

563

Degeneration of macula and posterior pole

1758

9991

1.49

49.46

4.0

3.5

1.84

1.95

mmol/l

0.56

1276

7451

Acetic acid derivatives and related substances

1136

3617

1.68

49.45

3.3

4.0

1.48

1.70

mmol/l

1.05

808

2583

Sciatica+with lumbago

1632

10536

1.50

49.36

3.3

1.88

1.71

mmol/l

1.21

1225

7754

Nonalcoholic fatty liver disease

367

1621

2.41

49.26

3.4

1.59

1.69

mmol/l

0.20

264

1221

Misadventures to patients during surgical and medical care

530

2696

2.06

49.12

4.4

3.4

1.58

1.84

mmol/l

0.75

390

1993

Localized swelling, mass and lump of skin and subcutaneous tissue

1143

7240

1.63

49.10

4.3

3.9

1.67

1.74

mmol/l

0.26

893

5324

Rotator cuff syndrome

2148

11359

1.43

49.08

3.2

3.4

1.64

1.79

mmol/l

1.12

1570

8393

Gingivitis and periodontal diseases

3376

13190

1.34

48.93

4.1

3.3

1.44

1.76

mmol/l

5.00

2480

9690

Disorders of eyelid, lacrimal system and orbit

3018

17823

1.35

48.93

3.9

3.6

1.73

1.72

mmol/l

0.04

2231

13132

Gout due to impairment of renal function

102

216

6.32

48.86

9.2

3.3

1.47

1.66

mmol/l

0.16

161

Dental pulpitis 4, only avohilmo

4131

16785

1.30

48.83

3.2

3.7

1.59

1.67

mmol/l

0.69

3003

12335

846

4723

1.77

48.35

4.1

3.6

1.91

2.07

mmol/l

0.54

614

3509

Unspecified acute lower respiratory infection

581

3064

1.98

48.35

6.8

3.5

2.24

1.64

mmol/l

3.50

443

2200

Disorders of synovium and tendon

1723

10693

1.48

48.30

3.3

3.4

1.57

1.72

mmol/l

0.97

1311

7848

Mouth breathing

1556

10573

1.51

48.14

3.9

4.3

1.60

1.50

mmol/l

0.55

1112

7803

Purpura and other haemorrhagic conditions

563

2957

2.01

47.85

5.7

4.4

1.81

1.68

mmol/l

0.39

420

2153

Sequelae of external causes of morbidity and mortality

918

5552

1.71

47.79

4.8

3.5

2.19

1.81

mmol/l

2.60

687

4109

Artificial joint operation, meniscal resection

3286

16665

1.33

47.68

3.2

3.5

1.80

1.75

mmol/l

0.30

2454

12385

Tobacco use

242

897

2.94

47.60

4.3

3.3

1.83

1.58

mmol/l

0.37

185

654

Type 1 diabetes, definitions combined

431

2050

2.20

47.57

4.0

5.2

0.95

1.22

mmol/l

0.67

291

1495

Dissociative [conversion] disorders

160

463

3.73

47.52

3.6

3.1

1.88

1.45

mmol/l

0.70

125

325

Other arthrosis

1791

8869

1.47

47.48

3.5

3.3

1.79

1.78

mmol/l

0.05

1342

6591

Dental pulpitis 1, only avohilmo

4126

16830

1.30

47.39

3.1

3.7

1.59

1.67

mmol/l

0.71

2997

12363

Cerebral palsy and other paralytic syndromes

486

2435

2.11

47.29

7.6

4.3

1.91

1.71

mmol/l

0.55

378

1796

Other disorders of patella

561

2935

1.97

47.22

3.2

3.0

1.23

1.67

mmol/l

2.54

420

2146

Type 1 diabetes, strict (exclude DM2)

429

2044

2.20

47.16

4.0

5.3

0.95

1.21

mmol/l

0.63

289

1493

Chronic pancreatitis

507

2583

2.07

47.14

4.7

3.6

1.28

1.73

mmol/l

1.23

374

1919

Direct fill therapy

581

3106

1.97

46.78

10.8

4.1

1.37

1.53

mmol/l

0.50

447

2298

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

500

2545

2.08

46.72

4.8

3.8

1.22

1.83

mmol/l

2.76

357

1820

Heartburn

381

1743

2.30

46.65

3.4

1.73

1.78

mmol/l

0.10

285

1306

Disorders of lacrimal system

1401

9378

1.53

46.61

4.0

3.4

1.64

1.90

mmol/l

1.97

1030

6980

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

661

3679

1.88

46.60

3.1

3.4

1.82

1.87

mmol/l

0.10

479

2696

Dental caries 1, only avohilmo

3183

12306

1.34

46.60

3.6

4.2

1.58

1.77

mmol/l

2.05

2338

9052

Dental operations, only avohilmo

2775

10532

1.37

46.53

3.9

4.2

1.59

1.82

mmol/l

2.35

2032

7740

Disorders of vestibular function (Vertigo)

1607

10984

1.49

46.53

3.4

3.5

1.59

1.91

mmol/l

3.07

1194

8186

Congenital malformations of heart and great arteries

645

3463

1.91

46.48

9.6

6.1

1.85

1.22

mmol/l

6.37

512

2504

Drug-induced osteoporosis with pathological fracture

113

267

5.16

46.36

7.2

3.3

2.18

2.12

mmol/l

0.05

202

Sleep disorders

721

4108

1.81

46.35

4.3

3.8

1.67

1.58

mmol/l

0.29

531

2988

Fracture of lower leg, including ankle

1873

13197

1.44

46.35

4.2

3.5

1.71

1.72

mmol/l

0.06

1433

9722

Acute bronchiolitis

437

1918

2.24

46.32

11.5

7.1

1.06

1.00

mmol/l

0.16

309

1376

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

953

4892

1.69

46.24

4.2

3.6

2.70

1.87

mmol/l

8.44

788

3556

Non-allergic asthma (mode), excluding more controls

550

2848

1.97

46.08

5.5

3.0

2.22

1.14

mmol/l

12.12

409

2014

Other local infections of skin and subcutaneous tissue

421

2023

2.20

45.96

5.9

4.2

1.81

1.63

mmol/l

0.39

335

1491

Other disorders of bladder

501

2567

2.06

45.87

4.3

3.5

1.92

1.69

mmol/l

0.65

380

1846

Budesonide

453

2227

2.12

45.81

4.2

3.0

1.29

1.70

mmol/l

1.45

338

1635

Lumbar disc prolapse

2093

11947

1.42

45.78

3.3

3.4

1.65

1.67

mmol/l

0.08

1550

8814

Use of disulfiram, acamprosate or naltrexone

354

1590

2.36

45.67

3.7

3.2

1.77

1.53

mmol/l

0.56

274

1188

Diseases of inner ear

1872

13013

1.44

45.52

3.5

1.59

1.85

mmol/l

2.42

1384

9683

FESS (DNB20)

467

2335

2.10

45.46

3.3

3.4

1.35

1.71

mmol/l

1.54

355

1734

Delirium, not induced by alcohol and other psychoactive substances

484

2457

2.08

45.43

4.0

3.7

2.34

1.89

mmol/l

1.66

346

1797

Other shoulder lesions

342

1516

2.37

45.22

3.7

3.5

1.50

1.73

mmol/l

0.59

252

1128

Status epilepticus

178

573

3.41

45.12

6.0

4.9

2.22

1.93

mmol/l

0.45

129

410

Special screening examination for infectious and parasitic diseases

603

2398

1.91

45.12

2.5

2.4

0.75

1.69

mmol/l

9.65

442

1706

Bronchitis, not specified as acute or chronic

342

1521

2.37

44.95

4.5

3.1

1.89

1.59

mmol/l

0.83

259

1079

Paracetamol of NSAID medication

759

2135

1.83

44.94

3.8

4.3

1.51

1.59

mmol/l

0.22

550

1536

Dipeptidyl peptidase 4 (DPP-4) inhibitors

470

2376

2.09

44.72

3.9

3.5

1.53

1.94

mmol/l

1.35

343

1776

Intentional self-harm by sharp object

132

352

4.16

44.70

3.2

3.9

0.71

1.06

mmol/l

0.36

242

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

359

1644

2.34

44.62

5.3

3.6

1.94

1.93

mmol/l

0.02

277

1193

Pneumonia due to other infectious organisms, not elsewhere classified

163

502

3.60

44.60

5.2

3.1

1.61

1.44

mmol/l

0.26

118

364

Renal tubulo-interstitial disorders in diseases classified elsewhere

145

6.90

44.56

7.1

2.7

0.45

1.97

mmol/l

2.99

108

Isolated proteinuria

171

547

3.54

44.44

6.9

3.6

0.43

1.72

mmol/l

3.72

120

397

Other and unspecified drugs and medicaments

344

1552

2.36

44.10

5.9

3.9

2.03

1.71

mmol/l

0.75

260

1147

Umbilical hernia

993

6248

1.64

44.07

4.3

3.5

1.58

1.62

mmol/l

0.14

730

4551

Type 1 diabetes, strict definition, subgroup 1

333

1474

2.38

44.05

3.5

5.3

1.03

1.07

mmol/l

0.06

216

1055

Temporomandibular joint disorders

475

2407

2.03

43.77

3.0

3.4

1.79

1.81

mmol/l

0.02

345

1791

Other and unspecified urticaria

703

4049

1.80

43.75

4.7

4.3

1.26

1.61

mmol/l

1.99

543

2955

Myocarditis

171

543

3.34

43.52

4.2

2.2

1.64

1.49

mmol/l

0.17

122

392

Psychotic depression

231

870

2.81

43.35

3.8

3.5

1.92

1.61

mmol/l

0.65

174

637

Right bundle-branch block

178

588

3.33

43.27

3.8

3.1

2.02

1.41

mmol/l

1.04

135

415

Other necrotizing vasculopathies (FG)

266

1084

2.64

43.14

6.5

3.4

1.40

2.01

mmol/l

2.00

210

795

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

394

1894

2.21

43.08

6.6

3.7

1.56

1.78

mmol/l

0.52

302

1384

Viral pneumonia (known virus, not influenza)

165

532

3.63

43.02

9.9

6.3

2.26

1.45

mmol/l

1.76

139

401

Missing teeth due to accident, extraction or parodontitis

448

2254

2.09

43.01

4.8

3.4

1.97

1.96

mmol/l

0.02

343

1668

Ethmoidectomy

477

2452

2.04

42.92

3.2

3.4

1.30

1.70

mmol/l

1.85

361

1820

Focal epilepsy, mode (most common among epilepsy diagnosis)

744

4389

1.76

42.78

4.2

4.3

1.62

1.65

mmol/l

0.09

554

3207

Diseases of male genital organs

2192

8025

1.41

42.70

4.1

4.2

1.44

1.47

mmol/l

0.15

1586

5829

Diabetic neuropathy

587

3254

1.93

42.64

6.4

3.6

1.51

1.60

mmol/l

0.23

423

2340

Other and unspecified local infections of skin and subcutaneous tissue

392

1889

2.20

42.53

5.9

4.2

1.74

1.64

mmol/l

0.19

309

1397

Ovarian cyst

1001

3585

1.65

42.20

3.1

3.0

1.65

1.84

mmol/l

0.77

726

2606

Mixed and other personality disorders

288

1222

2.48

42.14

3.3

2.9

1.80

1.46

mmol/l

0.73

205

913

Opening and dilatation of root channel of tooth

256

1035

2.64

41.93

3.9

3.4

1.26

1.55

mmol/l

0.68

179

773

Assault by bodily force

279

1171

2.51

41.85

3.5

3.1

1.03

1.35

mmol/l

0.77

213

865

Other symptoms and signs involving the urinary system

420

2090

2.12

41.76

4.4

3.6

1.93

1.68

mmol/l

0.62

261

1500

Diaphragmatic hernia

1268

8517

1.53

41.76

3.7

3.5

1.56

1.89

mmol/l

2.51

982

6338

Left bundle-branch block

279

1176

2.52

41.73

4.3

2.8

1.53

1.63

mmol/l

0.15

217

845

Type 1 diabetes, strict definition

352

1633

2.26

41.54

3.6

5.6

0.95

1.07

mmol/l

0.21

231

1177

Calcific aortic valvular stenosis

1172

7606

1.56

41.40

4.5

3.7

2.03

1.91

mmol/l

0.42

847

5574

Calcific aortic valvular stenosis, operated

1172

7606

1.56

41.40

4.5

3.7

2.03

1.91

mmol/l

0.42

847

5574

Injuries to the elbow and forearm

2349

15844

1.36

41.28

4.0

3.7

1.66

1.70

mmol/l

0.16

1715

11606

Haemorrhage, not elsewhere classified

184

638

3.17

41.21

4.5

3.6

2.40

1.66

mmol/l

1.08

127

459

Otitis media, unspecified

508

2483

1.98

41.17

8.3

5.3

0.92

1.26

mmol/l

1.59

366

1771

Hypopituitarism

361

1719

2.26

41.02

6.5

4.9

1.71

1.41

mmol/l

1.24

278

1267

Insomnia

526

2829

1.93

41.02

4.4

3.5

1.63

1.57

mmol/l

0.13

390

2089

Eating disorder

298

1295

2.40

40.97

4.9

3.9

1.48

1.05

mmol/l

1.44

206

890

Pneumothorax

302

1333

2.42

40.88

4.9

3.1

2.73

1.52

mmol/l

6.19

244

946

Congenital malformations of cardiac septa

436

2171

2.12

40.60

10.5

7.7

1.81

0.98

mmol/l

8.41

358

1553

Calcific aortic valvular stenosis, including rheumatic fever

1167

7594

1.55

40.52

4.4

3.6

2.03

1.91

mmol/l

0.41

842

5571

Operations 2 for CAVS

1163

7570

1.55

40.50

4.4

3.6

2.04

1.91

mmol/l

0.45

838

5551

Calcific aortic valvular stenosis, diagnosis (helper)

1163

7570

1.55

40.50

4.4

3.6

2.04

1.91

mmol/l

0.45

838

5551

Emotional disorders and disorders of social functioning with onset specific to childhood

282

1199

2.50

40.48

4.4

5.6

1.03

1.04

mmol/l

0.02

172

850

Abnormal findings on examination of urine, without diagnosis

227

889

2.80

40.45

7.4

4.0

1.10

1.71

mmol/l

1.29

153

666

Lack of expected normal physiological development

226

776

2.98

40.29

16.7

5.8

0.91

1.01

mmol/l

0.18

178

554

Gonarthrosis, primary, with knee surgery

2016

12056

1.40

40.08

3.2

3.6

1.94

1.85

mmol/l

0.53

1523

9020

Multiple myeloma and malignant plasma cell neoplasms

244

997

2.70

40.04

5.4

4.0

0.87

1.96

mmol/l

3.92

177

742

Seropositive rheumatoid arthritis

834

5131

1.67

39.91

4.2

3.2

2.22

1.87

mmol/l

2.08

621

3833

Weight loss

419

2125

2.09

39.82

5.3

4.5

1.98

1.72

mmol/l

0.65

310

1565

Disorders of skin appendages

1514

10609

1.45

39.48

3.9

3.4

1.36

1.63

mmol/l

1.96

1109

7745

Benign neoplasm of other and unspecified endocrine glands

447

2315

2.02

39.43

4.1

3.4

2.08

1.77

mmol/l

1.05

341

1703

Other complications of surgical and medical care, not elsewhere classified

362

1739

2.19

39.39

5.3

3.7

1.98

1.81

mmol/l

0.33

265

1291

Polymyalgia rheumatica

522

2853

1.92

39.37

3.9

3.6

2.08

2.13

mmol/l

0.09

384

2103

Other specified and unspecified personality disorders

318

1452

2.29

39.16

3.9

3.1

2.20

1.51

mmol/l

2.29

240

1090

Maltreatment syndromes

197

722

2.90

39.14

2.8

3.6

1.63

1.31

mmol/l

0.53

132

518

Neuromuscular dysfunction of bladder

359

1728

2.19

39.03

4.2

3.4

2.02

1.79

mmol/l

0.52

270

1256

Non-follicular lymphoma

413

2104

2.09

38.83

4.6

3.7

2.34

1.83

mmol/l

2.20

343

1527

Hepatic failure, not elsewhere classified

190

696

3.03

38.75

6.3

3.6

1.21

1.83

mmol/l

1.36

138

522

Isolated proteinuria with specified morphological lesion

185

5.58

38.52

7.1

3.4

0.77

1.71

mmol/l

1.49

140

Disorders of tooth development and eruption

310

1387

2.36

38.51

23.5

5.1

1.11

1.14

mmol/l

0.06

235

996

Other (seronegative) rheumatoid arthritis, wide

674

3986

1.75

38.32

3.7

3.4

2.01

1.92

mmol/l

0.28

513

2985

Reimbursement for rheumatic diseases

1937

14201

1.39

38.32

4.5

3.5

1.84

1.72

mmol/l

0.77

1453

10464

Eating disorders

356

1710

2.16

38.27

4.8

3.9

1.67

1.19

mmol/l

2.01

252

1201

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

820

4233

1.67

38.16

4.1

3.5

2.72

1.89

mmol/l

7.24

675

3065

Anosmia

126

5.92

38.13

2.6

2.1

1.28

1.75

mmol/l

0.54

Visual disturbances

1601

11428

1.43

38.00

4.1

3.7

1.48

1.76

mmol/l

2.26

1165

8427

Other embolism and thrombosis

482

2593

1.94

37.94

3.9

3.4

1.81

mmol/l

0.01

351

1916

Other skin changes

633

3697

1.78

37.92

4.9

3.7

1.38

1.90

mmol/l

3.43

479

2713

Endometriosis

935

3486

1.63

37.86

3.3

3.0

1.69

1.87

mmol/l

0.70

716

2545

L01XE Protein kinase inhibitors

266

1157

2.50

37.80

4.1

3.7

1.59

1.94

mmol/l

0.69

196

870

Other diseases of jaws

267

1153

2.45

37.78

3.8

3.2

1.39

1.91

mmol/l

1.48

204

860

Soft tissue disorders related to use, overuse and pressure

876

5546

1.62

37.71

4.1

3.4

1.67

1.81

mmol/l

0.56

658

4137

Drug-induced adrenocortical insufficiency

116

324

4.20

37.69

6.4

4.8

2.68

1.85

mmol/l

1.83

244

Immunodeficiencies

243

1019

2.60

37.48

9.6

4.6

1.51

1.67

mmol/l

0.26

188

753

Acute laryngitis and tracheitis

439

2254

1.99

37.48

7.3

3.9

1.26

1.21

mmol/l

0.09

305

1618

Speech and linguistic disorders

461

2364

1.99

37.44

9.8

6.8

1.03

1.12

mmol/l

0.26

321

1682

Conjunctivitis (acute, non atopic)

1003

6542

1.57

37.42

5.6

4.7

1.47

1.49

mmol/l

0.07

732

4787

Adjustment and management of implanted device

680

4062

1.74

37.37

4.6

3.4

2.11

1.91

mmol/l

0.65

503

2960

Other eating disorders

204

781

2.77

37.28

5.5

4.8

1.59

1.01

mmol/l

1.68

140

535

Symptoms and signs involving speech and voice

1106

7397

1.53

37.22

4.0

3.5

1.94

1.79

mmol/l

0.76

863

5468

Scoliosis

321

1504

2.24

37.19

6.5

4.2

2.00

1.67

mmol/l

0.98

257

1107

Open wound of ankle and foot

392

1983

2.08

37.14

3.8

3.9

1.15

1.66

mmol/l

1.78

268

1456

Collagenous colitis

344

1664

2.19

37.00

5.9

3.9

1.45

1.84

mmol/l

1.11

256

1245

Thrombocytopenia, unspecified

315

1479

2.28

36.97

6.5

4.5

1.82

1.68

mmol/l

0.29

240

1090

Duodenal ulcer

444

2353

1.98

36.74

4.7

3.6

1.50

1.86

mmol/l

0.84

323

1666

Migraine without aura and triptan purchases

436

2283

1.96

36.62

3.4

3.2

0.81

1.47

mmol/l

3.92

286

1619

Other follicular disorders

262

1138

2.43

36.57

3.9

3.3

1.35

1.49

mmol/l

0.22

194

828

Other necrotizing vasculopathies

304

1413

2.30

36.53

6.6

3.6

1.36

2.00

mmol/l

2.40

239

1043

Other general symptoms and signs

247

1041

2.52

36.41

7.5

5.0

1.23

1.25

mmol/l

0.03

169

749

Crohn disease

456

2439

1.94

36.36

3.9

3.6

1.35

1.65

mmol/l

0.81

329

1813

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

438

2303

1.96

36.35

3.3

3.1

1.35

1.61

mmol/l

0.63

323

1640

Fracture of shoulder and upper arm

1238

8501

1.49

36.33

4.1

3.8

1.93

1.74

mmol/l

0.89

923

6269

Vitamin deficiency, wide

210

831

2.72

36.28

5.3

3.8

1.07

1.74

mmol/l

1.44

165

621

Vitamin deficiency

210

831

2.72

36.28

5.3

3.8

1.07

1.74

mmol/l

1.44

165

621

Injuries to the neck

736

4510

1.68

36.26

3.3

3.4

1.70

1.58

mmol/l

0.38

548

3272

Fluid overload

15.03

36.23

9.6

3.0

2.29

2.13

mmol/l

0.07

Intestinal adhesions without obstruction

326

1561

2.21

36.00

5.6

3.5

1.79

2.03

mmol/l

0.43

251

1155

Molar incisor enamel hypoplasia, with caries

154

591

4.79

35.76

25.0

5.9

1.07

1.14

mmol/l

0.11

123

408

Parkinson's disease, excluding more controls

407

2052

2.00

35.52

3.4

3.6

2.40

1.79

mmol/l

2.57

303

1455

Non-allergic asthma (mode)

550

3096

1.80

35.46

5.5

3.1

2.22

1.23

mmol/l

10.42

409

2197

Corns and callosities

282

1285

2.34

35.45

5.1

3.4

1.72

1.83

mmol/l

0.18

216

943

Acute and transient psychotic disorders

392

2011

2.03

35.37

3.6

3.2

2.62

1.58

mmol/l

5.82

304

1503

Coronary revascularization (ANGIO or CABG)

1705

8627

1.41

35.19

4.3

3.5

1.61

1.77

mmol/l

0.86

1202

6456

Amenorrhoea

209

829

2.63

35.16

3.7

3.0

1.53

1.42

mmol/l

0.15

148

557

Emotional disorders starting during childhood or adolescence

268

1194

2.40

35.14

4.5

5.8

1.08

1.05

mmol/l

0.04

163

840

Superficial injury of wrist and hand

645

3852

1.72

35.14

3.6

3.8

1.38

1.52

mmol/l

0.50

458

2808

Other metabolic disorders

401

2077

2.00

35.09

4.9

3.3

2.06

1.76

mmol/l

0.95

295

1550

Superficial injury of head

799

5040

1.63

35.08

3.7

4.2

1.73

1.65

mmol/l

0.23

577

3684

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

415

2190

2.00

35.01

4.6

3.7

1.16

1.81

mmol/l

2.65

295

1575

Care involving use of rehabilitation procedures

2067

14753

1.35

34.88

5.4

3.4

2.23

1.64

mmol/l

10.14

1450

10860

Asthma and allergy, excluding more controls

348

1690

2.09

34.80

3.6

3.0

1.09

0.95

mmol/l

0.32

243

1153

Benign neoplasm: Colon, unspecified

899

5852

1.59

34.78

4.4

3.5

1.58

1.85

mmol/l

1.25

648

4344

Barrett oesophagus

211

857

2.67

34.72

3.9

3.7

1.30

1.81

mmol/l

1.02

165

620

Valvular operations

534

3053

1.82

34.43

6.6

3.9

2.14

1.47

mmol/l

3.51

401

2212

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1093

7410

1.51

34.38

4.6

3.8

2.03

1.72

mmol/l

2.11

809

5516

Mental retardation, excluding more controls

254

1117

2.48

34.31

12.8

6.9

1.83

1.18

mmol/l

2.10

199

813

Schizophrenia

528

3009

1.81

34.11

3.5

3.3

3.10

1.56

mmol/l

13.81

408

2237

Systemic atrophies primarily affecting the central nervous system

214

887

2.65

34.10

4.9

4.8

2.79

1.80

mmol/l

3.27

193

667

Adverse effects, not elsewhere classified

658

3990

1.70

33.95

4.8

4.3

1.85

1.56

mmol/l

1.29

494

2909

Post-traumatic stress disorder

228

957

2.47

33.94

3.9

2.8

1.13

1.29

mmol/l

0.35

145

669

Abnormal weight loss

373

1925

2.06

33.83

5.2

4.5

1.94

1.72

mmol/l

0.50

279

1416

Other disorders of nervous system

277

1280

2.31

33.78

4.7

3.5

1.88

1.85

mmol/l

0.04

221

942

Secondary parkinsonism, excluding more controls

101

271

4.04

33.72

3.7

2.16

1.66

mmol/l

0.66

194

Other diseases of stomach and duodenum

248

1096

2.40

33.47

4.1

3.6

1.89

1.88

mmol/l

0.01

179

787

Hypoplasia of dental enamel, including avohilmo

166

690

4.27

33.40

30.4

6.5

1.09

1.16

mmol/l

0.14

137

480

Dependence on enabling machines and devices, not elsewhere classified

119

374

4.04

33.36

33.6

6.0

1.30

0.99

mmol/l

0.47

269

Other diseases of lip and oral mucosa

553

3220

1.78

33.31

4.1

3.4

1.79

1.91

mmol/l

0.33

432

2398

Fissure and fistula of anal and rectal regions

788

5012

1.61

33.29

3.2

1.54

1.78

mmol/l

1.11

588

3665

Varicose veins

2138

12243

1.34

33.24

3.8

3.4

2.04

1.80

mmol/l

2.08

1646

9084

Other specified/unspecified bacterial intestinal infections

271

1250

2.31

33.16

4.2

3.5

1.50

1.79

mmol/l

0.66

207

924

Other and unspecified mood [affective] disorders

218

908

2.50

33.13

3.0

3.4

1.19

1.41

mmol/l

0.40

169

645

Extrapyramidal and movement disorders

1278

9000

1.45

33.06

3.7

3.6

2.03

1.81

mmol/l

1.38

973

6669

Pruritus

379

1971

2.01

33.06

5.1

3.6

1.29

1.87

mmol/l

2.80

284

1448

Seronegative rheumatoid arthritis

400

2116

1.97

33.06

3.5

3.2

1.97

mmol/l

0.00

299

1567

Coxarthrosis, primary

2088

13766

1.34

32.84

3.4

3.6

1.91

1.86

mmol/l

0.24

1537

10323

Sequelae with surgical and medical care as external cause

695

4320

1.66

32.75

4.8

3.5

2.27

1.83

mmol/l

2.52

512

3194

386

2022

1.97

32.61

4.1

3.3

1.59

1.70

mmol/l

0.24

260

1511

Hypoparathyroidism

166

621

2.92

32.40

5.4

3.8

2.69

1.95

mmol/l

1.58

139

464

Superficial injury of abdomen, lower back and pelvis

506

2896

1.81

32.34

4.0

3.8

1.92

1.64

mmol/l

0.89

363

2138

Alcohol withdrawal state with delirium

300

1456

2.19

32.31

4.1

3.6

1.86

1.71

mmol/l

0.24

236

1079

Mixed hyperlipidaemia

181

708

2.76

32.17

4.6

3.2

1.22

1.98

mmol/l

1.22

125

531

Rheumatoid arthritis, including avohilmo

1249

8803

1.45

31.99

3.8

3.4

2.10

1.85

mmol/l

1.61

923

6576

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

587

3310

1.74

31.95

4.0

3.5

2.56

1.90

mmol/l

3.99

484

2394

SLE (Finngen)

143

495

3.11

31.90

5.4

3.4

1.35

1.80

mmol/l

0.57

115

371

Inflammatory bowel disease

1033

7038

1.50

31.64

4.3

3.4

1.60

1.58

mmol/l

0.04

752

5143

Asthma and allergy

347

1746

2.01

31.49

3.2

3.0

1.09

0.97

mmol/l

0.25

242

1199

Follow-up examination after treatment for malignant neoplasms

338

1718

2.05

31.40

3.8

3.1

2.04

2.46

mmol/l

1.27

247

1263

Spondylosis

1731

11029

1.37

31.39

3.5

3.4

2.12

1.76

mmol/l

3.92

1261

8195

Morphin

100

284

4.00

31.39

7.7

3.7

4.21

2.04

mmol/l

5.20

212

Other benign neoplasms of skin

1159

7927

1.46

31.38

3.8

3.4

1.49

1.84

mmol/l

2.53

829

5815

Migraine with aura and triptan purchases

407

2195

1.91

31.35

2.8

3.3

0.81

1.52

mmol/l

3.84

281

1575

Other disorders of bone

637

3910

1.68

31.28

3.7

3.5

1.63

1.60

mmol/l

0.05

480

2872

Inflammatory diseases of prostate (prostatitis)

505

2931

1.80

31.12

3.5

1.52

1.61

mmol/l

0.24

381

2108

Other otitis externa (chronic)

263

1230

2.27

31.07

4.0

3.7

1.68

1.78

mmol/l

0.16

200

911

Pneumonia due to Streptococcus pneumoniae

177

696

2.72

30.97

7.2

3.3

2.33

1.39

mmol/l

2.93

140

492

Postmenopausal bleeding

775

2675

1.63

30.94

3.5

3.2

2.08

2.17

mmol/l

0.25

610

2059

Atopic dermatitis, strict definition with reimbursement

931

6043

1.52

30.83

4.9

4.6

1.11

1.33

mmol/l

1.08

671

4295

Infections with a predominantly sexual mode of transmission

784

5060

1.58

30.66

3.8

2.9

1.16

1.45

mmol/l

1.51

580

3608

Other extrapyramidal and movement disorders in other diseases

764

4932

1.60

30.62

3.8

3.6

1.95

1.88

mmol/l

0.19

578

3669

Gingival hyperplasia

193

805

2.66

30.62

20.5

5.1

1.04

1.74

mmol/l

2.12

146

609

Superficial injury of hip and thigh

515

3016

1.77

30.44

3.7

1.91

1.81

mmol/l

0.23

383

2179

Other disorders of gingiva or/and edentulous alveolar ridge

242

1110

2.35

30.33

17.7

4.5

1.16

1.77

mmol/l

1.86

181

819

Parkinson's disease, strict definition, excluding more controls

367

1899

1.96

30.32

3.2

3.7

2.28

1.84

mmol/l

1.50

270

1350

Benign neoplasm of other and unspecified endocrine glands

447

2522

1.85

30.30

4.1

3.6

2.08

1.84

mmol/l

0.76

341

1883

Diffuse large B-cell lymphoma, helper endpoint

196

823

2.58

30.20

6.3

3.5

2.08

1.81

mmol/l

0.48

167

586

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

196

823

2.58

30.20

6.3

3.5

2.08

1.81

mmol/l

0.48

167

586

Agoraphobia

108

325

3.53

30.19

3.3

3.0

1.49

1.38

mmol/l

0.11

215

Car occupant injured in other and unspecified transport accidents

576

3478

1.70

30.12

3.9

3.3

1.73

1.58

mmol/l

0.47

451

2518

Intentional self-harm by unspecified means

157

5.08

30.10

4.5

3.1

0.58

1.00

mmol/l

0.34

120

Disorders of magnesium metabolism

106

6.65

29.96

5.7

3.3

1.59

2.11

mmol/l

0.38

Suppurative and necrotic conditions of lower respiratory tract

244

1128

2.32

29.96

6.3

3.9

2.26

1.79

mmol/l

0.96

180

836

Mental and behavioural disorders due to use of other stimulants, including caffeine

106

318

3.57

29.90

2.9

1.94

1.05

mmol/l

2.06

226

Other obstructive and reflux uropathy

170

666

2.71

29.85

5.2

3.1

0.88

1.89

mmol/l

2.04

117

484

Blood alcohol or alcohol intoxication level

119

387

3.37

29.84

4.0

3.1

1.75

1.58

mmol/l

0.18

283

Congenital iodine-deficiency syndrome/hypothyroidism

144

523

3.01

29.73

3.6

4.0

1.64

2.05

mmol/l

0.49

106

392

Benign neoplasm: Sigmoid colon

613

3786

1.68

29.72

4.5

3.4

1.21

1.92

mmol/l

4.45

481

2784

Drug-induced neutropenia

274

1327

2.19

29.61

4.3

3.6

2.31

1.78

mmol/l

1.45

210

1014

Dermatitis due to substances taken internally

225

1007

2.37

29.59

5.8

3.9

1.63

1.73

mmol/l

0.15

166

732

Organic, including symptomatic, mental disorders

1776

9635

1.36

29.49

3.5

3.7

2.07

1.88

mmol/l

1.26

1304

7183

Cholangitis (primary sclerosing, PSC)

261

1246

2.23

29.37

7.0

4.3

0.96

1.72

mmol/l

1.94

182

925

Other/unspecified rheumatoid arthritis

452

2583

1.82

29.36

4.1

3.5

2.05

2.00

mmol/l

0.09

336

1945

Transient ischemic attack

1804

11299

1.35

29.28

3.4

3.6

1.79

1.88

mmol/l

0.44

1302

8429

Urolithiasis

1169

8290

1.44

29.22

3.6

3.7

1.51

1.68

mmol/l

0.85

839

6066

Sequelae of injuries, of poisoning and of other consequences of external causes

745

4827

1.58

29.15

4.1

3.4

1.71

1.67

mmol/l

0.09

574

3571

Stomatitis and related lesions

306

1546

2.07

29.15

5.6

3.8

1.40

1.79

mmol/l

1.14

234

1165

Other infectious diseases

314

1606

2.06

29.14

5.4

4.0

1.95

1.81

mmol/l

0.27

219

1177

Endocarditis

152

573

2.87

29.09

7.5

3.0

1.58

1.40

mmol/l

0.24

110

406

Other diseases of oesophagus

351

1861

1.97

29.05

4.4

3.5

2.18

1.93

mmol/l

0.52

270

1315

Disorders of ocular muscles, binocular movement, accommodation and refraction

1521

11156

1.38

29.01

5.7

4.1

1.52

1.51

mmol/l

0.03

1122

8111

Disturbance of activity and attention

376

2012

1.92

28.87

5.6

5.0

0.98

1.08

mmol/l

0.21

250

1433

Pure hyperglyceridaemia

114

371

3.41

28.74

4.8

3.5

1.21

1.90

mmol/l

1.02

283

Other disorders starting during childhood or adolecense, excluding more controls

252

1153

2.25

28.69

14.1

7.3

0.89

0.98

mmol/l

0.16

168

824

Immunodeficiency with predominantly antibody defects

136

491

3.06

28.61

11.0

4.1

1.53

1.70

mmol/l

0.18

107

360

Disturbances of skin sensation

784

5156

1.55

28.52

3.3

3.2

1.26

1.66

mmol/l

2.69

590

3746

Cervicalgia

643

4052

1.63

28.38

3.4

1.61

1.86

mmol/l

1.11

469

2993

Benign neoplasm: Adrenal gland

261

1261

2.19

28.31

4.5

3.3

2.44

1.82

mmol/l

1.89

208

931

Amputation of foot

139

514

3.04

28.25

7.3

3.8

0.72

1.99

mmol/l

2.93

105

387

Benign neoplasm: Caecum

357

1927

1.94

28.16

4.6

3.5

1.23

1.90

mmol/l

2.62

276

1416

Aortic aneurysm

874

5816

1.52

28.04

4.1

3.4

1.88

1.75

mmol/l

0.46

649

4228

Type1 diabetes, definitions combined, early onset

317

1643

2.03

28.01

3.6

6.0

1.00

1.10

mmol/l

0.15

200

1178

Focal brain injury

197

848

2.42

27.91

4.1

3.8

2.06

1.81

mmol/l

0.42

156

598

Infection due to other mycobacteria

249

4.01

27.81

6.3

3.1

1.67

2.06

mmol/l

0.40

187

Sarcoidosis

455

2646

1.78

27.73

3.3

3.4

1.98

1.78

mmol/l

0.54

346

1985

Septal defects

392

2168

1.91

27.57

9.6

8.2

1.77

1.00

mmol/l

6.66

321

1578

Benign neoplasm: Transverse colon

357

1941

1.93

27.55

4.8

3.5

1.34

1.85

mmol/l

1.79

271

1418

Deviated nasal septum

1113

7893

1.44

27.53

3.3

3.5

1.47

1.66

mmol/l

1.06

824

5741

Dyshidrosis [pompholyx]

217

4.17

27.50

3.7

3.0

0.68

1.61

mmol/l

0.95

155

Crohn's disease NAS

250

1201

2.19

27.47

4.2

3.9

1.23

1.52

mmol/l

0.46

181

892

Sulfasalazine

819

5479

1.52

27.40

3.8

2.9

1.88

1.65

mmol/l

1.12

618

3996

Coronary angioplasty

1373

7719

1.40

27.36

4.2

3.6

1.72

1.77

mmol/l

0.19

951

5768

Oesophageal varices

192

837

2.49

27.32

7.1

3.8

0.71

1.79

mmol/l

2.79

141

610

Primary coxarthrosis, bilateral

997

6964

1.47

27.25

3.5

3.6

1.98

1.92

mmol/l

0.22

750

5204

Noninflammatory disorders of female genital tract

1162

4090

1.45

27.25

3.7

3.1

1.41

1.74

mmol/l

2.07

854

2929

Oter anti-inflammatory and antirheumatic agents, non-steroids

871

3217

1.54

27.19

3.1

4.0

1.69

1.80

mmol/l

0.34

653

2341

Intestinal malabsorption

184

786

2.50

27.07

6.8

3.6

0.79

1.78

mmol/l

1.97

117

582

Other noninflammatory disorders of uterus, except cervix

614

2605

1.65

26.84

3.5

3.3

2.09

2.19

mmol/l

0.24

483

1999

Orchitis and epididymitis

355

1944

1.91

26.69

4.2

3.7

1.73

1.69

mmol/l

0.08

257

1400

Fall on and from stairs and steps

824

5567

1.52

26.60

3.9

3.6

1.43

1.78

mmol/l

1.84

608

4110

Disorders of plasma-protein metabolism, not elsewhere classified

118

5.85

26.55

4.1

2.9

2.62

1.76

mmol/l

0.89

Spinal instabilities

126

452

3.01

26.52

3.1

3.7

1.70

1.90

mmol/l

0.19

100

343

5-aminosalicylic acid

616

3902

1.61

26.49

4.6

3.0

1.44

1.56

mmol/l

0.38

456

2818

Certain conditions originating in the perinatal period

427

2189

1.81

26.47

10.2

6.1

1.02

1.00

mmol/l

0.05

304

1519

Amyloidosis

105

343

3.41

26.40

5.8

3.4

1.33

2.13

mmol/l

1.28

263

Microscopic polyangiitis

109

6.37

26.23

12.5

4.2

0.74

1.94

mmol/l

1.66

Other and unspecified injuries of lower leg

250

1220

2.14

26.22

3.5

3.6

1.58

1.56

mmol/l

0.03

174

881

Ulcerative colitis, NAS

459

2715

1.75

26.20

5.0

3.7

1.30

1.65

mmol/l

1.32

343

2013

Cluster headache, strict

109

360

3.19

26.17

3.7

3.8

1.46

1.70

mmol/l

0.25

267

Pyogenic arthritis

250

1223

2.15

26.16

4.6

3.4

1.72

1.90

mmol/l

0.32

186

907

Other hearing loss

941

6434

1.47

26.09

3.6

3.7

2.26

1.98

mmol/l

1.47

673

4776

Late syphilis

229

4.08

25.84

7.9

3.2

1.19

1.79

mmol/l

0.65

169

Vascular disorders of the intestines

259

1292

2.11

25.82

4.9

3.4

1.43

2.10

mmol/l

1.64

194

924

Atopic dermatitis

1641

10616

1.34

25.80

4.2

4.0

1.23

1.50

mmol/l

2.51

1193

7677

Simple and mucopurulent chronic bronchitis

189

835

2.41

25.78

6.2

5.7

2.31

1.58

mmol/l

2.84

148

609

Hidradenitis suppurativa

132

491

2.86

25.75

3.2

3.0

1.86

1.54

mmol/l

0.40

103

348

Nonorganic sleeping disorders

568

3561

1.64

25.68

4.3

3.9

1.61

1.54

mmol/l

0.20

419

2609

Pericarditis

148

586

2.71

25.65

6.5

2.9

1.87

1.51

mmol/l

0.40

108

421

Attention to artificial openings

180

784

2.48

25.63

9.4

3.5

2.88

1.77

mmol/l

3.01

129

570

Respiratory disorders in diseases classified elsewhere

240

3.98

25.61

6.7

3.8

1.60

1.83

mmol/l

0.23

181

Vasomotor and allergic rhinitis

1163

8288

1.41

25.51

3.6

4.2

1.32

1.58

mmol/l

1.91

837

5974

Benign paroxysmal vertigo

901

6247

1.48

25.50

3.6

3.5

1.63

1.96

mmol/l

1.94

677

4687

Asthma mixed form (mode), excluding more controls

163

674

2.52

25.29

3.8

2.9

2.66

0.94

mmol/l

7.51

106

458

Unspecified nephritic syndrome

117

417

3.11

25.28

7.1

3.1

0.62

1.76

mmol/l

2.43

303

Other diseases of arteries and capillaries

326

1769

1.93

25.25

5.5

3.5

1.11

1.85

mmol/l

2.78

240

1283

Unspecified chronic bronchitis

151

608

2.64

25.19

5.2

3.4

1.58

1.55

mmol/l

0.04

123

441

Schizoaffective disorder

248

1228

2.10

24.97

3.5

3.1

2.93

1.52

mmol/l

5.45

203

921

Other enthesopathies

868

5990

1.48

24.92

3.3

1.35

1.77

mmol/l

3.02

645

4421

Cluster headache, wide

115

403

3.00

24.88

3.6

3.8

1.55

1.75

mmol/l

0.21

296

Asthma and opportunity respiratory infection

189

850

2.38

24.85

6.4

3.6

2.04

1.86

mmol/l

0.29

151

630

Drug-induced hypoglycaemia without coma

294

3.57

24.83

5.5

3.6

1.60

1.62

mmol/l

0.02

217

Personal history of certain other diseases

227

3.83

24.80

3.1

4.4

1.20

1.04

mmol/l

0.12

152

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

246

1226

2.13

24.76

4.2

3.4

2.20

1.88

mmol/l

0.63

199

878

Explicit fungal Sepsis

102

6.05

24.60

9.5

2.8

1.85

1.63

mmol/l

0.12

Social phobias

233

1130

2.13

24.60

3.8

3.1

1.07

1.32

mmol/l

0.51

182

808

Benign neoplasm: Rectum, anus and anal canal

643

4199

1.58

24.60

4.2

3.4

1.62

1.89

mmol/l

0.85

478

3083

ILD medications: nintedanib

6.39

24.56

4.6

3.6

2.20

2.07

mmol/l

0.10

Parodontitis or/and operation codes

2123

9912

1.29

24.50

3.7

3.3

1.51

1.61

mmol/l

0.66

1569

7316

Unspecified contracted kidney

103

6.13

24.49

9.3

4.5

0.59

1.63

mmol/l

0.96

Persons with potential health hazards related to communicable diseases

1130

8127

1.40

24.43

6.8

4.3

1.57

1.31

mmol/l

1.68

742

5846

Spondylolisthesis/Spondylolysis

557

3520

1.62

24.43

3.3

3.5

1.79

1.84

mmol/l

0.12

414

2644

Dislocation, sprain and strain of joints and ligaments at neck level

435

2584

1.73

24.34

2.9

3.3

1.44

1.59

mmol/l

0.42

321

1890

Enthesopathies of lower limb, excluding foot

649

4249

1.56

24.24

3.5

3.4

1.38

1.74

mmol/l

1.72

475

3148

Paralytic ileus

163

695

2.51

24.22

5.0

3.8

1.54

2.01

mmol/l

0.58

117

513

Obsessive-compulsive disorder

190

858

2.30

24.12

3.2

3.4

1.12

1.28

mmol/l

0.26

127

617

Hyperkinetic disorders

404

2336

1.77

24.02

5.4

5.5

0.99

1.08

mmol/l

0.21

269

1642

Cardiodefibrillation

1313

9802

1.37

23.90

3.9

3.7

2.11

1.77

mmol/l

2.68

967

7230

Systemic lupus erythematosus

143

577

2.65

23.87

5.4

3.5

1.35

1.83

mmol/l

0.62

115

434

Neuralgia and neuritis, unspecified

173

758

2.40

23.85

3.9

3.7

1.70

1.76

mmol/l

0.08

129

564

Spondyloarthritis

573

3667

1.60

23.76

3.8

3.3

1.96

1.70

mmol/l

0.88

412

2677

Vertigo of central origin

272

3.62

23.70

4.0

3.5

0.91

1.90

mmol/l

1.18

210

Artificial opening status

214

1032

2.21

23.60

10.3

3.9

1.93

1.74

mmol/l

0.29

161

755

Non-small cell lung cancer

587

3798

1.60

23.60

4.0

3.7

2.56

1.79

mmol/l

5.28

484

2765

Lesion of ulnar nerve

445

2692

1.71

23.43

4.0

3.3

2.04

1.70

mmol/l

1.05

318

2004

Chronic sinusitis

1257

9331

1.37

23.41

3.5

3.4

1.48

1.77

mmol/l

2.25

931

6841

Malignant neoplasm of urinary organs

379

2207

1.80

23.39

5.0

3.7

1.07

1.90

mmol/l

3.53

268

1598

Left ventricular outflow tract obstruction (LVOTO), broad definition

389

2280

1.78

23.39

6.7

4.9

1.68

1.50

mmol/l

0.45

304

1708

Acquired haemolytic anaemia

126

488

2.86

23.37

7.3

4.3

1.44

1.83

mmol/l

0.46

359

Diseases of salivary glands

588

3802

1.58

23.33

4.1

3.2

1.55

1.85

mmol/l

1.23

448

2805

Olecranon bursitis

240

1214

2.08

23.12

4.6

3.6

1.81

1.62

mmol/l

0.31

187

879

Toxic effects of substances chiefly nonmedicinal as to source

376

2183

1.78

23.11

3.9

3.7

1.28

1.63

mmol/l

0.92

274

1588

Atopic dermatitis, strict definition

898

6200

1.45

23.07

5.1

4.9

1.03

1.30

mmol/l

1.45

646

4409

Fall on same level involving ice and snow

1766

13785

1.30

23.06

3.5

1.65

1.75

mmol/l

0.54

1296

10182

Abnormal findings on examination of blood, without diagnosis

1667

12096

1.31

23.00

4.7

3.8

1.78

1.64

mmol/l

0.81

1243

8868

Disorders of oesophagus in diseases classified elsewhere

339

3.23

22.98

4.8

3.8

1.76

2.22

mmol/l

0.62

250

Colonic or urogenital fistula

860

6029

1.46

22.95

3.3

3.4

1.55

1.74

mmol/l

0.85

639

4438

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1745

9236

1.31

22.94

3.7

3.4

1.63

1.84

mmol/l

1.53

1288

6832

Calculus of kidney and ureter

1045

7592

1.41

22.80

3.6

1.45

1.68

mmol/l

1.24

745

5551

Disorders of sclera, cornea, iris and ciliary body

1687

13113

1.30

22.78

4.0

3.5

1.67

1.68

mmol/l

0.03

1221

9665

Pyothorax

184

851

2.32

22.74

5.7

3.7

2.28

1.83

mmol/l

0.71

136

636

Ulcerative colitis

759

5203

1.49

22.74

4.5

3.5

1.57

1.63

mmol/l

0.19

558

3816

In situ neoplasms

1025

7068

1.41

22.63

4.2

3.3

1.66

1.87

mmol/l

1.05

787

5171

Personal history of other diseases and conditions

405

2404

1.74

22.63

8.8

4.2

1.09

1.19

mmol/l

0.20

292

1700

Secondary and unspecified malignant neoplasm of lymph nodes

311

1727

1.89

22.56

4.8

3.9

2.33

1.81

mmol/l

1.66

255

1261

Superficial injury of thorax

485

3028

1.65

22.55

3.9

3.5

2.01

1.72

mmol/l

0.89

353

2206

Other renal tubulo-interstitial diseases

319

3.21

22.49

5.9

2.6

1.05

2.11

mmol/l

1.87

240

Acute gastritis

260

1363

1.99

22.38

4.7

3.6

2.17

1.94

mmol/l

0.41

197

985

Otitis externa, unspecified

362

2100

1.79

22.37

4.8

3.9

1.22

1.62

mmol/l

1.56

270

1565

Event of undetermined intent

221

1096

2.11

22.37

3.7

1.40

1.53

mmol/l

0.14

165

795

Benign neoplasm: Rectum

567

3682

1.59

22.35

4.1

3.4

1.74

1.90

mmol/l

0.39

411

2712

Disorders of muscles

323

1813

1.84

22.29

4.0

3.7

1.87

1.76

mmol/l

0.21

245

1328

Diffuse large B-cell lymphoma

196

939

2.25

22.25

6.3

3.8

2.08

1.84

mmol/l

0.44

167

707

Amyloidosis, other/unspecified

277

3.47

22.24

6.0

3.4

1.06

2.04

mmol/l

1.67

216

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1596

8420

1.32

22.24

3.7

3.4

1.67

1.87

mmol/l

1.31

1173

6230

Benign intracranial hypertension

126

4.87

22.19

4.5

3.9

-0.10

0.81

mmol/l

0.45

Abscess of anal and rectal regions

279

1501

1.93

22.12

4.3

3.8

1.16

1.70

mmol/l

1.33

206

1103

Other bursopathies

422

2558

1.70

22.09

4.3

3.5

2.00

1.86

mmol/l

0.36

341

1923

Trigger finger

422

2556

1.70

22.05

3.4

3.6

1.43

1.76

mmol/l

1.14

306

1919

Pneumocystosis

296

3.42

22.02

5.9

3.8

1.46

1.90

mmol/l

0.55

223

Alcohol-induced chronic pancreatitis

252

1322

2.01

21.92

4.2

3.5

1.50

1.66

mmol/l

0.18

185

993

Amputation of ankle bones

111

416

2.95

21.92

7.4

3.7

0.92

1.96

mmol/l

1.45

314

Other or ill-defined heart diseases

181

837

2.26

21.89

4.9

3.4

1.59

1.39

mmol/l

0.24

143

594

Cerebral cysts

210

1032

2.14

21.88

7.1

3.8

1.69

1.72

mmol/l

0.04

144

761

Adhesive capsulitis of shoulder

525

3363

1.60

21.83

4.1

3.4

1.72

1.85

mmol/l

0.34

381

2530

Emergency coronary revascularization (for ACS)

1989

11353

1.28

21.82

4.2

3.7

1.66

1.83

mmol/l

1.00

1394

8440

Discitis, unspecified

287

3.40

21.68

5.0

3.9

2.30

2.23

mmol/l

0.04

220

Complications of cardiac and vascular prosthetic devices, implants and grafts

106

391

3.01

21.62

6.6

3.9

1.51

2.06

mmol/l

0.54

285

Restless leg syndrome

389

2329

1.73

21.48

3.5

3.6

1.54

1.90

mmol/l

1.22

305

1731

Asthma mixed form (mode)

163

726

2.33

21.46

3.8

2.9

2.66

1.08

mmol/l

6.46

106

503

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

192

923

2.22

21.46

5.2

3.5

2.35

1.97

mmol/l

0.60

145

661

Nail disorders

281

1533

1.91

21.44

5.1

3.7

1.43

1.64

mmol/l

0.42

203

1133

Appendectomy

1904

14560

1.27

21.40

3.3

1.69

1.62

mmol/l

0.36

1385

10680

Allergic urticaria

284

1557

1.90

21.31

6.7

4.4

1.66

1.53

mmol/l

0.28

212

1142

SLE, strict definition

135

560

2.58

21.31

5.5

3.3

1.29

1.87

mmol/l

0.81

108

421

SLE, ICD10

135

560

2.58

21.31

5.5

3.3

1.29

1.87

mmol/l

0.81

108

421

Wet age-related macular degeneration

601

3924

1.55

21.28

3.4

3.6

1.96

2.12

mmol/l

0.41

415

2901

Secondary uncertain malignant neoplasm

451

2817

1.66

21.17

4.5

3.8

2.04

1.82

mmol/l

0.57

375

2043

Hyperosmolality and hypernatraemia

231

3.68

20.98

4.8

4.3

2.32

2.15

mmol/l

0.13

185

Unstable angina pectoris

1350

8528

1.34

20.96

3.6

3.5

1.90

1.82

mmol/l

0.32

974

6340

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

808

5692

1.45

20.88

3.1

3.4

1.33

1.54

mmol/l

0.95

578

4154

Seborrhoeic dermatitis

336

1950

1.79

20.87

5.3

4.1

1.44

1.77

mmol/l

0.88

264

1418

ILD and respiratory illness in diseases classified elsewhere

6.70

20.87

8.0

3.3

1.97

2.16

mmol/l

0.12

Injuries to unspecified part of trunk, limb or body region

345

2019

1.78

20.81

4.0

4.1

1.92

1.68

mmol/l

0.52

256

1471

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

177

836

2.26

20.73

4.7

3.2

1.39

1.97

mmol/l

1.07

124

604

Thyroiditis, ILD-related definition

345

2017

1.76

20.66

4.0

3.5

1.54

1.71

mmol/l

0.37

264

1498

Crohn's disease of large intestine

186

892

2.19

20.65

3.9

3.5

1.24

1.54

mmol/l

0.43

140

656

Polyarteritis nodosa and related conditions

275

3.41

20.63

5.0

4.0

1.57

1.68

mmol/l

0.09

195

Superficial injury of ankle and foot

379

2275

1.72

20.61

3.8

4.1

1.49

1.53

mmol/l

0.07

269

1679

Pre-eclampsia

463

2912

1.62

20.59

3.1

2.8

1.68

1.60

mmol/l

0.17

342

2134

Superficial injury of shoulder and upper arm

362

2149

1.74

20.58

3.5

3.7

2.01

1.67

mmol/l

0.96

267

1571

Redundant prepuce, phimosis and paraphimosis

666

4522

1.50

20.58

4.0

3.6

1.75

1.50

mmol/l

0.98

476

3282

Other diseases of blood and blood-forming organs

244

1293

1.98

20.54

3.8

3.6

2.50

1.80

mmol/l

1.91

176

955

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

232

1203

1.99

20.46

3.6

3.2

1.24

1.60

mmol/l

0.82

177

892

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

874

6270

1.42

20.44

3.1

3.4

1.84

1.61

mmol/l

1.05

651

4602

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

424

2631

1.67

20.42

4.1

3.6

1.84

2.02

mmol/l

0.39

310

1904

Allergic rhinitis

931

6685

1.40

20.32

3.6

4.5

1.18

1.40

mmol/l

1.29

661

4815

Parodontitis, operation under 40 years and operation codes

200

984

2.08

20.28

4.1

2.6

1.01

0.89

mmol/l

0.20

135

656

Paraplegia, diplegia of upper limbs

108

415

2.85

20.27

7.4

3.9

2.49

1.81

mmol/l

0.99

319

Benign neoplasm: Sigmoid colon

613

4137

1.53

20.27

4.5

3.5

1.21

1.86

mmol/l

3.89

481

3066

Sudden idiopathic hearing loss

340

1997

1.77

20.24

3.7

3.6

2.03

1.90

mmol/l

0.25

262

1496

Acute posthaemorrhagic anaemia

142

618

2.45

20.19

7.5

3.7

1.71

2.00

mmol/l

0.32

108

461

Malnutrition

129

548

2.66

20.15

12.8

7.3

1.47

1.58

mmol/l

0.10

387

Haemolytic anaemias

162

751

2.33

20.06

7.0

4.5

1.53

1.78

mmol/l

0.31

123

535

Nonischemic cardiomyopathy

219

1130

2.04

20.05

5.5

4.0

1.82

1.69

mmol/l

0.18

158

829

Spontaneous rupture of synovium and tendon

269

1480

1.89

19.99

3.7

3.6

1.67

1.88

mmol/l

0.40

212

1088

Drug-induced osteoporosis

189

3.91

19.89

5.5

3.1

1.32

2.13

mmol/l

0.89

142

Excessive vomiting in pregnancy

200

994

2.07

19.85

2.2

2.8

1.16

1.60

mmol/l

1.00

137

726

Seropositive rheumatoid arthritis, wide

834

5971

1.43

19.85

4.2

3.4

2.22

1.87

mmol/l

2.09

621

4484

Autism spe, excluding more controls

333

2.99

19.67

3.0

5.2

1.17

1.23

mmol/l

0.06

217

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

1387

8332

1.32

19.64

3.7

3.5

1.97

1.84

mmol/l

0.50

1001

6160

Malignant neoplasm of kidney, except renal pelvis

340

2021

1.76

19.58

5.0

3.7

1.04

1.89

mmol/l

3.56

243

1469

Traumatic subarachnoid haemorrhage

111

435

2.69

19.57

3.5

3.6

1.66

2.05

mmol/l

0.40

307

Invasive ventilation

295

1688

1.84

19.55

13.5

4.5

2.95

1.61

mmol/l

7.02

203

1210

Benign neoplasm: Adrenal gland

261

1439

1.90

19.49

4.5

3.5

2.44

1.80

mmol/l

2.07

208

1091

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

809

5784

1.43

19.43

4.2

3.4

2.21

1.88

mmol/l

1.97

602

4355

Pre-eclampsia or eclampsia

495

3206

1.57

19.42

3.3

2.8

1.71

1.66

mmol/l

0.11

367

2365

Other/unspecified seropositive rheumatoid arthritis

823

5903

1.42

19.39

4.2

3.4

2.21

1.88

mmol/l

1.98

612

4433

Fracture of skull and facial bones

641

4391

1.49

19.39

4.5

3.6

1.53

1.61

mmol/l

0.19

473

3243

Salpingitis and oophoritis

454

2889

1.61

19.37

3.7

3.2

2.06

1.96

mmol/l

0.22

347

2226

Pneumonia derived septicemia

156

722

2.32

19.34

7.9

4.2

2.05

1.64

mmol/l

0.71

117

529

Other specified disorders of kidney and ureter

143

638

2.41

19.34

9.0

3.6

0.88

1.86

mmol/l

2.04

110

484

Carcinoma in situ of other and unspecified sites

151

691

2.36

19.32

4.4

3.4

1.11

1.80

mmol/l

1.45

118

487

Parodontitis, under 40 years and operation codes

197

982

2.05

19.30

3.7

2.6

1.00

0.88

mmol/l

0.19

134

655

Benign neoplasm: Transverse colon

357

2159

1.72

19.24

4.8

3.7

1.34

1.86

mmol/l

1.85

271

1575

Mixed disorders of conduct and emotions, excluding more controls

303

3.04

19.24

6.3

5.0

1.39

1.10

mmol/l

0.39

208

Parodontitis, under 40 years, or operation codes

207

1053

2.01

19.15

4.3

2.6

1.06

0.88

mmol/l

0.33

142

700

Benign neoplasm: Ascending colon

409

2558

1.65

19.11

4.9

3.4

1.47

1.91

mmol/l

1.50

318

1864

Fracture at wrist and hand level

1012

7509

1.37

19.10

3.2

3.5

1.59

1.58

mmol/l

0.02

734

5509

Specific development disorders of speech and language

302

1689

1.82

19.06

11.2

7.0

1.04

1.11

mmol/l

0.17

222

1207

Diffuse brain injury

104

399

2.72

19.01

4.8

3.5

1.57

1.89

mmol/l

0.45

283

Disorders of myoneural junction and muscle in diseases classified elsewhere

121

4.73

18.96

7.3

3.3

1.54

1.86

mmol/l

0.21

Oxicams

835

3371

1.43

18.96

3.4

4.0

1.79

1.76

mmol/l

0.07

607

2430

Sicca syndrome [Sjögren]

266

1483

1.86

18.94

4.0

3.4

1.77

2.02

mmol/l

0.51

200

1136

Other benign neoplasms of skin

1159

8797

1.34

18.93

3.8

3.5

1.49

1.84

mmol/l

2.53

829

6545

Somnolence, stupor and coma

170

817

2.20

18.91

5.3

4.0

2.44

1.65

mmol/l

1.67

123

600

Abnormal findings on diagnostic imaging of other body structures

381

2345

1.68

18.90

4.0

3.5

2.15

1.77

mmol/l

1.13

288

1717

Viral warts

323

1905

1.75

18.89

8.7

3.9

1.29

1.61

mmol/l

0.78

230

1385

Postmenopausal osteoporosis with pathological fracture

195

986

2.08

18.88

4.5

3.4

2.78

2.30

mmol/l

0.77

150

748

Aortic valve malfunction, age under 60 years

324

1917

1.76

18.86

5.6

3.9

1.71

1.61

mmol/l

0.20

252

1450

Benign neoplasm: Caecum

357

2171

1.71

18.84

4.6

3.6

1.23

1.92

mmol/l

2.76

276

1588

severe traumatic brain injury, does not include concussion

745

5289

1.44

18.77

4.2

3.6

1.86

1.77

mmol/l

0.24

561

3831

Inflammatory disease of uterus

322

1893

1.74

18.74

3.2

2.9

1.38

1.64

mmol/l

0.65

234

1359

Generalized skin eruption due to drugs and medicaments

157

736

2.27

18.72

6.9

4.2

1.69

1.77

mmol/l

0.10

120

548

Evidence of alcohol involvement determined by level of intoxication

162

4.00

18.71

4.3

3.1

1.71

1.47

mmol/l

0.17

113

Allergic contact dermatitis

375

2301

1.67

18.67

3.4

3.7

1.60

1.75

mmol/l

0.30

268

1698

Lung transplant status

162

4.26

18.51

12.3

4.2

1.75

1.70

mmol/l

0.04

122

Lung transplantation

162

4.26

18.50

12.3

4.2

1.75

1.70

mmol/l

0.04

122

Other disorders of electrolyte and fluid balance, not elsewhere classified

132

4.42

18.44

4.5

3.4

3.23

1.90

mmol/l

0.75

101

Thoracic aortic aneurysm

482

3162

1.58

18.42

4.1

3.4

1.77

1.73

mmol/l

0.09

370

2315

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

261

1462

1.86

18.42

4.2

3.6

1.72

1.84

mmol/l

0.18

184

1075

Non-small cell lung cancer, adenocarcinoma

246

1360

1.91

18.35

4.2

3.6

2.20

1.89

mmol/l

0.62

199

997

Non-small cell lung cancer, adenocarcinoma, helper endpoint

246

1360

1.91

18.35

4.2

3.6

2.20

1.89

mmol/l

0.62

199

997

Arterial embolism and thrombosis

225

1206

1.96

18.35

4.4

3.6

2.06

1.95

mmol/l

0.16

160

875

Other disorders of optic [2nd] nerve and visual pathways

243

1337

1.91

18.34

5.8

4.9

1.37

1.63

mmol/l

0.54

177

996

Systemic lupus erythematosus, unspecified

116

482

2.57

18.33

4.7

3.5

1.36

1.85

mmol/l

0.55

365

Nonhereditary hypogammaglobulinemia

165

3.98

18.32

7.5

3.7

1.86

1.73

mmol/l

0.08

124

Other diseases of biliary tract

288

1665

1.80

18.23

5.4

4.0

1.63

1.87

mmol/l

0.43

201

1236

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

194

3.65

18.21

4.3

3.5

2.24

1.52

mmol/l

0.60

146

Coxarthrosis, primary, with hip surgery

1535

11512

1.28

18.20

3.3

3.6

1.79

1.88

mmol/l

0.43

1132

8648

Parodontitis, under 40 years

204

1053

1.98

18.12

3.9

2.6

1.05

0.88

mmol/l

0.31

141

699

Abnormal involuntary movements

430

2755

1.61

18.11

4.1

4.0

1.84

1.74

mmol/l

0.20

312

2037

TMD related pain

116

483

2.54

18.10

2.9

3.5

1.42

1.78

mmol/l

0.68

362

Inflammatory disease of cervix uteri

190

965

2.05

18.00

3.4

2.05

2.10

mmol/l

0.07

140

736

Other symptoms and signs involving general sensations and perceptions

153

721

2.25

18.00

4.3

4.5

2.05

1.69

mmol/l

0.49

114

545

Other diseases of pancreas

253

1415

1.87

17.99

4.1

3.7

1.74

1.85

mmol/l

0.14

187

1053

Behavioural disorders, excluding more controls

271

3.10

17.96

3.3

4.8

1.12

1.46

mmol/l

0.31

186

Pollen allergy

592

4014

1.49

17.91

3.6

5.1

0.89

1.27

mmol/l

2.27

416

2861

Fibroblastic disorders

760

5455

1.42

17.89

4.0

3.6

1.57

1.77

mmol/l

0.70

540

4007

Cardiomyopathy, other and unspecified

249

1386

1.86

17.85

4.4

3.1

2.25

1.55

mmol/l

1.48

182

998

Vitamin B12 deficiency anaemia

369

2289

1.67

17.84

3.6

3.5

1.42

1.92

mmol/l

1.63

248

1649

Other and unspecified nerve root and plexus disorders, also in other diseases

532

3575

1.52

17.80

3.4

3.2

1.92

1.68

mmol/l

0.88

402

2659

Background retinopathy and retinal vascular changes

372

2.81

17.74

5.1

3.6

0.75

1.93

mmol/l

2.49

284

ILD medications: pirfenidone

170

3.96

17.73

4.7

3.4

2.62

1.88

mmol/l

0.88

135

Mental retardation

254

1450

1.90

17.65

12.8

8.3

1.83

1.15

mmol/l

2.36

199

1040

Multiple myeloma

114

482

2.57

17.60

5.8

4.0

0.48

2.07

mmol/l

3.58

368

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

114

482

2.57

17.60

5.8

4.0

0.48

2.07

mmol/l

3.58

368

Other inflammatory liver diseases

218

1171

1.94

17.60

4.5

3.5

1.93

1.80

mmol/l

0.19

162

882

Other peripheral vertigo

302

1787

1.75

17.60

3.1

3.6

1.63

1.92

mmol/l

0.82

234

1332

Other specified/unspecified systemic involvement of connective tissue

186

947

2.05

17.58

4.8

3.4

1.87

mmol/l

0.01

145

711

Disorders of conjunctiva

2555

17868

1.21

17.49

4.4

3.8

1.55

1.63

mmol/l

0.51

1894

13024

Molar incisor enamel hypoplasia

245

1374

1.95

17.44

24.9

6.8

1.06

0.93

mmol/l

0.31

192

965

Nosocomial condition (hospital)

5.09

17.41

5.4

2.8

1.53

1.94

mmol/l

0.32

Benign neoplasm: Descending colon

229

1257

1.91

17.40

4.0

3.5

1.56

1.86

mmol/l

0.57

167

912

Crohn's disease of small intestine

217

1169

1.93

17.29

3.7

3.5

1.30

1.58

mmol/l

0.46

151

875

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

110

466

2.65

17.27

6.7

5.6

1.54

1.42

mmol/l

0.15

345

Thyrotoxicosis, other and/or unspecified

528

3563

1.51

17.26

3.6

3.4

1.91

1.84

mmol/l

0.15

387

2642

Dermatophytosis

426

2758

1.59

17.21

4.9

3.6

1.84

1.72

mmol/l

0.24

331

2016

Oligomenorrhoea

100

396

2.63

17.20

3.7

3.0

1.02

1.82

mmol/l

1.47

287

Bulimia nervosa (incl. atypical)

338

2.77

17.18

3.0

2.8

1.07

0.82

mmol/l

0.29

224

Scabies

164

807

2.14

17.17

3.9

4.0

1.32

1.52

mmol/l

0.27

123

592

Inflammatory diseases of the central nervous system

274

1589

1.79

17.13

4.7

3.9

1.64

1.70

mmol/l

0.10

215

1178

Impotence

204

1086

1.98

17.13

3.9

3.5

1.46

1.76

mmol/l

0.54

150

791

Keratitis

1032

7823

1.34

17.01

4.3

3.4

1.64

1.72

mmol/l

0.30

751

5757

Pneumococcal septicemia

150

722

2.23

16.93

6.8

4.5

2.09

1.70

mmol/l

0.63

113

525

Abnormal spermatozoa

459

3045

1.57

16.88

3.1

3.7

1.97

1.65

mmol/l

1.31

314

2202

Mental retardation, wide definition

259

1505

1.85

16.87

12.7

8.1

1.82

1.21

mmol/l

1.96

203

1083

Need for other prophylactic measures

219

1201

1.92

16.80

10.5

4.6

1.41

1.74

mmol/l

0.60

164

896

Benign neoplasm: Rectosigmoid junction

149

715

2.21

16.79

3.5

3.4

1.35

1.85

mmol/l

0.87

111

508

Eosinophilic disease (BM)

173

3.62

16.77

4.1

3.1

1.77

0.79

mmol/l

1.72

125

Other disorders of white blood cells

201

1072

1.97

16.75

6.7

4.1

2.22

1.71

mmol/l

1.18

149

799

Postprocedural endocrine and metabolic disorders, not elsewhere classified

304

1820

1.71

16.69

3.7

3.0

2.12

1.82

mmol/l

0.84

225

1362

Poisoning by narcotics and psychodysleptics [hallucinogens]

209

3.35

16.69

3.4

3.1

2.01

1.39

mmol/l

0.77

150

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

150

728

2.23

16.69

5.6

6.8

1.76

1.54

mmol/l

0.36

124

540

Atypical mycobacterium lung infection

207

3.48

16.62

5.7

3.4

1.78

1.92

mmol/l

0.10

160

Recurrent dislocation and subluxation of joint

193

1011

1.97

16.61

3.7

3.1

1.24

1.58

mmol/l

0.68

145

754

Henoch-Schönlein purpura nephritis (HSPN)

6.79

16.61

8.8

3.4

0.80

1.11

mmol/l

0.14

IBD patients in KELA-register

657

4655

1.44

16.60

4.5

3.4

1.37

1.57

mmol/l

0.68

482

3419

Ingrowing nail

188

982

2.00

16.58

4.4

3.6

1.58

1.65

mmol/l

0.10

134

732

Monoamine oxidase A inhibitors

339

2093

1.66

16.58

3.3

3.4

1.76

1.87

mmol/l

0.21

253

1540

Endometriosis of rectovaginal septum and vagina

204

1090

1.93

16.55

3.0

3.1

1.63

2.17

mmol/l

1.03

164

827

Bitten or struck by other mammals

315

1911

1.70

16.54

4.2

3.8

1.31

1.53

mmol/l

0.57

238

1409

Subjective visual disturbances

693

4963

1.42

16.54

3.4

3.5

1.27

1.81

mmol/l

3.59

506

3688

Alzheimer disease, excluding more controls

466

2037

1.56

16.51

2.9

3.6

1.99

1.88

mmol/l

0.22

324

1456

Ankle and foot

129

4.23

16.49

3.3

3.5

1.08

1.60

mmol/l

0.45

Hypoplasia of dental enamel , including avohilmo

221

1232

1.97

16.48

23.9

6.3

1.06

1.03

mmol/l

0.06

171

862

Atrial septal defect

242

1384

1.88

16.41

9.9

7.8

1.82

0.97

mmol/l

5.96

199

989

5.99

16.32

6.6

3.4

2.00

mmol/l

0.00

Spondylopathies (FG)

373

2363

1.61

16.32

3.6

3.1

1.87

1.66

mmol/l

0.52

267

1730

Carcinoma in situ, bladder

137

647

2.28

16.30

4.4

3.4

1.04

1.76

mmol/l

1.57

108

460

Other factor of the environment

183

3.56

16.23

4.6

2.9

2.62

1.64

mmol/l

0.93

137

Persistent delusional disorders

240

1363

1.83

16.15

3.3

3.4

2.51

1.73

mmol/l

1.90

189

1012

Other specified/unspecified soft tissue disorders

160

798

2.09

16.05

4.3

3.5

2.04

2.08

mmol/l

0.05

127

598

Other/unspecified synovitis and tenosynovitis

335

2080

1.65

16.03

3.5

3.4

1.39

1.78

mmol/l

1.22

257

1523

Personal history of risk-factors, not elsewhere classified

205

3.38

16.02

4.2

4.0

1.37

1.70

mmol/l

0.24

150

Folate deficiency anaemia

147

3.99

15.96

4.5

3.0

2.63

1.77

mmol/l

0.71

110

Other infective otitis externa

206

1124

1.91

15.93

5.0

3.9

1.15

1.77

mmol/l

1.86

164

833

Abnormal findings on diagnostic imaging of central nervous system

153

755

2.13

15.90

4.9

3.7

1.60

1.61

mmol/l

0.01

103

562

Osteonecrosis

200

1084

1.93

15.86

5.1

3.5

1.59

1.83

mmol/l

0.29

153

812

Myeloid leukaemia

107

460

2.50

15.84

6.2

3.8

0.81

1.84

mmol/l

2.31

339

Chronic hepatitis, not elsewhere classified

125

573

2.31

15.79

4.1

3.3

0.88

1.87

mmol/l

1.75

432

Erosion of teeth, including avohilmo

576

3886

1.46

15.74

5.4

3.0

1.20

1.55

mmol/l

1.75

416

2844

Other predominantly sexually transmitted diseases, not elsewhere classified

398

2578

1.57

15.74

3.6

2.9

1.29

1.44

mmol/l

0.41

287

1840

Protozoal diseases

114

506

2.42

15.72

5.5

3.7

1.37

1.78

mmol/l

0.64

383

Chronic diseases of tonsils and adenoids

2481

13164

1.20

15.72

3.8

4.0

1.24

1.63

mmol/l

6.90

1814

9626

Acute generalized exanthematous pustulosis

163

828

2.07

15.70

6.7

4.2

1.67

1.77

mmol/l

0.12

125

626

Congenital malformations and deformations of the musculoskeletal system

369

2356

1.62

15.70

7.8

7.3

1.43

1.13

mmol/l

0.99

277

1710

Disorders of optic nerve and visual pathways

305

1865

1.69

15.68

5.3

4.5

1.46

1.62

mmol/l

0.31

223

1374

Burns and corrosions

441

2935

1.54

15.65

4.1

4.4

1.36

1.54

mmol/l

0.43

325

2162

Acquired absence of organs, not elsewhere classified

193

3.45

15.64

5.1

3.5

0.83

1.78

mmol/l

0.84

142

Pain in thoracic spine

402

2620

1.57

15.56

3.0

3.4

1.91

1.77

mmol/l

0.34

298

1925

Chronic rhinitis, nasopharyngitis and pharyngitis

894

6726

1.35

15.55

3.4

3.7

1.54

1.72

mmol/l

1.01

675

4943

Ulcer of oesophagus

243

1404

1.80

15.54

4.8

3.5

2.11

1.85

mmol/l

0.44

178

1001

Sequelae of injuries of head

179

942

1.99

15.48

4.5

3.7

1.24

1.65

mmol/l

0.79

136

704

Heart failure and hypertrophic cardiomyopathy

340

2.79

15.47

5.0

3.8

1.72

1.83

mmol/l

0.11

270

Wide developmental disorders, excluding more controls

148

725

2.15

15.47

5.2

6.6

0.99

1.04

mmol/l

0.05

506

Mixed connective tissue disease

196

1063

1.92

15.38

4.6

3.5

1.79

1.84

mmol/l

0.07

152

801

Ovarian dysfunction

162

820

2.03

15.36

3.5

2.7

1.06

1.22

mmol/l

0.28

111

570

Faecal incontinence

248

1441

1.77

15.36

4.3

3.3

1.53

2.15

mmol/l

1.80

190

1109

Papilloedema, unspecified

399

2.59

15.33

5.2

5.5

0.50

1.48

mmol/l

1.40

294

Psoriatic and enteropathic arthropathies

328

2049

1.64

15.33

3.2

3.1

1.86

1.75

mmol/l

0.16

235

1508

Postprocedural disorders of digestive system, not elsewhere classified

135

648

2.22

15.33

14.4

4.7

1.46

1.78

mmol/l

0.33

483

Oesophagitis

186

995

1.95

15.32

4.1

3.7

1.99

1.89

mmol/l

0.10

148

712

Other viral hepatitis

183

971

1.95

15.30

3.6

3.3

1.79

1.50

mmol/l

0.48

138

712

Secondary polycythaemia

101

431

2.53

15.27

4.2

3.5

2.92

1.84

mmol/l

1.94

316

Trochanteric bursitis

359

2293

1.60

15.26

3.8

3.4

1.82

2.04

mmol/l

0.60

277

1736

Other noninflammatory disorders of vagina

194

1049

1.90

15.19

2.9

3.1

1.60

2.02

mmol/l

0.81

137

794

Chondropathies

450

3026

1.52

15.13

3.6

3.5

1.51

1.62

mmol/l

0.24

334

2237

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

141

691

2.17

15.11

6.1

3.8

1.41

1.82

mmol/l

0.52

111

493

Other Crohn's disease

209

1164

1.86

15.01

3.8

3.3

1.19

1.53

mmol/l

0.59

152

862

Carrier of infectious disease

378

2.60

14.99

6.3

3.3

1.80

1.81

mmol/l

0.00

276

Benign neoplasm: Rectum, anus and anal canal

643

4637

1.42

14.97

4.2

3.6

1.62

1.86

mmol/l

0.75

478

3447

Abnormal serum enzyme levels

622

8459

0.71

14.89

3.9

3.8

1.80

1.57

mmol/l

0.85

456

6187

Papulosquamous disorders

1161

9107

1.29

14.89

3.9

3.4

1.79

1.72

mmol/l

0.24

851

6788

Osteomyelitis of vertebra

6.75

14.82

7.5

3.2

2.94

2.59

mmol/l

0.19

Specific development disorders of scholastic skills

197

1076

1.91

14.82

7.6

5.2

0.94

1.12

mmol/l

0.36

125

769

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1493

8257

1.26

14.78

3.7

3.4

1.65

1.87

mmol/l

1.52

1104

6112

Other benign neoplasms of uterus

163

845

2.01

14.75

3.4

3.3

2.42

mmol/l

0.00

131

638

Inflammatory bowel disease, strict (require KELA)

657

4756

1.40

14.72

4.5

3.5

1.37

1.56

mmol/l

0.63

482

3490

Viral infections of the central nervous system

223

1275

1.81

14.70

4.5

3.6

1.89

1.60

mmol/l

0.63

167

949

Flat foot [pes planus] (acquired)

260

1549

1.73

14.69

3.0

3.4

1.49

1.91

mmol/l

1.00

186

1166

Psoriasis vulgaris

561

3961

1.45

14.66

4.0

3.5

1.92

1.68

mmol/l

0.61

397

2938

Abdominal aortic aneurysm (AAA)

384

2504

1.57

14.57

4.5

3.5

1.98

1.86

mmol/l

0.22

273

1779

Previous suicide attempt

140

3.80

14.56

2.9

4.4

1.46

1.55

mmol/l

0.05

102

Pneumoconiosis due to asbestos and other mineral fibres

108

486

2.41

14.55

7.5

3.7

2.54

1.83

mmol/l

1.08

344

Childhood allergy (age < 16)

489

2759

1.49

14.55

6.6

6.9

0.66

0.83

mmol/l

0.52

321

1882

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1473

8172

1.26

14.54

3.7

3.4

1.64

1.88

mmol/l

1.65

1091

6051

Other orthopaedic follow-up care

170

897

1.97

14.52

3.0

2.9

1.88

1.76

mmol/l

0.19

123

660

Other and unspecified injuries of ankle and foot

143

712

2.10

14.52

5.2

4.1

1.89

1.65

mmol/l

0.27

102

514

Excessive attrition of teeth

1238

5269

1.29

14.50

5.2

3.2

1.35

1.56

mmol/l

1.25

882

3863

Mental disorders, not otherwise specified

220

1255

1.80

14.50

3.2

3.1

1.84

1.47

mmol/l

0.76

150

930

Propionic acid derivatives

1120

4347

1.31

14.50

3.6

4.5

1.51

1.65

mmol/l

0.60

813

3109

Complications of genitourinary prosthetic devices, implants and grafts

415

2.50

14.49

5.2

3.4

2.15

2.08

mmol/l

0.06

314

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

114

524

2.32

14.45

6.3

3.6

1.53

1.88

mmol/l

0.33

376

Vitamin D deficiency

273

2.88

14.43

5.6

3.6

1.11

1.44

mmol/l

0.23

198

Mixed specific developmental disorders

199

1059

1.97

14.36

12.5

8.6

0.84

0.91

mmol/l

0.13

144

758

Coronary artery bypass grafting

979

5729

1.33

14.36

4.1

3.5

1.57

1.73

mmol/l

0.58

693

4217

Myasthenia gravis

287

2.85

14.30

4.8

4.1

1.45

1.73

mmol/l

0.26

214

Chronic viral hepatitis

153

783

2.03

14.27

3.4

2.8

1.89

1.51

mmol/l

0.59

118

571

Colorectal cancer, excluding all cancers (controls excluding all cancers)

841

6152

1.35

14.23

3.7

3.4

1.91

1.90

mmol/l

0.04

607

4518

Total colectomy operation

151

774

2.05

14.23

6.6

3.6

0.30

1.69

mmol/l

2.51

106

581

Total colectomy

151

774

2.05

14.23

6.6

3.6

0.30

1.69

mmol/l

2.51

106

581

Recurrent dislocation of patella

130

626

2.14

14.22

3.1

3.0

1.06

1.32

mmol/l

0.37

444

Squamous cell neoplasms and carcinomas of the skin

424

2864

1.53

14.21

4.1

3.7

1.84

1.94

mmol/l

0.19

310

2065

Leiomyoma of uterus

1082

4709

1.31

14.18

3.0

2.07

1.84

mmol/l

1.14

811

3449

Malignant neoplasm of respiratory system and intrathoracic organs

743

5082

1.37

14.18

4.1

3.7

2.46

1.78

mmol/l

5.21

617

3667

Anti-inflammatory and antirheumatic products, non-steroids

1118

4352

1.31

14.16

3.7

4.5

1.59

1.65

mmol/l

0.19

806

3113

Psoriasis

827

6247

1.35

14.13

4.1

3.4

1.95

1.68

mmol/l

1.13

607

4628

Benign neoplasm: Rectum

567

4046

1.44

14.11

4.1

3.6

1.74

1.87

mmol/l

0.32

411

2998

Temporomandibular joint disorders, including avohilmo

1014

7853

1.30

14.08

2.7

3.2

1.64

1.55

mmol/l

0.38

729

5682

Strabismus

841

6365

1.34

14.04

5.5

4.6

1.56

1.49

mmol/l

0.22

622

4649

Carcinoma in situ of other and unspecified sites

151

783

2.07

14.04

4.4

3.7

1.11

1.92

mmol/l

1.97

118

577

Pediculosis, acariasis and other infestations

194

1082

1.87

14.01

3.9

1.41

1.55

mmol/l

0.21

145

812

Intracerebral haemorrhage

417

2812

1.52

14.00

4.2

3.6

1.89

1.97

mmol/l

0.15

291

2021

Dislocation, sprain and strain of joints and ligaments of knee

1673

12757

1.23

14.00

2.9

3.2

1.52

1.57

mmol/l

0.28

1228

9303

Dental caries 2 and operation codes

2203

14718

1.20

13.99

4.6

3.6

1.11

1.59

mmol/l

8.79

1625

10699

Benign lipomatous neoplasm

813

6134

1.35

13.99

3.4

3.3

1.83

1.79

mmol/l

0.14

607

4531

Diabetes mellitus in pregnancy

592

2717

1.43

13.97

2.5

0.85

1.20

mmol/l

1.44

370

1885

Pre-eclampsia or poor fetal growth

614

4416

1.40

13.93

3.2

2.7

1.53

1.51

mmol/l

0.04

451

3167

Evidence of alcohol involvement determined by blood alcohol level

245

2.97

13.89

3.5

2.8

1.70

1.49

mmol/l

0.18

179

Clear cell adenocarcinoma of kidney

177

968

1.94

13.89

4.7

3.6

1.39

1.90

mmol/l

0.92

124

728

Fall involving bed

132

655

2.16

13.87

4.2

5.2

2.48

1.99

mmol/l

0.49

484

Disorders of refraction and accommodation

802

6026

1.35

13.85

6.9

4.5

1.47

1.43

mmol/l

0.12

585

4379

Other ulcerative colitis

183

1006

1.89

13.82

5.9

3.6

1.33

1.64

mmol/l

0.55

135

744

Other and unspecified follicular disorders

136

679

2.11

13.79

4.3

3.4

0.97

1.69

mmol/l

1.38

500

Spondylopathies in diseases classified elsewhere

220

3.14

13.77

3.9

4.1

1.97

2.42

mmol/l

0.39

173

Conjunctivitis

2212

16261

1.20

13.74

4.4

3.8

1.56

1.64

mmol/l

0.48

1643

11883

Mental and behavioural disorders due to cannabinoids

330

2.59

13.74

2.9

2.8

2.34

1.01

mmol/l

2.16

237

Retinal vascular occlusion

394

2642

1.54

13.68

4.5

3.6

1.72

1.99

mmol/l

0.67

301

1929

Crystal arthropathies, rheuma endpoint

299

2.75

13.68

5.1

3.6

1.56

2.24

mmol/l

0.60

228

Small fibre neuropathy

116

551

2.26

13.68

5.0

4.1

1.84

1.81

mmol/l

0.03

417

Infective dermatitis

357

2343

1.57

13.63

3.6

1.62

1.76

mmol/l

0.22

267

1723

Pilonidal cyst

233

1376

1.74

13.60

3.3

3.2

1.22

1.40

mmol/l

0.39

181

1007

Rare circulating lymphoid malignancy

150

786

2.05

13.60

5.6

6.7

1.76

1.62

mmol/l

0.21

124

587

Presbycusis

447

3058

1.49

13.58

3.3

3.6

2.39

2.15

mmol/l

0.61

306

2240

Other autoimmune haemolytic anaemias

222

3.12

13.57

3.1

4.0

2.00

1.84

mmol/l

0.11

169

Triptan medication for migraine, min. 3 purchases

1306

8250

1.26

13.53

2.8

3.1

1.22

1.58

mmol/l

3.71

935

6021

Selective deficiency of immunoglobulin G [IgG] subclasses

114

4.11

13.52

10.0

4.6

2.39

1.59

mmol/l

0.73

Other abnormalities of plasma proteins

297

2.79

13.51

5.7

4.2

2.53

1.90

mmol/l

0.72

217

Other disorders of amino-acid metabolism

4.61

13.49

6.1

6.8

0.96

1.94

mmol/l

0.54

Myeloproliferative diseases

275

1707

1.67

13.49

3.9

3.6

1.80

1.93

mmol/l

0.20

197

1256

Anomalies of dental arch relationship, including avohilmo

598

3881

1.41

13.48

9.2

4.4

1.35

mmol/l

0.00

432

2807

!Aliquae complicationes praecoces traumatis

148

768

2.02

13.47

5.4

3.7

1.64

1.75

mmol/l

0.12

113

575

Early complications of trauma

148

768

2.02

13.47

5.4

3.7

1.64

1.75

mmol/l

0.12

113

575

Other disorders of eyelid

1380

10798

1.25

13.46

3.6

1.82

1.92

mmol/l

0.48

1029

8061

Retinal vascular disorders

400

2700

1.52

13.44

4.5

3.6

1.72

2.00

mmol/l

0.71

305

1969

Ankylosing spondylitis

258

1573

1.68

13.40

3.9

3.3

2.01

1.66

mmol/l

0.75

189

1156

Complications following infusion, transfusion and therapeutic injection

268

2.85

13.38

7.4

4.7

1.73

1.92

mmol/l

0.15

206

Congenital malformations of cardiac chambers and connections

340

3.03

13.29

20.0

10.3

1.80

0.87

mmol/l

2.37

253

Erosion of teeth

379

2.55

13.26

15.9

3.8

1.38

1.51

mmol/l

0.15

287

Artificial joint re-operation

234

1404

1.74

13.21

3.9

3.6

2.20

2.06

mmol/l

0.20

169

1057

Diseases of spleen

299

2.72

13.19

4.7

3.8

1.60

1.56

mmol/l

0.04

234

Blindness, monocular

140

3.68

13.19

6.6

3.2

2.70

1.51

mmol/l

1.21

108

Polyp of the female genital tract

736

3169

1.37

13.17

2.9

3.1

1.88

1.99

mmol/l

0.33

551

2363

Lymphoid leukaemia

212

1242

1.79

13.13

5.0

5.3

1.51

1.63

mmol/l

0.18

159

887

Hydrocele

414

2827

1.50

13.10

5.1

4.1

1.66

1.63

mmol/l

0.05

299

2028

Nontraumatic intracranial haemmorrhage

630

4627

1.39

13.09

4.3

3.5

1.86

1.96

mmol/l

0.25

444

3408

Anorexia (incl.atypical)

175

963

1.87

13.07

4.0

3.6

1.97

1.29

mmol/l

2.03

130

680

Fracture of forearm

1592

12277

1.23

13.05

3.8

3.5

1.80

mmol/l

0.01

1175

9103

Conotruncal defects

129

669

2.25

13.02

15.3

9.4

2.26

0.86

mmol/l

7.70

112

481

Other fall from one level to another

733

5513

1.35

13.01

3.8

4.4

1.34

1.51

mmol/l

0.60

531

4014

Lifestyle-related condition

188

3.22

12.98

4.7

2.8

2.56

1.82

mmol/l

0.58

134

Vascular diseases of the intestine

138

710

2.05

12.92

4.8

3.6

1.47

1.93

mmol/l

0.69

104

531

Unspecified/other endometriosis

192

1087

1.80

12.92

3.3

2.7

1.35

1.47

mmol/l

0.20

139

739

Retinal detachments and breaks

1084

8596

1.28

12.87

4.1

3.4

1.58

1.84

mmol/l

1.53

807

6399

Other disorders of penis

353

2348

1.55

12.84

5.3

5.1

1.18

1.53

mmol/l

1.17

253

1705

Dental caries 2

2246

14988

1.19

12.76

4.6

3.6

1.10

1.59

mmol/l

9.28

1653

10915

Effects of foreign body entering through natural orifice

754

5711

1.34

12.75

3.6

4.1

1.32

1.51

mmol/l

0.78

555

4206

Benign neoplasm: Skin of other and unspecified parts of face

316

2051

1.58

12.71

3.9

3.4

1.35

1.88

mmol/l

1.82

213

1498

Listeriosis

5.38

12.71

3.0

2.5

1.85

2.18

mmol/l

0.18

Alcohol-induced acute pancreatitis

137

710

2.04

12.64

3.8

3.4

1.20

1.67

mmol/l

0.56

529

Benign neoplasm: Parathyroid gland

159

3.40

12.64

4.3

3.6

1.22

2.03

mmol/l

0.85

121

Autism

454

2.31

12.62

3.4

5.7

1.18

1.12

mmol/l

0.06

316

Amputation of thigh

116

567

2.17

12.62

6.5

3.9

1.47

1.93

mmol/l

0.51

413

Myocardial infarction, unclassifiable

795

5414

1.33

12.59

5.1

3.6

2.01

1.85

mmol/l

0.48

594

3913

Other crystal arthropathies

312

2.63

12.57

5.1

3.6

1.56

2.04

mmol/l

0.39

238

Amiodarone users

345

2297

1.55

12.54

5.1

3.8

2.10

1.77

mmol/l

0.72

256

1679

Primary biliary cholangitis (PBC)

312

2.59

12.44

4.5

3.4

0.70

1.80

mmol/l

1.34

246

Endometriosis of ovary

369

2472

1.51

12.41

3.0

3.1

1.66

1.94

mmol/l

0.89

284

1836

Other specific arthropathies, wide

337

2.52

12.39

3.6

3.2

3.04

1.85

mmol/l

2.01

260

Benign neoplasm: Descending colon

229

1391

1.72

12.38

4.0

3.7

1.56

1.90

mmol/l

0.67

167

1037

Myeloid leukaemia

107

512

2.23

12.37

6.2

3.9

0.81

2.00

mmol/l

3.04

378

Vulvovaginal ulceration/inflammation in other diseases

131

667

2.02

12.37

3.8

3.1

1.33

1.47

mmol/l

0.15

488

Burns and corrosions of external body surface, specified by site

350

2339

1.54

12.35

4.1

4.4

1.45

1.56

mmol/l

0.19

253

1716

Polycystic ovarian syndrome

113

545

2.13

12.34

2.7

2.6

0.87

0.98

mmol/l

0.17

366

Colectomy operation

523

3769

1.42

12.33

4.6

3.6

1.47

1.85

mmol/l

1.06

368

2792

Benign neoplasm: Rectosigmoid junction

149

802

1.96

12.30

3.5

3.8

1.35

2.03

mmol/l

1.40

111

610

Other specified/unspecified necrotizing vasculopathies

251

2.83

12.27

6.1

3.4

1.35

1.58

mmol/l

0.21

194

Motor disorders, excluding more controls

142

736

2.10

12.27

17.3

7.7

0.43

0.92

mmol/l

1.25

105

533

Diplopia

390

2667

1.50

12.26

3.6

1.64

1.86

mmol/l

0.58

283

1968

Systemic sclerosis (FG)

326

2.53

12.25

5.8

2.9

1.75

mmol/l

0.00

250

Examination and encounter for administrative purposes

127

645

2.05

12.22

2.3

3.0

1.38

2.32

mmol/l

2.49

459

Nonalcoholic steatohepatitis

112

3.91

12.22

5.7

3.7

0.08

1.79

mmol/l

1.30

Other benign neoplasm of uterus: Other parts/unspecified

131

675

2.03

12.20

3.3

2.51

2.50

mmol/l

0.01

102

515

Benign leiomyoma with endometriosis

381

2591

1.50

12.19

3.7

3.2

2.17

2.19

mmol/l

0.05

295

1980

Pregnancy hypertension

862

6006

1.31

12.16

3.1

2.9

1.68

1.63

mmol/l

0.15

620

4409

Adult respiratory distress syndrome

241

2.88

12.15

7.4

3.3

2.84

1.96

mmol/l

1.15

181

Other noninfective disorders of lymphatic vessels and lymph nodes

114

560

2.13

12.11

4.7

3.3

2.64

1.91

mmol/l

1.39

413

Sequelae of other external causes

174

984

1.84

12.09

4.3

3.7

2.20

1.68

mmol/l

1.23

131

731

Assault by unspecified means

298

2.60

12.08

2.7

3.1

1.38

1.33

mmol/l

0.04

213

Chronic lymphocytic leukaemia, helper endpoint

105

503

2.22

12.07

4.4

3.5

1.98

1.81

mmol/l

0.17

369

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

105

503

2.22

12.07

4.4

3.5

1.98

1.81

mmol/l

0.17

369

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1088

5274

1.28

12.02

3.6

1.53

1.56

mmol/l

0.09

780

3801

Carcinoma in situ, bladder

137

728

2.01

11.93

4.4

3.8

1.04

1.92

mmol/l

2.30

108

539

Hemiplegia

176

1003

1.82

11.91

4.9

3.9

1.65

1.69

mmol/l

0.04

133

734

Endometriosis of pelvic peritoneum

332

2171

1.53

11.91

3.0

2.9

1.40

1.77

mmol/l

1.48

244

1588

Disorders of continuity of bone

259

1632

1.63

11.86

4.5

3.4

2.00

1.65

mmol/l

0.73

192

1220

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

973

6702

1.28

11.85

3.0

1.65

1.69

mmol/l

0.12

697

4958

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

138

732

1.98

11.84

4.3

3.4

2.32

1.82

mmol/l

0.87

107

530

Acute nephritic syndrome

396

2.37

11.83

9.1

3.6

1.20

1.81

mmol/l

0.84

290

Generalized epilepsy

164

920

1.86

11.79

4.2

5.9

0.86

1.41

mmol/l

1.15

117

667

Other strabismus

668

5018

1.35

11.76

6.0

4.7

1.45

mmol/l

0.02

493

3648

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

271

1716

1.62

11.75

14.2

7.7

0.86

0.93

mmol/l

0.13

181

1251

Corneal ulcer

498

3584

1.41

11.73

4.2

3.5

1.66

1.74

mmol/l

0.19

356

2646

Methotrexate

379

2595

1.49

11.72

4.1

3.1

1.85

1.76

mmol/l

0.20

272

1907

Recurring oral aphthae, including avohilmo

415

2898

1.47

11.71

4.7

4.3

1.67

1.71

mmol/l

0.10

304

2143

Calculus of lower urinary tract

202

1207

1.75

11.70

3.8

3.6

2.14

1.85

mmol/l

0.51

150

867

Gluteal tendinitis

108

526

2.14

11.70

2.8

3.5

1.52

2.06

mmol/l

0.92

409

Metabolic disorder, other/unspecified

4.95

11.64

15.1

8.5

0.88

1.34

mmol/l

0.23

Hypertension, Pulmonary Arterial

131

3.55

11.57

7.8

4.2

2.01

1.83

mmol/l

0.14

101

conjunctival haemorrhage

242

1515

1.66

11.57

4.0

3.7

1.60

1.83

mmol/l

0.46

170

1130

Open wound of hip and thigh

112

557

2.11

11.55

4.3

3.6

0.46

1.44

mmol/l

1.60

408

Syphilis

465

2.24

11.53

6.9

3.5

1.25

1.70

mmol/l

0.52

345

Osteonecrosis due to drugs

225

2.90

11.51

4.8

4.0

1.54

2.10

mmol/l

0.49

175

Bacterial, viral and other infectious agents

260

1654

1.62

11.49

7.3

4.0

1.66

1.48

mmol/l

0.36

194

1218

Herpesviral [herpes simplex] infections

325

2171

1.53

11.47

5.5

3.5

1.34

1.78

mmol/l

1.51

249

1621

Thyrotoxicosis

659

4971

1.35

11.46

3.6

3.4

2.05

1.88

mmol/l

0.48

494

3710

Testicular dysfunction

122

628

2.04

11.44

3.1

3.3

1.35

1.48

mmol/l

0.21

471

Delayed milestone in childhood

231

1356

1.82

11.44

19.8

10.2

0.93

0.80

mmol/l

0.29

179

980

Contusion of other and unspecified parts of foot

157

875

1.86

11.44

3.9

4.8

1.37

1.56

mmol/l

0.24

113

628

Other specified and unspecified disorders of lens

127

3.57

11.42

2.2

4.5

2.09

2.05

mmol/l

0.02

Other and unspecified mononeuropathies, also in other diseases

111

554

2.11

11.40

4.1

3.4

1.82

1.77

mmol/l

0.05

420

Other diseases of spinal cord

115

582

2.09

11.40

5.2

4.0

3.18

1.75

mmol/l

2.98

435

Psoriatic arthropathies

275

1773

1.59

11.39

3.2

1.91

1.81

mmol/l

0.15

197

1319

Superficial injury of forearm

280

1818

1.58

11.29

3.9

4.1

1.53

1.59

mmol/l

0.10

198

1331

Unspecified event, undetermined intent

436

2.26

11.27

4.0

3.8

0.93

1.55

mmol/l

0.62

308

Benign neoplasm: Ascending colon

409

2875

1.46

11.25

4.9

3.7

1.47

1.90

mmol/l

1.46

318

2143

Wegener granulomatosis

280

2.63

11.24

6.9

3.7

1.28

1.74

mmol/l

0.51

210

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

5.32

11.23

4.7

3.1

1.98

1.71

mmol/l

0.18

Achilles tendinitis

295

1940

1.56

11.22

3.4

1.15

1.74

mmol/l

1.95

207

1447

Deficiency of other B group vitamins

347

2.42

11.21

5.2

3.8

1.11

1.91

mmol/l

0.94

264

Congenital malformations of great arteries

187

1116

1.84

11.17

14.2

10.4

2.01

0.65

mmol/l

12.16

160

774

In situ neoplasms

1025

8213

1.26

11.16

4.2

3.4

1.66

1.90

mmol/l

1.30

787

6057

Thrombotic microangiopathy

4.07

11.16

10.3

3.8

0.89

1.64

mmol/l

0.42

Medical abortion

1540

6924

1.22

11.13

3.4

3.0

2.01

1.84

mmol/l

0.96

1159

5105

Other and unspecified vascular occlusions

304

2022

1.55

11.11

4.2

3.5

1.78

2.09

mmol/l

0.63

229

1467

Vasculitis limited to skin, not elsewhere classified

473

2.20

11.08

5.5

3.6

2.27

1.99

mmol/l

0.33

356

Mesothelioma, excluding all cancers (controls excluding all cancers)

253

2.73

11.07

4.4

3.9

2.94

1.91

mmol/l

1.48

190

Cluster headache, strict, including avohilmo

138

747

1.91

11.02

3.3

3.2

1.34

1.54

mmol/l

0.25

553

Sequelae of injuries of neck and trunk

105

520

2.13

11.01

4.8

3.7

2.25

1.66

mmol/l

0.86

391

Fenamates

444

2114

1.44

10.98

3.4

3.9

1.65

1.79

mmol/l

0.29

335

1537

Synovial cyst of popliteal space [Baker]

212

1299

1.68

10.96

3.9

3.7

2.13

1.95

mmol/l

0.33

167

964

Other enthesopathy of foot (+metatarsalgia)

255

1631

1.60

10.94

2.8

3.6

1.52

1.85

mmol/l

0.84

185

1228

Other benign neoplasms of uterus

163

933

1.82

10.93

3.4

3.3

2.42

2.28

mmol/l

0.17

131

710

Exclusion endpoint for clefts

130

706

2.01

10.91

12.5

9.3

1.63

1.08

mmol/l

1.06

103

521

Complications predominantly related to the puerperium

521

3816

1.38

10.91

2.6

2.9

1.70

1.61

mmol/l

0.21

376

2783

Cardiac murmurs and other cardiac sounds

317

2106

1.53

10.91

5.9

5.7

1.41

1.26

mmol/l

0.39

231

1502

Mild mental retardation

124

658

2.01

10.90

8.1

5.6

2.66

1.46

mmol/l

2.45

476

Lichen simplex chronicus and prurigo

192

1150

1.73

10.89

4.9

3.5

2.07

1.84

mmol/l

0.36

144

848

Habit and impulse disorders

223

2.76

10.88

2.8

3.3

1.11

1.35

mmol/l

0.17

162

Myositis

449

2.21

10.87

4.7

3.8

1.89

1.94

mmol/l

0.04

338

Hyperaldosteronism

101

497

2.15

10.84

4.5

3.7

2.30

1.89

mmol/l

0.37

384

Malignant neoplasm of skin

1999

12849

1.18

10.84

3.7

3.6

1.68

1.90

mmol/l

1.76

1479

9581

Radiculopathy

481

3492

1.40

10.82

3.4

2.05

1.88

mmol/l

0.51

357

2575

Personal history of malignant neoplasm

112

570

2.05

10.82

3.4

3.1

1.71

1.90

mmol/l

0.26

435

Secondary parkinsonism+Parkinsonism in other disease

106

532

2.11

10.80

3.6

2.15

1.79

mmol/l

0.50

402

Disorders of vitreous body and globe

1485

12091

1.21

10.80

4.3

3.5

1.61

1.87

mmol/l

2.12

1101

9082

Leiomyoma of uterus

1508

7110

1.22

10.80

3.1

3.2

2.12

1.98

mmol/l

0.73

1140

5354

Disorders of speech understanding and production

224

1386

1.68

10.76

10.8

7.0

1.21

1.08

mmol/l

0.28

162

991

Non-Hodgkin lymphoma, all

145

808

1.88

10.76

5.2

3.9

2.17

1.97

mmol/l

0.28

123

601

Other and unspecified disorders of white blood cells

143

795

1.88

10.66

6.7

3.8

2.50

1.84

mmol/l

1.22

104

600

Cramp and spasm

153

867

1.84

10.66

3.9

4.7

1.60

1.62

mmol/l

0.02

110

657

Crohn disease (strict definition, require KELA, min 2 HDR)

179

1057

1.75

10.65

3.5

1.20

1.51

mmol/l

0.48

130

771

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

193

1164

1.71

10.61

3.4

3.5

1.26

1.55

mmol/l

0.49

140

860

Hydrocephalus in other diseases

3.96

10.60

6.7

4.8

2.26

1.49

mmol/l

0.56

Mixed conductive and sensorineural hearing loss

367

2555

1.47

10.59

4.1

3.7

1.68

1.93

mmol/l

0.61

291

1912

Symptoms and signs involving emotional state

101

500

2.12

10.58

4.0

4.6

1.14

1.62

mmol/l

0.78

356

Urethral stricture

201

1231

1.70

10.56

5.0

3.4

1.55

1.73

mmol/l

0.28

151

865

Iridocyclitis

635

4826

1.34

10.56

3.7

3.5

1.78

1.75

mmol/l

0.09

454

3561

Alcohol abuse counselling and surveillance

294

2.51

10.56

4.0

3.1

1.32

1.41

mmol/l

0.05

215

Benign neoplasm: Parathyroid gland

177

3.04

10.56

4.3

3.6

1.22

2.16

mmol/l

1.14

137

Visual field defects

261

1698

1.58

10.55

4.6

3.8

1.64

1.88

mmol/l

0.49

183

1238

Hallux valgus (acquired)

888

5068

1.28

10.55

3.3

3.2

1.78

1.91

mmol/l

0.49

681

3806

Respiratory conditions due to other external agents

364

2.35

10.55

3.6

3.2

3.76

1.88

mmol/l

4.72

278

Abnormal blood-pressure reading, without diagnosis

132

716

1.91

10.51

5.6

3.8

1.64

1.58

mmol/l

0.07

103

529

Arterial embolism and thrombosis of lower extremity artery

130

705

1.93

10.50

4.3

4.2

1.98

1.87

mmol/l

0.13

524

Kyphosis

217

2.79

10.49

6.4

4.6

2.15

2.43

mmol/l

0.21

167

Injury of muscle and tendon at shoulder and upper arm level

1078

8754

1.25

10.48

3.1

3.6

1.50

1.65

mmol/l

0.80

798

6483

Crohn disease (strict definition, require KELA)

181

1078

1.73

10.45

3.5

1.20

1.54

mmol/l

0.54

130

789

Post-traumatic wound infection, not elsewhere classified

450

2.18

10.43

4.9

3.6

1.29

1.66

mmol/l

0.40

334

Use of biperiden

164

953

1.78

10.42

3.2

3.3

2.90

1.70

mmol/l

3.72

134

708

Fracture of neck

193

1174

1.71

10.42

4.2

3.7

1.98

1.80

mmol/l

0.27

150

863

Problems related to social environment

462

2.15

10.42

3.7

3.6

3.21

1.82

mmol/l

2.53

332

Right ventricular outflow tract obstruction

414

2.46

10.41

17.3

9.2

2.04

1.01

mmol/l

3.54

308

Other and unspecified mental retardation

145

841

1.96

10.38

15.8

9.6

1.11

1.00

mmol/l

0.17

117

593

Cerebral palsy

469

2.20

10.37

19.2

7.3

1.39

1.14

mmol/l

0.28

331

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

175

1046

1.78

10.36

10.7

8.6

1.72

1.15

mmol/l

1.56

139

769

Assault by sharp object

247

2.62

10.35

3.9

2.7

1.88

1.36

mmol/l

0.40

177

Other specified congenital malformation syndromes affecting multiple systems

115

613

2.07

10.34

13.3

9.7

1.75

1.08

mmol/l

1.35

454

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1763

11818

1.19

10.34

3.8

3.6

1.70

1.93

mmol/l

1.73

1309

8813

Congenital malformations of trachea and bronchus

234

2.81

10.33

14.3

7.0

2.11

1.81

mmol/l

0.28

170

Perforation of tympanic membrane

297

1995

1.53

10.30

5.3

3.7

1.64

1.75

mmol/l

0.18

218

1465

Metatarsalgia

239

1529

1.60

10.29

2.9

3.6

1.46

1.85

mmol/l

1.02

172

1146

Bell's palsy

328

2247

1.49

10.26

4.1

3.5

1.74

1.80

mmol/l

0.13

243

1665

Complications following abortion and ectopic and molar pregnancy

103

519

2.07

10.25

4.2

3.2

2.66

1.81

mmol/l

1.59

413

Unspecified visual impairment (binocular)

332

2.43

10.24

6.8

6.1

1.20

1.76

mmol/l

0.65

242

Other nutritional anaemias

163

3.07

10.20

2.9

3.7

2.29

2.13

mmol/l

0.09

120

Viral hepatitis

197

1207

1.68

10.19

3.6

3.3

1.74

1.52

mmol/l

0.35

147

895

Malignant neoplasm of bronchus and lung

625

4461

1.34

10.16

4.0

3.7

2.44

1.82

mmol/l

3.82

516

3207

Toxic effect of other and unspecified substances

191

2.86

10.15

2.7

3.0

2.18

1.44

mmol/l

0.57

131

Hepatomegaly and splenomegaly, not elsewhere classified

164

3.08

10.15

6.8

3.6

1.53

1.72

mmol/l

0.11

121

Aspergillosis

143

3.29

10.14

8.6

3.7

2.14

1.66

mmol/l

0.49

107

Blepharochalasis

846

6713

1.28

10.14

3.4

3.5

1.70

2.03

mmol/l

1.91

632

5102

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

214

1344

1.65

10.14

4.0

4.2

2.56

1.81

mmol/l

2.01

177

963

Other and unspecified abdominal hernia

138

771

1.87

10.13

5.3

3.8

2.37

1.98

mmol/l

0.47

103

580

Other/unspecified enthesopathies, not elsewhere classified

246

1592

1.58

10.12

3.6

3.5

1.43

1.91

mmol/l

1.20

183

1177

Benign neoplasm of other and ill-defined parts of digestive system

471

3449

1.39

10.11

3.8

3.4

1.64

1.96

mmol/l

1.07

349

2569

Infection of intervertebral disc (pyogenic)

222

2.75

10.09

6.0

3.7

1.74

2.27

mmol/l

0.42

164

Testicular hypofunction

107

551

2.04

10.09

3.2

1.38

1.46

mmol/l

0.10

408

Disorders of vitreous body

1432

11741

1.21

10.09

4.3

3.5

1.59

1.87

mmol/l

2.41

1060

8823

Autism spe

457

2.15

10.03

3.0

6.8

1.17

1.02

mmol/l

0.16

318

Injury of other and unspecified intrathoracic organs

198

1223

1.67

10.03

3.9

3.6

1.81

1.71

mmol/l

0.10

140

908

Other specified/unspecified spondylopathies

430

2.18

10.02

3.5

3.7

2.48

2.16

mmol/l

0.32

325

Benign neoplasm of urinary organs

142

803

1.84

9.97

5.0

3.2

1.41

1.72

mmol/l

0.49

107

582

Adenomyosis (Endometriosis of uterus)

302

2045

1.50

9.94

3.2

1.89

2.14

mmol/l

0.60

243

1548

Encephalitis

105

541

2.04

9.93

4.5

4.4

1.83

1.59

mmol/l

0.29

399

Unspecified misadventure during surgical and medical care

172

1029

1.74

9.91

5.1

3.7

1.33

1.79

mmol/l

0.72

135

771

Granulomatous disorders of skin and subcutaneous tissue

418

2.19

9.91

5.5

3.5

0.35

1.82

mmol/l

2.68

306

Anterior Iridocyclitis

569

4300

1.34

9.90

3.8

3.5

1.73

mmol/l

0.01

408

3180

Palindromic rheumatism

166

3.01

9.89

4.1

3.6

3.32

1.97

mmol/l

1.34

135

Hyperhidrosis

377

2.23

9.88

2.4

3.5

0.79

1.48

mmol/l

0.71

279

Secondary parkinsonism

101

515

2.07

9.88

3.7

3.6

2.16

1.85

mmol/l

0.40

388

Other and unspecified trigeminal disorders

241

2.61

9.88

3.0

2.8

1.99

1.93

mmol/l

0.03

188

Cluster headache, wide,, including avohilmo

144

818

1.82

9.88

3.3

3.1

1.42

1.54

mmol/l

0.15

105

606

Acute and subacute iridocyclitis

533

3992

1.36

9.86

3.9

3.5

1.74

1.77

mmol/l

0.07

381

2961

Lactose intolerance

104

534

2.03

9.86

4.5

3.9

2.00

1.83

mmol/l

0.19

405

Necrobiosis lipoidica, not elsewhere classified

4.09

9.82

3.5

2.2

-0.90

1.19

mmol/l

1.31

Plantar fascial fibromatosis

242

1570

1.57

9.81

3.5

1.71

1.83

mmol/l

0.24

175

1176

Intermittent heterotropia

240

1564

1.59

9.80

6.9

5.9

1.39

1.17

mmol/l

0.46

174

1115

Degenerative macular diseases

374

2656

1.44

9.75

4.0

3.5

1.60

2.12

mmol/l

1.80

271

1950

Other and unspecified vasculitis limited to skin

429

2.18

9.75

5.7

3.7

2.30

1.98

mmol/l

0.34

320

Other specified disorders of external ear

139

790

1.85

9.75

3.7

3.8

1.40

1.76

mmol/l

0.58

105

592

Encephalopathy

192

2.88

9.69

8.1

3.9

2.34

1.92

mmol/l

0.26

139

Recurrent and persistent haematuria

130

3.30

9.68

4.3

3.2

2.11

1.44

mmol/l

0.42

Juvenile arthritis (FINNGEN)

159

936

1.76

9.68

5.5

5.2

1.05

1.24

mmol/l

0.29

113

669

Coeliac disease

367

2599

1.44

9.67

3.9

4.2

1.39

1.72

mmol/l

0.94

273

1905

Personal history of medical treatment

152

3.11

9.66

9.2

4.8

1.75

1.89

mmol/l

0.08

112

Postinfectious hypothyroidism

4.37

9.66

4.2

1.35

1.74

mmol/l

0.23

Other other unspecified disorders of the circulatory system

136

771

1.85

9.60

5.3

4.3

2.45

1.80

mmol/l

1.09

106

579

Acute lymphadenitis

176

1067

1.70

9.56

4.8

4.4

1.67

1.51

mmol/l

0.26

131

786

Degeneration of the brain due to alcohol

468

2.12

9.54

3.9

3.7

1.82

1.67

mmol/l

0.16

354

Schizotypal disorder

338

2.29

9.54

3.6

2.9

1.82

1.50

mmol/l

0.33

244

Other endocrine disorders

297

1969

1.52

9.52

14.0

7.6

1.18

1.07

mmol/l

0.20

212

1438

Deep endometriosis

229

1479

1.58

9.49

2.8

3.2

1.59

1.90

mmol/l

0.53

180

1090

Mixed disorders of conduct and emotions

425

2.14

9.49

6.3

5.8

1.39

1.05

mmol/l

0.48

297

Open wound of abdomen, lower back and pelvis

102

528

2.02

9.48

4.8

3.5

2.04

1.50

mmol/l

0.59

383

Special screening examination for neoplasms

129

719

1.85

9.45

6.1

3.2

0.92

2.23

mmol/l

4.24

530

Impetigo

170

1029

1.72

9.45

6.6

6.2

1.41

1.34

mmol/l

0.10

123

745

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1047

5108

1.25

9.43

3.5

3.6

1.58

1.56

mmol/l

0.05

748

3679

Myeloproliferative diseases (CML excluded)

238

1559

1.57

9.43

3.9

3.6

2.01

1.93

mmol/l

0.11

172

1150

Chronic mastoiditis

510

2.05

9.42

3.2

3.8

1.34

1.77

mmol/l

0.64

384

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

571

4353

1.33

9.41

3.3

3.5

1.86

1.90

mmol/l

0.07

414

3180

malignant neoplasm of male genital organs

1478

7908

1.20

9.36

3.4

3.9

1.58

1.60

mmol/l

0.09

1050

5771

Degeneration of nervous system due to alcohol

472

2.10

9.33

3.9

3.7

1.82

1.66

mmol/l

0.17

352

Sequelae of injuries of upper limb

267

1792

1.52

9.32

4.0

3.5

1.61

1.72

mmol/l

0.20

207

1355

Puerperal sepsis

297

2033

1.49

9.32

2.9

3.2

2.21

1.86

mmol/l

0.87

221

1575

Outcome of delivery

131

1417

0.57

9.32

1.9

2.6

1.01

1.20

mmol/l

0.32

992

Occupational exposure to risk-factors

120

661

1.91

9.32

5.0

3.9

2.07

1.68

mmol/l

0.69

495

Allergic purpura

104

546

1.99

9.29

5.6

3.5

1.69

1.76

mmol/l

0.07

396

Tonsillectomy and adenotomy

1540

9066

1.19

9.29

4.5

4.0

1.05

1.37

mmol/l

3.29

1077

6485

Achalasia of cardia

292

2.40

9.28

4.1

3.6

1.68

1.96

mmol/l

0.24

215

Severe visual impairment, binocular

3.91

9.26

8.2

3.1

0.15

1.70

mmol/l

0.96

Postprocedural disorders of nervous system

173

1051

1.68

9.25

3.0

3.2

1.33

1.57

mmol/l

0.45

121

782

Conduct disorder

390

2.18

9.21

3.2

5.5

1.20

1.27

mmol/l

0.05

278

Manic episode

450

2.08

9.18

3.3

3.0

1.76

1.91

mmol/l

0.14

317

Residual foreign body in soft tissue

144

837

1.78

9.16

4.0

3.5

1.72

1.75

mmol/l

0.03

103

613

Lymphoid leukaemia

212

1367

1.61

9.16

5.0

5.3

1.51

1.70

mmol/l

0.32

159

1024

Nontoxic single thyroid nodule

196

1234

1.63

9.16

2.8

3.6

1.64

1.97

mmol/l

0.63

135

931

Abscess of lung

302

2.39

9.15

6.8

4.0

2.36

2.00

mmol/l

0.25

222

Other and unspecified injuries of shoulder and upper arm

100

521

2.01

9.15

4.0

3.5

1.83

1.59

mmol/l

0.25

379

Other disorders starting during childhood or adolescence

259

1733

1.54

9.14

14.7

7.9

0.86

0.87

mmol/l

0.02

174

1236

Radial styloid tenosynovitis [de Quervain]

130

734

1.82

9.07

3.3

3.5

2.04

1.72

mmol/l

0.39

100

550

Biological medicines for asthma

197

2.72

9.06

3.2

3.0

1.13

1.29

mmol/l

0.14

141

Oesophageal obstruction

116

637

1.90

9.04

4.6

3.7

1.93

2.00

mmol/l

0.07

465

Unspecified protein-energy malnutrition

105

3.62

9.04

3.4

5.9

2.27

2.06

mmol/l

0.10

Alzheimer’s disease, wide definition, excluding more controls

383

1858

1.42

9.04

2.8

3.5

2.07

1.93

mmol/l

0.28

267

1321

Dislocation of lens

227

2.58

9.04

3.8

4.1

2.11

1.94

mmol/l

0.10

171

Other benign neoplasm of uterus: Other parts/unspecified

131

747

1.83

9.02

3.3

3.5

2.51

2.40

mmol/l

0.10

102

565

Diseases of appendix

2170

17247

1.15

9.02

3.4

1.66

1.62

mmol/l

0.18

1603

12619

Fitting and adjustment of external prosthetic device

5.91

9.02

5.8

4.1

1.58

2.34

mmol/l

0.60

Palmar fascial fibromatosis [Dupuytren]

500

3767

1.35

9.02

4.2

3.7

1.42

1.76

mmol/l

1.00

353

2742

Vestibular neuronitis

254

1702

1.53

9.01

3.0

3.6

1.44

1.88

mmol/l

1.36

187

1278

Appendicitis, broad definition

2149

17130

1.15

9.00

3.4

3.3

1.66

1.62

mmol/l

0.18

1585

12536

Erythema intertrigo

429

2.12

8.99

7.0

4.2

2.36

1.81

mmol/l

0.59

319

Postzoster neuralgia

247

2.52

8.97

6.9

3.7

2.15

1.89

mmol/l

0.18

191

Other and unspecified disorders of adult personality and behaviour

4.21

8.97

3.5

2.4

0.78

1.01

mmol/l

0.09

Portal vein thrombosis

279

2.43

8.94

8.6

4.0

1.47

1.72

mmol/l

0.19

203

Otalgia

254

1707

1.53

8.93

3.8

5.6

1.51

1.53

mmol/l

0.04

180

1274

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

548

4186

1.33

8.93

4.1

3.4

1.76

1.95

mmol/l

0.48

399

3061

Congenital malformations of the respiratory system

110

608

1.99

8.91

12.9

9.7

1.69

1.43

mmol/l

0.39

452

Mesothelioma

281

2.44

8.90

4.4

4.2

2.94

2.00

mmol/l

1.28

217

Urethritis and urethral syndrome

329

2.26

8.88

5.0

3.1

2.03

2.05

mmol/l

0.01

242

Myocardial infarction, with ST-elevation

583

4502

1.32

8.83

4.5

3.6

1.65

1.77

mmol/l

0.27

422

3250

Other contact dermatitis

220

1434

1.57

8.82

4.7

3.4

1.63

1.76

mmol/l

0.20

169

1058

Mild or no visual impairment, binocular

4.03

8.82

5.3

4.7

0.25

1.76

mmol/l

0.81

Other congenital malformations

314

2206

1.46

8.78

9.2

6.9

1.60

1.26

mmol/l

1.04

226

1617

Allergic contact dermatitis due to drugs in contact with skin

385

2.17

8.77

4.7

3.5

1.75

1.79

mmol/l

0.03

290

Kela reimbursement Agammaglobulinemia (D80-84)

138

3.10

8.77

8.1

3.4

0.74

1.73

mmol/l

0.67

6-mercaptopurine

472

2.03

8.75

3.7

4.7

0.87

1.44

mmol/l

0.81

346

Other encephalitis

502

2.01

8.75

4.5

1.72

1.58

mmol/l

0.14

371

Other immunodeficiencies

252

2.52

8.73

7.8

6.3

1.53

1.37

mmol/l

0.12

184

Chondrocostal junction syndrome [Tietze]

109

593

1.91

8.72

3.5

1.23

1.77

mmol/l

0.53

449

Dementia, including avohilmo

1428

8336

1.20

8.70

3.2

3.8

2.05

1.97

mmol/l

0.31

1023

6218

Traction detachment of retina

150

3.00

8.70

6.3

3.0

1.40

1.70

mmol/l

0.15

102

Protein-energy malnutrition of moderate and mild degree

230

2.67

8.69

8.7

8.3

1.13

1.65

mmol/l

0.30

157

Endometriosis ASRM stages 3,4

504

3814

1.34

8.67

3.0

3.1

1.66

1.88

mmol/l

0.62

391

2830

Other drug-induced secondary parkinsonism

156

2.96

8.67

4.9

3.6

1.98

2.05

mmol/l

0.04

124

Disorders of phosphorus metabolism and phosphatases

103

3.61

8.66

8.5

4.4

2.66

1.74

mmol/l

0.87

Systemic sclerosis

380

2.15

8.63

5.8

3.2

1.75

1.92

mmol/l

0.16

296

Pulmonary oedema

328

2.27

8.63

7.0

3.6

1.61

1.95

mmol/l

0.30

239

Systemic disorders of connective tissue in diseases classified elsewhere

4.64

8.62

10.5

4.3

0.81

1.39

mmol/l

0.26

Other intracranial haemorrhages

113

627

1.89

8.61

4.4

1.40

2.05

mmol/l

0.82

473

Benign neoplasm of meninges

256

1735

1.51

8.57

3.6

3.3

2.21

2.03

mmol/l

0.32

182

1296

All dysplastic lesions of the vulva

108

588

1.90

8.57

4.3

3.0

1.39

1.81

mmol/l

0.60

453

Moderate mental retardation

183

2.89

8.57

8.4

5.7

1.93

1.46

mmol/l

0.34

137

Trigeminal neuralgia

160

975

1.69

8.57

2.9

3.2

1.76

1.81

mmol/l

0.06

122

720

Failure of sterile precautions during surgical operation

5.39

8.56

4.8

2.7

2.16

1.63

mmol/l

0.25

Infective bursitis

520

1.97

8.54

5.1

3.8

1.83

1.92

mmol/l

0.10

380

Malignant neoplasm of heart, mediastinum and pleura

254

2.49

8.54

4.9

4.8

2.66

1.76

mmol/l

1.10

197

Mitochondrial myopathy

4.45

8.54

4.6

5.1

0.79

1.02

mmol/l

0.10

Correction of physiology of bite - demanding therapy visit

173

1075

1.65

8.53

3.4

1.95

1.64

mmol/l

0.71

131

801

Chronic lymphocytic leukaemia

105

572

1.94

8.53

4.4

4.1

1.98

1.99

mmol/l

0.01

436

Cardiomyopathy in other diseases

4.13

8.53

5.4

3.5

1.64

1.74

mmol/l

0.06

Cushing syndrome

168

2.82

8.52

3.7

3.5

2.50

2.20

mmol/l

0.13

129

Other juvenile arthritis

139

820

1.75

8.47

5.8

5.2

0.81

1.22

mmol/l

0.71

582

Injury of eye and orbit

378

2753

1.40

8.45

3.3

3.6

1.57

1.51

mmol/l

0.14

273

2010

Other hammer toe(s) (acquired)

454

3188

1.36

8.41

3.4

2.07

mmol/l

0.00

339

2444

Other and unspecified psoriasis

193

1239

1.60

8.39

4.2

3.6

2.24

1.77

mmol/l

0.77

150

923

Implicit parasitic Sepsis

3.82

8.38

4.2

2.3

1.69

1.87

mmol/l

0.07

Contact with and exposure to communicable diseases

794

6365

1.25

8.37

5.1

4.3

1.65

1.22

mmol/l

2.85

494

4541

Benign neoplasm: Kidney

104

567

1.91

8.33

4.4

3.3

1.23

1.86

mmol/l

1.07

419

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

311

2.23

8.28

3.1

3.0

0.94

2.01

mmol/l

1.52

231

Lateral epicondylitis

323

2298

1.43

8.28

3.2

3.3

1.03

1.65

mmol/l

2.44

239

1719

Injuries involving multiple body regions

114

640

1.85

8.27

3.2

3.6

2.01

1.72

mmol/l

0.34

477

Injury of unspecified body region

232

1557

1.53

8.24

4.2

4.3

1.83

1.67

mmol/l

0.24

178

1154

Other bacterial agents as the cause of diseases classified to other chapters

196

2.68

8.24

9.2

5.5

1.62

1.61

mmol/l

0.00

147

Other and unspecified paralytic syndromes

257

2.42

8.24

3.7

3.9

1.63

1.85

mmol/l

0.18

193

Congenital malformations of great veins

211

3.29

8.22

17.8

12.6

1.81

0.87

mmol/l

1.66

150

Additional codes for the location of defect, injury or illness

169

1058

1.65

8.20

3.6

4.1

1.30

1.70

mmol/l

0.77

117

797

Crossbite

311

2052

1.45

8.20

8.6

6.2

1.12

1.16

mmol/l

0.08

216

1441

Ankylosing spondylitis, ICD10

244

1654

1.51

8.18

3.9

3.5

1.98

1.67

mmol/l

0.62

180

1236

Benign neoplasm: Skin of eyelid, including canthus

395

2915

1.38

8.18

3.2

3.4

1.61

1.97

mmol/l

1.18

280

2176

Hypertension, portal

4.94

8.17

4.3

3.1

1.05

0.91

mmol/l

0.05

Algoneurodystrophy

470

1.99

8.15

3.3

3.1

1.78

1.58

mmol/l

0.23

345

Other arterial embolism and thrombosis

100

543

1.93

8.15

4.5

3.6

2.18

2.01

mmol/l

0.18

398

Benign neoplasm: Skin, unspecified

117

665

1.82

8.15

4.6

3.4

1.29

1.85

mmol/l

0.90

485

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

323

2.24

8.14

5.2

4.4

3.03

1.81

mmol/l

1.81

241

Complex cardiac defects

254

2.62

8.13

17.3

9.1

1.08

1.18

mmol/l

0.10

190

Other specified/unspecified dorsopathies

102

556

1.90

8.11

3.7

3.4

2.18

2.06

mmol/l

0.14

416

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

357

2.17

8.11

5.5

5.4

1.86

1.77

mmol/l

0.07

264

Benign leiomyoma with endometriosis

381

2799

1.38

8.10

3.7

3.3

2.17

2.13

mmol/l

0.06

295

2167

Dental caries 2, only avohilmo

2130

14736

1.15

8.07

3.5

3.7

1.10

1.59

mmol/l

9.13

1561

10733

Acne

238

1605

1.51

8.07

4.2

3.5

1.21

1.18

mmol/l

0.04

162

1143

Lactose intolerance, other/unspecified

473

1.98

8.06

4.6

3.4

1.94

1.89

mmol/l

0.05

360

Other and unspecified injuries of head

185

1189

1.60

8.03

4.2

4.3

2.04

1.69

mmol/l

0.58

133

867

Systemic sclerosis, icd10

391

2.09

8.03

5.8

3.2

1.75

1.87

mmol/l

0.11

300

Sequelae of infectious and parasitic diseases

213

1410

1.55

8.02

3.6

3.4

1.88

1.69

mmol/l

0.28

160

1047

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

360

2630

1.40

8.00

3.1

3.5

2.08

1.83

mmol/l

0.55

254

1918

Hypertrophy of breast in women and men

447

3368

1.34

7.99

2.5

3.2

1.68

1.72

mmol/l

0.08

333

2513

Symptoms and signs involving appearance and behaviour

117

3.13

7.98

2.4

2.9

2.10

1.53

mmol/l

0.28

Hypersensitivity pneumonitis due to organic dust

280

2.32

7.95

7.6

3.9

2.34

1.70

mmol/l

0.60

220

Benign neoplasm: Skin of other and unspecified parts of face

316

2263

1.43

7.93

3.9

3.6

1.35

1.89

mmol/l

1.91

213

1663

Other disorders of conjunctiva

407

3036

1.37

7.93

3.9

3.7

1.61

1.84

mmol/l

0.61

295

2249

Hallux rigidus

373

2742

1.38

7.92

2.7

3.4

1.79

1.92

mmol/l

0.26

285

2065

Failed induction of labour

104

572

1.86

7.92

2.0

2.5

-0.07

0.97

mmol/l

1.86

377

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

212

2.54

7.88

3.6

4.9

2.09

2.16

mmol/l

0.04

151

Suggestive for eosinophilic asthma

253

1742

1.49

7.88

3.7

3.5

1.61

1.75

mmol/l

0.29

194

1282

Other lesions of median nerve

499

1.95

7.87

3.8

3.4

1.39

2.00

mmol/l

0.74

378

Trichomoniasis

124

3.08

7.86

3.7

3.1

2.15

1.78

mmol/l

0.23

Thyrotoxicosis with diffuse goitre

321

2303

1.42

7.86

2.9

3.4

2.12

1.86

mmol/l

0.50

234

1713

Polycythaemia vera

109

615

1.85

7.85

4.3

3.4

2.40

1.91

mmol/l

0.51

452

Hypotension due to drugs

257

2.39

7.82

3.6

4.2

1.05

1.72

mmol/l

0.39

200

Other and unspecified acquired haemolytic anaemias

171

2.75

7.81

4.2

3.0

1.69

1.80

mmol/l

0.05

127

Ulcerative colitis (strict definition, require KELA)

431

3245

1.35

7.79

4.8

3.6

1.38

1.55

mmol/l

0.49

315

2397

Dystonia

155

962

1.66

7.79

3.5

1.83

1.81

mmol/l

0.03

128

714

Other coagulation defects

198

1300

1.56

7.79

5.6

3.7

1.68

1.71

mmol/l

0.04

145

956

Polyarteritis nodosa

114

3.18

7.78

5.6

3.0

1.43

1.44

mmol/l

0.01

Congenital malformations of the musculoskeletal system, not elsewhere classified

270

2.33

7.77

8.8

4.7

1.60

1.29

mmol/l

0.31

193

Acne vulgaris

183

1178

1.58

7.76

3.3

3.7

1.01

1.13

mmol/l

0.17

119

819

Alzheimer’s disease (Late onset), excluding more controls

362

1754

1.40

7.75

2.8

3.5

2.18

1.96

mmol/l

0.46

253

1249

Hypersomnia

238

2.42

7.75

2.9

3.3

1.85

1.74

mmol/l

0.07

175

Malignant neoplasm of prostate

1438

7764

1.18

7.74

3.4

3.9

1.62

1.60

mmol/l

0.06

1021

5677

Dental pulpitis 3

394

2097

1.37

7.71

3.7

5.6

0.99

0.84

mmol/l

0.45

257

1396

Behavioural disorders

404

2.05

7.71

3.3

5.2

1.12

1.28

mmol/l

0.13

288

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

466

3554

1.33

7.70

5.0

3.6

1.38

1.54

mmol/l

0.42

341

2624

Other and unspecified visual disturbances

252

1742

1.48

7.69

4.0

3.8

1.61

1.82

mmol/l

0.38

188

1296

Congenital malformations of pulmonary and tricuspid valves

348

2.31

7.68

17.1

10.5

2.00

0.83

mmol/l

3.52

258

232

1543

1.57

7.68

20.7

9.2

0.81

0.84

mmol/l

0.06

171

1105

Superficial injuries involving multiple body regions

432

2.00

7.67

3.6

3.5

1.97

1.70

mmol/l

0.23

316

Atrophic disorders of skin

345

2519

1.39

7.65

3.1

3.3

2.06

1.97

mmol/l

0.19

253

1903

Reactive arthropathies

230

1562

1.50

7.65

3.4

1.55

1.77

mmol/l

0.40

175

1166

Dislocation, sprain and strain of joints and ligaments of thorax

100

554

1.88

7.63

3.7

3.4

1.82

1.63

mmol/l

0.21

412

Benign neoplasm of other and unspecified female genital organs

107

604

1.83

7.61

3.5

3.3

1.87

1.97

mmol/l

0.08

456

Crowding of teeth, including avohilmo

329

1966

1.41

7.59

9.7

4.9

1.24

1.04

mmol/l

0.66

233

1353

Motorcycle rider injured in other and unspecified transport accidents

157

983

1.64

7.58

3.8

3.4

0.91

1.33

mmol/l

0.69

115

729

Other and unspecified immunodeficiencies with predominantly antibody defects

248

2.39

7.58

15.4

4.1

1.30

1.63

mmol/l

0.24

176

Other disorders of the musculoskeletal system and connective tissue

396

2962

1.36

7.57

4.0

3.6

1.84

1.86

mmol/l

0.05

291

2191

Hypoplasia of dental enamel, prenatal

280

5.29

7.57

52.8

10.1

1.16

1.12

mmol/l

0.04

194

373

2.08

7.55

5.2

3.8

1.27

0.83

mmol/l

0.49

254

Hypermobility syndrome

116

671

1.77

7.52

2.7

3.1

1.78

1.43

mmol/l

0.66

492

Biological medication for rheuma

382

2843

1.36

7.49

3.3

3.6

1.56

1.53

mmol/l

0.05

271

2114

Benign neoplasm: Pituitary gland, craniopharyngeal duct

136

826

1.69

7.45

3.4

3.3

1.70

1.71

mmol/l

0.02

605

Other disorders of the genitourinary system

332

2423

1.40

7.45

3.9

3.6

1.61

2.08

mmol/l

1.54

266

1858

Chondromalacia

501

1.91

7.45

2.7

3.5

1.43

1.65

mmol/l

0.28

378

Left ventricular outflow tract obstruction, narrow definition

203

1362

1.55

7.44

10.7

6.5

2.11

1.26

mmol/l

3.69

159

1011

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

414

3122

1.35

7.43

4.8

3.6

1.36

1.54

mmol/l

0.51

304

2307

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

106

603

1.83

7.43

5.5

3.3

0.81

1.75

mmol/l

1.54

440

Any dementia, excluding more controls

1057

6137

1.21

7.42

3.2

3.6

2.12

1.93

mmol/l

0.81

753

4503

Dependent personality disorder

307

2.18

7.42

3.1

2.25

1.97

mmol/l

0.20

231

Respiratory and cardiovascular disorders specific to the perinatal period

244

1549

1.55

7.41

16.9

9.4

1.06

0.78

mmol/l

0.76

180

1117

Triptan medication for migraine, single purchase ok

2030

12072

1.14

7.41

2.8

3.4

1.30

1.66

mmol/l

5.40

1463

8889

Migraine, single triptan purchase ok & required. ICD-code if available is included

2030

12072

1.14

7.41

2.8

3.4

1.30

1.66

mmol/l

5.40

1463

8889

TMD related operations

388

2899

1.36

7.41

3.3

1.95

1.60

mmol/l

1.58

283

2165

Collapsed vertebra, not elsewhere classified

106

3.17

7.40

3.0

3.9

1.37

2.50

mmol/l

0.64

Benign neoplasm of mouth and pharynx

288

2055

1.43

7.39

4.0

3.4

1.67

1.77

mmol/l

0.19

216

1510

151

2.77

7.39

4.2

3.5

1.55

0.97

mmol/l

0.61

109

Acute appendicitis

1974

16382

1.14

7.38

3.4

3.3

1.63

1.60

mmol/l

0.18

1454

11981

Cardiomyopathy, Hypertrophic obstructive

295

2.21

7.37

5.6

3.2

1.81

1.35

mmol/l

0.63

221

Diseases of tongue

172

1109

1.59

7.37

4.2

3.5

1.45

2.13

mmol/l

1.40

129

825

Hodgkin lymphoma

474

1.93

7.36

4.2

3.2

2.39

1.74

mmol/l

0.88

346

Benign lipomatous neoplasm

813

6666

1.23

7.36

3.4

1.83

1.79

mmol/l

0.12

607

4972

Benign neoplasm: Cerebral meninges

226

1544

1.50

7.35

3.7

3.3

1.97

1.99

mmol/l

0.03

159

1149

Toxic effect of ethanol

116

678

1.76

7.34

5.3

3.5

1.51

1.54

mmol/l

0.03

502

Ocular pain

213

1440

1.51

7.30

3.4

3.8

1.65

1.67

mmol/l

0.04

146

1070

Disorders of purine and pyrimidine metabolism

3.34

7.28

5.5

3.2

2.35

1.82

mmol/l

0.20

Voice disturbances

697

5629

1.25

7.28

3.8

3.5

1.76

1.78

mmol/l

0.04

538

4172

Sequelae of intentional self-harm, assault and events of undetermined intent

3.35

7.28

5.2

4.1

2.32

1.26

mmol/l

0.81

Specific developmental disorder of motor function

143

894

1.74

7.27

17.2

8.0

0.44

0.97

mmol/l

1.46

106

641

Other noninflammatory disorders of cervix uteri

121

717

1.73

7.26

4.7

3.3

1.86

2.36

mmol/l

0.99

559

Pulmonary eosinophilia, not elsewhere classified

208

2.47

7.22

4.3

2.8

1.60

1.85

mmol/l

0.18

152

Covid-19 suspected case

494

3831

1.30

7.21

7.0

3.5

1.87

1.39

mmol/l

2.11

381

2740

Unspecified jaundice

158

1007

1.62

7.18

5.8

3.6

1.69

1.74

mmol/l

0.05

117

726

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

171

2.62

7.18

4.4

3.3

2.48

1.92

mmol/l

0.44

127

Single spontaneous delivery

713

4695

0.80

7.18

2.9

3.5

2.05

1.90

mmol/l

0.49

525

3527

Other and unspecified types of non-Hodgkin lymphoma, hilmo

138

854

1.68

7.15

4.3

3.8

2.32

1.88

mmol/l

0.73

107

651

Renal agenesis and other reduction defects of kidney

152

2.92

7.12

7.8

9.6

0.25

1.36

mmol/l

1.29

109

Polycystic ovarian syndrome, broad definition

182

1192

1.55

7.12

2.3

2.5

1.03

0.97

mmol/l

0.10

118

776

Thiamine deficiency

3.35

7.11

2.9

3.1

-0.28

1.87

mmol/l

1.94

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

4.56

7.10

5.7

3.5

0.99

2.73

mmol/l

0.96

Antenatal screening

246

1981

0.69

7.09

2.1

2.7

1.07

1.26

mmol/l

0.40

158

1392

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

989

5383

1.21

7.08

2.8

3.0

2.23

1.98

mmol/l

1.21

777

4039

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

989

5383

1.21

7.08

2.8

3.0

2.23

1.98

mmol/l

1.21

777

4039

Endocrine disorders, other/unspecified

320

2.13

7.07

3.7

3.3

2.42

1.87

mmol/l

0.43

249

Viral encephalitis, not elsewhere classified/unspecified

390

2.03

7.07

4.6

4.1

1.73

1.57

mmol/l

0.16

296

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

327

2401

1.38

7.06

3.6

3.2

1.97

1.73

mmol/l

0.52

238

1769

Hyperfunction of pituitary gland

129

784

1.69

7.06

4.9

3.4

1.51

1.64

mmol/l

0.17

583

Shock, not elsewhere classified

143

2.78

7.05

6.5

3.5

0.47

1.63

mmol/l

0.69

113

Congenital malformations of gallbladder, bile ducts and liver

321

2.24

7.05

23.0

7.8

0.96

1.37

mmol/l

0.81

235

Haemolytic-uraemic syndrome

4.00

7.04

23.2

6.6

1.05

1.39

mmol/l

0.17

Other epidermal thickening

136

841

1.67

7.04

5.8

3.6

1.50

1.89

mmol/l

0.63

101

612

Alcoholic gastritis

275

2.24

7.03

5.6

3.9

2.44

1.78

mmol/l

0.73

197

Pyoderma

370

2.05

7.01

7.8

5.1

2.24

1.63

mmol/l

0.55

281

Gestational diabetes (for exclusion)

613

3443

1.27

7.00

2.0

2.6

0.87

1.23

mmol/l

1.89

397

2395

Other salmonella infections

106

614

1.78

6.96

4.3

3.4

1.64

1.84

mmol/l

0.23

453

Other localized connective tissue disorders

295

2.17

6.96

4.7

2.9

1.77

2.06

mmol/l

0.22

224

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

287

2071

1.42

6.96

3.1

3.6

2.06

1.84

mmol/l

0.40

207

1490

Eustachian salpingitis and obstruction

184

1218

1.54

6.95

3.3

2.8

1.10

1.53

mmol/l

1.05

143

885

Reactive arthropathies, FINNGEN

180

1188

1.55

6.93

3.6

3.4

1.43

1.72

mmol/l

0.53

135

868

Neovascular glaucoma

132

814

1.68

6.92

4.8

3.8

0.97

1.82

mmol/l

1.07

600

Benign neoplasm: Skin of ear and external auricular canal

116

691

1.74

6.92

3.2

3.3

1.96

1.76

mmol/l

0.21

495

Sacroiliitis, not elsewhere classified

104

598

1.78

6.92

2.7

3.0

1.23

1.75

mmol/l

0.83

439

Benign neoplasm of eye and adnexa

255

1804

1.44

6.91

3.3

3.7

1.50

1.83

mmol/l

0.67

175

1317

Narcolepsy and cataplexy

3.43

6.89

4.2

3.9

1.66

2.29

mmol/l

0.42

Hypersplenism

3.77

6.89

6.1

3.5

1.29

1.48

mmol/l

0.09

Fibrosis of liver

117

3.03

6.89

7.1

3.0

1.05

1.63

mmol/l

0.19

Delivery

727

4726

0.81

6.89

2.9

3.5

2.01

1.89

mmol/l

0.37

532

3550

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

245

2.32

6.89

7.4

3.5

2.25

1.98

mmol/l

0.22

182

Other injuries of upper limb, level unspecified

194

2.50

6.88

4.0

4.2

1.60

1.25

mmol/l

0.27

143

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

144

903

1.62

6.87

3.2

2.4

1.23

1.36

mmol/l

0.14

100

641

Other congenital malformations of urinary system

155

2.85

6.85

26.0

5.6

1.21

1.28

mmol/l

0.04

105

Retinal haemorrhage

444

1.94

6.84

4.0

3.8

1.44

2.09

mmol/l

0.98

335

Lesion of lateral popliteal nerve

142

893

1.64

6.84

3.6

3.4

2.00

1.79

mmol/l

0.29

102

663

Localized skin eruption due to drugs and medicaments

188

2.51

6.84

3.4

3.5

1.53

1.23

mmol/l

0.22

139

Dronedarone medication

494

1.88

6.82

3.8

2.8

1.76

1.52

mmol/l

0.21

353

Osteopathy in diseases classified elsewhere

112

3.04

6.79

7.6

6.3

2.25

2.11

mmol/l

0.06

Hypothermia

340

2.08

6.79

3.2

3.7

1.42

1.84

mmol/l

0.26

254

Memory loss

127

2021

0.61

6.78

3.5

3.6

1.57

2.02

mmol/l

0.79

1485

Assault by blunt object

213

2.38

6.78

2.8

3.6

2.22

1.20

mmol/l

1.25

154

Deep bite

387

2566

1.35

6.77

8.4

5.1

1.30

1.31

mmol/l

0.04

274

1849

Basal cell carcinoma, including avohilmo

1786

12363

1.15

6.76

3.7

3.6

1.66

1.92

mmol/l

2.26

1320

9222

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

276

1990

1.42

6.74

3.1

3.5

1.93

1.84

mmol/l

0.15

200

1440

Other congenital malformations of heart

288

2.33

6.74

16.7

9.0

1.60

0.74

mmol/l

2.05

207

Systemic sclerosis,strict definition

129

2.83

6.73

5.2

3.8

1.35

1.65

mmol/l

0.24

Other misadventures during surgical and medical care

383

2.01

6.71

4.1

3.8

2.09

1.81

mmol/l

0.24

291

Open wound of shoulder and upper arm

355

2.04

6.70

3.7

3.8

1.50

1.63

mmol/l

0.09

254

Benign neoplasm of urinary organs

142

899

1.63

6.69

5.0

3.7

1.41

1.95

mmol/l

1.05

107

679

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

3.30

6.68

1.8

1.9

2.26

0.47

mmol/l

0.73

Foreign body in alimentary tract

179

1195

1.54

6.67

3.4

5.1

1.32

1.62

mmol/l

0.40

128

878

Congenital malformations of the nervous system

107

636

1.78

6.65

14.7

7.6

1.15

mmol/l

0.00

456

Astigmatism

225

1572

1.47

6.65

9.5

5.5

1.64

1.41

mmol/l

0.41

160

1145

Congenital malformations of aortic and mitral valves

160

1047

1.59

6.63

11.2

5.6

2.25

1.28

mmol/l

3.47

123

759

Complications associated with artificial fertilization

140

2.65

6.63

2.1

2.3

-0.26

1.29

mmol/l

2.41

Basal cell carcinoma

1743

12207

1.15

6.63

3.7

3.6

1.65

1.92

mmol/l

2.26

1288

9107

Juvenile rheumatoid arthirtis

300

2.11

6.61

3.8

3.9

1.74

1.52

mmol/l

0.18

213

Other proliferative retinopathy

3.64

6.59

3.7

3.1

1.64

1.94

mmol/l

0.14

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

178

2.49

6.59

4.1

3.1

1.65

2.25

mmol/l

0.41

137

Panniculitis, unspecified

148

2.66

6.59

4.2

3.3

1.74

1.93

mmol/l

0.11

111

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

162

2.65

6.56

5.3

3.7

1.14

2.17

mmol/l

0.87

117

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS